Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b) (a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.29
Appears in 2 contracts
Samples: Asset Purchase Agreement (BOVIE MEDICAL Corp), Asset Purchase Agreement (BOVIE MEDICAL Corp)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cAdjusted Purchase Price 2.9(d) Acquisition Proposal 5.17(j)(iAgreed Rate 2.9(e) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(dAllocation Schedule 2.10 Amendment to the Articles of Association 2.7(a)(iii) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a3.5(a) Business Recitals Business Intellectual Property 2.1(c) Business Permits 2.1(g) Buyer Preamble Buyer Employees 5.3(a)(ii) Indemnified Parties 8.2 Buyer Expenses 8.4(cSavings Plan 5.6(d) Buyer Welfare Benefit Plans 5.7(e5.6(e)(i) CERCLA 3.17(d)(iiCertidão Negativa perante o INSS 2.7(a)(iv) Claim Notice 7.4(aCertificado de Regularidade perante o FGTS 2.7(A)(v) Certidão Conjunta de Débitos Relativos a Tributos Federais e à Dívida Ativa da União 2.7(a)(vi) Certidão Negative de Débitos da Receita Estadual 27(A)(vii) Closing 2.6 Closing Date 2.6 Closing Date Amount 2.7(b) COBRA Coverage 5.6(e)(i) Confidentiality Agreement 5.7 Contracts 2.1(a) Disclosure Schedules Article III EMS Brazil Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d3.5(b) Code 1.1 Competing Business 5.3(a)(iEMS Brazil Contracts 3.16(a) Confidential Information 5.8(bEMS Brazil Financial Statements 3.5(b) Copyrights 1.1 Customer 5.3(a)(iiiEMS Brazil Receivables 3.17 EMS Brazil Unaudited Balance Sheet 3.5(b) Debt Financing 5.21(aEMS Permits 3.7(c) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 Fundamental Representations 8.1 HSR Act 3.3(b3.36b) Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(a2.9(c) Initial Allocation 2.1 Interim Financial Statements 3.5(aInventory 2.1(f) Intervening Event 5.17(j)(iiiLandlord Estoppels 5.8(e) Intervening Event Change Leased Real Property 3.12 Losses 8.2 Material Contracts 3.16(a) Names 5.9 Notice of Recommendation 5.17(d)(iiDisagreement 2.9(b) Licensed Excluded Owned Business Patents 3.13(a) Owned Business Registered Copyrights 3.13(a) Owned Business Registered IP 3.13(h3.13(a) Losses 7.2 Owned Business Registered Marks 1.1 Notice 3.13(a) Party Preamble Permits 3.7(b) Pre-Closing Tax Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a6.1(b) Post-Closing Claims 5.13(aTax Period 6.1(b) Pre-Closing Contract Liabilities 2.4(fProduct Authorizations 3.3(b) Privacy Laws 3.26(aProduct Warranties Notice of Disagreement 5.17(a) Proxy Statement 3.29Product Warranty Costs Schedule 5.17(a) Quotas 2.1(j) Real Property 2.1(b) Receivables 2.1(d) Representatives 5.2(a) Required Consents 5.8(a) Royalty Payment 5.15(a) Royalty Period 5.15(a) Seller Preamble Seller Indemnified Parties 8.3 Tangible Personal Property 2.1(e) Target Amount 5.15(a) Target SelectaCell Payment 5.15(a) Termination Date 9.1(d) Third Party Claim 8.4(a) Transfer Taxes 6.1(a) Transferred Assets 2.1 Transferred Employees 5.6(a) WARN Act 3.23
Appears in 2 contracts
Samples: Asset Purchase Agreement (Ems Technologies Inc), Asset Purchase Agreement (Andrew Corp)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cAcquiror Preamble Acquiror Indemnified Parties 9.2(a) Acquisition Proposal 5.17(j)(iAffected Employees 5.7(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAntitrust Laws 5.9(b) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b3.6(a) Balance Sheet Date 3.6(a) Bylaws 2.4 Cap 9.3(a) Cash-Through Amount 2.2(a) Certificate of Incorporation 2.4 Certificate of Merger 2.2(b) Certificates 2.10(d) Claim Notice 9.5(a) Closing 2.2(a) Closing Balance Sheet 2.14(c) Closing Date 2.2(a) Closing Estimate 2.14(a) Closing Working Capital 2.14(b) Company Preamble Company Fundamental Representations 9.1 Confidentiality Agreement 5.8 D&O Indemnified Liabilities 5.12(a) D&O Indemnified Parties 5.12(a) Damages 9.2(a) Debt Commitment Letter 4.5 Debt Financing 4.5 Deductible 9.3(a) Delivery Date 2.14(c) DGCL Recitals Disclosure Schedules Article III Dispute 2.15(a) Dispute Notice 9.5(b), 2.15(a) Dispute Period 2.15(a) Disputed Return 6.4 Dissenting Shares 2.8 Effective Time 2.2(b) Employee Plans 3.10(a) Environmental Laws 3.16(b) Environmental Permits 3.16(b) Equity Commitment Letter 4.5 ERISA 3.10(a) Escrow Agent 7.1(c) Estimated Closing Working Capital 2.14(a) Expiration Date 9.1 Financial Statements 3.6(a) Hazardous Substances 3.16(b) Indemnified Party 9.5(a) Indemnitor 9.5(a) Indemnity Escrow Agreement 7.1(c) J.A.M.S. Rules 10.18(a) Letter of Transmittal 2.10(d) Majority Holders 2.13(b)
(a) Business Merger Recitals Buyer Non-US Plans 3.10(f) Party 5.9(c) Paying Agent 2.10(a) Payment Fund 2.10(a) Permits 3.8(b) Registered Intellectual Property 3.14(a) Related Persons 3.18 Representatives 5.2(a) Securities Act 3.5 Seller Indemnified Parties 9.2(b) Stockholder 2.10(a) Stockholder Representative 2.13(a) Straddle Period 6.2(d) Sub Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Surviving Corporation 2.1 Target Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(iTax Claim 6.3(a) Confidential Information 5.8(bTerminating Option Bonus Amount 2.9 Termination Date 8.1(d) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change Termination Fee 8.3 Xxxxxxx Letter of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.29Credit 1.1
Appears in 2 contracts
Samples: Agreement and Plan of Merger (STR Holdings (New) LLC), Agreement and Plan of Merger (STR Holdings LLC)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c2020 Business Statements 3.5(a) Acquisition Proposal 5.17(j)(i5.10(b)(i) Affiliate Agreements 5.16 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAllocation Dispute Notice 6.1(a) Allocation Exhibit 6.1(a) Alternative Financing 5.21(bRecovery 8.5(a)(v) Applicable Date 3.6(dArbiter 6.1(a) Assumed Contracts 2.1(a) Assumed Leases 2.1(b) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(aAssumed Warranties 2.3(e) Automatic Transferred Employees 5.5(a) Basket Amount 8.5(a)(i) Business Recitals Employee Severance Agreement 5.5(a) Business Information Systems 3.13(h) Business Statements 3.5(a) Buyer Preamble Buyer Employees 5.3(a)(ii) Indemnified Parties 8.2 Buyer Expenses 8.4(cParty Recitals Buyer Savings Plan 5.5(f) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(iiBenefit Plan 5.5(g)(i) Claim Notice 7.4(aInformation 8.4(a) Closing 2.6 Closing Balance Sheet 2.7 2.7(a) Closing Date 2.6 2.7(a) COBRA 5.7(d2.4(g) Code 1.1 COBRA Obligations 5.5(g)(ii) Competing Acquiror 5.10(c) Competing Acquisition 5.10(c) Competing Business 5.3(a)(i5.10(a) Confidential Information 5.8(b5.6(e) Copyrights 1.1 Confidentiality Agreement 5.6(a) Contract Disclosure Update 2.5(c) Contributor 3.13(f) Customer 5.3(a)(iiiNotification Letter 5.19 Customer Standard Forms 3.16(a)(i) Debt Financing 5.21(aDe Minimis Business 5.10(b)(i) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DDisclosure Schedules ARTICLE III Discussion Period 6.1(a) DGCL 4.6 Direct Claim 7.4(cDLA Piper 2.2(n) Effect 1.1 Electronic Intellectual Property Assets 2.8 Employment Agreements Recitals Employment Practices 3.10(b) Environmental Laws 3.17(d)(i3.15(b)(i) Equity Financing 5.21(aEnvironmental Permits 3.15(b)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Contracts 2.2(g) Excluded Intellectual Property 2.2(c2.2(i) Excluded Liabilities 2.4 Existing Stock 5.14(bExcluded Patents 2.2(h) Fairness Opinion 3.2(bExcluded Technology 2.2(j) FDA 1.1 Financial Statements 3.5(aExploitation 5.10(c) Financing 5.21(aFinal Allocation 6.1(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aForm 8594 6.1(b) Group Health Plan 5.7(dFundamental Representations 8.1(a) Hazardous Substances 3.17(d)(iiIllegal Activities 3.7(c) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bIndemnification Ancillary Agreements 8.1(a) Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a8.4(a) Initial Allocation 2.1 Press Release 5.14 Interim Financial Statements 3.5(aContract 2.5(c) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hInventory 2.1(g) Losses 7.2 Marks 1.1 Notice 8.2 Material Contracts 3.16(a) Maximum Benefit Period 5.17(d)(i)(D5.5(a) Outside Date 8.1(b)(iNon-Automatic Transferred Employees 5.5(a) Patents 1.1 Personal Information 3.26(aNon-Competing Products 5.10(c) PostNon-Closing Claims 5.13(aOffered Severance and Acceleration Payments 5.5(b) Non-Solicitation Period 5.9(a) OFAC 3.7(e) Permits 3.7(b) Pre-Closing Contract IP Infringement 2.3(g) Preliminary Inventory 2.1(g) Proposed Allocation 6.1(a) Rebates 5.18(b) Related Person 3.20 Release Documentation 5.22(a) Relevant Excluded Contracts 5.12(a) Relevant Licensors 5.12(a) Required Amounts 4.4(b) Required Filing 5.7(a) Required Financial Information 5.22(a) Restricted Benefits 3.7(c) Restricted Employees 5.9(a) Restricted Entities 5.10(a) Restriction Period 5.10(a) Retained Business 5.8(f) Sanctioned Countries 3.7(d) Security Breach 3.13(h) Seller Preamble Seller Employee 5.9(b) Seller Indemnified Parties 8.3 Seller Party Recitals Seller Savings Plan 5.5(f) Severance and Acceleration Payment Amount 2.6 Severance and Acceleration Payments 5.5(b) Shared Contracts 5.8(f) Shared Contractual Liabilities 2.4(f5.8(h) Privacy Laws 3.26(aSignificant Customer 3.17(a) Proxy Statement 3.29Significant Supplier 3.17(a) Singapore Transfer Taxes 6.4 Specified Claim 8.4(d) Termination Date 9.1(c) Third Party Claim 8.4(a) Third-Party Claim Assumption Notice 8.4(b) Total Compensation Opportunities 5.5(a) Trade Licenses 3.7(d) Transferred Assets 2.1 Transferred Employees 5.5(a) Transferred Intellectual Property 2.1(d) Transferred Patents 2.1(c) Transferred Personal Property 2.1(f) Transferred Technology 2.1(e) U.S. Transferred Employees 5.5(f) WARN Act 3.10(c)
Appears in 2 contracts
Samples: Asset Purchase Agreement (Silicon Laboratories Inc.), Asset Purchase Agreement (Skyworks Solutions, Inc.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) Definition Location Additional Cash Consideration 2.3 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a3.7(b) Business Recitals Basket 7.5(a) Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(iiCash Consideration 2.1(a) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 2.2(a) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing 3.11(b) Company Preamble Company Group Employees 5.1(a)(ii) Company Registered Intellectual Property Rights 3.15(a) Company Source Code 3.15(s) Company Unregistered Intellectual Property Rights 3.15(c) Competitive Business 5.3(a)(i5.1(a)(i) Confidential Information 5.8(b5.5(a) Copyrights 1.1 Consultants 3.12(f) Contest 6.6(a) Customer 5.3(a)(iii5.1(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(iDisclosure Schedules Article III Disqualification Event 3.23(i) Equity Financing 5.21(aERISA 3.11(a)(i) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cEvaluation Date 4.10 Exchange Act 4.6(a)
(a) Excluded Liabilities 2.4 Existing Stock 5.14(bFundamental Representations 7.1(a)(i) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bGeneral Cap 7.5(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Issuance Limit 5.8 License Preamble Losses 7.2 Marks 1.1 Material Contracts 3.18(a) NIAID Preamble Permits 3.9(b) Permitted Encumbrances 3.13(a) Plans 3.11(a)(ii) PTO 3.15(a) Purchase Price 2.1 Purchase Price Allocation 6.8 Registration Statement 5.7(a) Restricted Period 5.1(a) SEC Documents 4.6(a) Securities Act 4.5 Seller Preamble Set-off Amount 7.8 Set-off Notice Period 5.17(d)(i)(D7.8 Share Consideration 2.1(c) Outside Date 8.1(b)(iShares Preamble Tax Consideration 6.8 Territory 5.1(a)(i) Patents 1.1 Personal Information 3.26(aThird Party Claim 7.4(a) Post-Closing Claims 5.13(aValid Business Reason 5.7(c) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.29Warrant Shares 2.1(d)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cDefinition Location 401(k) Acquisition Proposal 5.17(j)(i) Plan 3.23 Acquiror Preamble Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EArticles of Merger 2.2(b) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(eCancelled Shares 2.7(b) CERCLA 3.17(d)(ii3.16(e)(iii) Claim Notice 7.4(aCertificates 2.8(a) Closing 2.6 2.2(a) Closing Balance Sheet 2.7 2.11(a) Closing Company Debt 2.11(a) Closing Date 2.6 COBRA 5.7(d2.2(a) Closing Net Working Capital 2.11(a) Code 1.1 Competing Business 5.3(a)(i3.10(b) Confidential Information 5.8(bCompany Preamble Company Common Stock Recitals Company Registered IP 3.14(e) Copyrights 1.1 Customer 5.3(a)(iiiCore Representations 7.1(a) Debt Financing 5.21(aDefinition Location Disclosure Schedules Article III Earn-Out Amount 2.12(d) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DEarn-Out Statement 2.12(a) DGCL 4.6 Direct Claim 7.4(cEffective Time 2.2(b) Effect 1.1 Environmental Laws 3.17(d)(i3.16(e)(i) Equity Financing 5.21(aEnvironmental Permits 3.16(e)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cERISA 3.10(a)(i) Excluded Liabilities 2.4 Existing Stock 5.14(bEstimated Company Debt 2.10(a) Fairness Opinion 3.2(bEstimated Net Working Capital 2.10(a) FDA 1.1 Estimated Transaction Expenses 2.10(a) Final Closing Statement 2.11(a) Financial Statements 3.5(a3.6(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Florida Law Recitals Hazardous Substances 3.17(d)(ii3.16(e)(iii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a2.11(c) Initial Allocation 2.1 Interim Financial Statements 3.5(a2.10(b) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hIRS 3.10(b) Losses 7.2 Marks 1.1 Majority Holders 2.14(b) Material Contracts 3.17(a) Merger Recitals Multiemployer Plan 3.10(c) Multiple Employer Plan 3.10(c) Net Adjustment Amount 2.11(d)(i) Notice Period 5.17(d)(i)(Dof Disagreement 2.11(b) Outside Date 8.1(b)(iNotice of Earn-Out Disagreement 2.12(b) Patents 1.1 Personal Information 3.26(aPermits 3.8(b) Post-Permitted Encumbrances 3.12(a) Plans 3.10(a) Preliminary Closing Claims 5.13(aBalance Sheet 2.10(a) Pre-Preliminary Closing Contract Liabilities 2.4(fStatement 2.10(a) Privacy Laws 3.26(aRelease 3.16(e)(iv) Proxy Statement 3.29Shares 2.7 Stockholder Representative 2.14(a) Sub Preamble Surviving Corporation 2.1 Third Party Claim 7.4(a) Transaction Expenses Payoff Instructions 6.3(f)
Appears in 1 contract
Samples: Merger Agreement (Dole Food Co Inc)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cDefinition Location 409A 3.10(n) 8-K 5.2 Acquiror Preamble Acquiror Indemnification Claim 8.4(a) Acquiror Indemnified Parties 8.2 Acquisition Proposal 5.17(j)(i5.2 Additional Transaction Expenses 2.9(g) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAlternate Audit 5.2 Alternate Auditor 5.2 Alternate Auditor Expenses 10.1(b) Alternative Financing 5.21(bAntitrust Authority 5.6(a) Applicable Date 3.6(dAntitrust Filings 5.6(a) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(eAudited Financial Statements 3.6(a) CERCLA 3.17(d)(ii1.1 Certificate of Merger 2.2(b) Claim Notice 7.4(aCertificates 2.9(c) Class A Common Stock Recitals Class B Common Stock Recitals Closing 2.2(a) Closing 2.6 Date 2.2(a) Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(dSchedules 2.9(g) Code 1.1 Competing Business 5.3(a)(i3.10(b) Confidential Information 5.8(bCompany Preamble Company 401(a) Plan 3.10(o) Company Common Stock Recitals Company Indemnified Parties 8.3 Company IP 3.14(a) Confidentiality Agreement 5.5 Contractors 3.22 Copyrights 1.1 Customer 5.3(a)(iiiCounsel 5.12 Delaware Law Recitals Disclosure Schedules Article III Dissenting Shares 2.8 Divestiture 5.6(d) Debt Financing 5.21(aDOJ 5.6(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DEffective Time 2.2(b) DGCL 4.6 Direct Claim 7.4(cERISA 3.10(a)(i) Effect 1.1 Environmental Laws 3.17(d)(iEstimated Net Working Capital Amount 2.9(g) Equity Financing 5.21(aEstimated Net Working Capital Deficit 2.9(g) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cEstimated Net Working Capital Surplus 2.9(g) Excluded Liabilities 2.4 Existing Stock 5.14(bExpiration Time 5.10 Definition Location Final Net Working Capital Amount 2.9(h) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a3.6(a) Financing 5.21(aFTC 5.6(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aFundamental and Tax Losses 8.4(b) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 Fundamental Representations and Tax Matters Expiration Date 8.1 General Expiration Date 8.1 GT 5.2 GT Confirmation 5.2 Historical Financials 5.2 HSR Act 3.3(b) Inbound License Agreements 3.14(e) Indemnified Party 7.4(a8.5(a) Indemnifying Party 7.4(a8.5(a) Independent Accounting Firm 2.8(aAccountants 2.9(h) Initial Allocation 2.1 Interim Financial Statements 3.5(aIRS 3.10(b) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hLegal Privilege 5.6(b) Losses 7.2 8.2 Marks 1.1 Notice Period 5.17(d)(i)(DMaterial Contracts 3.17(a) Material Supplier 3.23(b) Merger Recitals Multiemployer Plan 3.10(c) Multiple Employer Plan 3.10(c) Net Working Capital Amount Schedule 2.9(g) Net Working Capital Target Noncompetition Agreements Recitals Non-Solicitation Agreements 7.3(g) Officer’s Certificate 8.4(c) Open Source License 3.14(g) Option Payment 2.7(e) Outbound License Agreements 3.14(e) Outside Date 8.1(b)(i9.1(c) Patents 1.1 Personal Information 3.26(aPayment Agent 2.9(c) Post-Closing Claims 5.13(aPermits 3.8(b) Permitted Encumbrances 3.12(a) Plans 3.10(a)(iv) Pre-Closing Contract Liabilities 2.4(fStraddle Amount 6.2 Pre-Closing Tax Return 6.3 Principal Stockholders 7.3(g) Privacy Laws 3.26(aPro Rata Share 2.11(b) Proxy Statement 3.29Reduced Tax Liability 6.4 Representatives 5.10 Schedule of Expenses 2.9(g) Second Request 5.6(b) Definition Location Shares 2.7 Significant Stockholder-Employees 1.1 Stockholder Representative 2.11(a) Stockholders Agreement Recitals Straddle Period 6.2 Sub Preamble Surviving Corporation 2.1 Systems 3.14(i) Tax Benefit 8.6(b) Tax Cost 8.6(b) Third Party Claim 8.5(a) Trade Secrets 1.1 Unaudited Financial Statements 3.6(a) Voting Agreements Recitals
Appears in 1 contract
Samples: Merger Agreement (Infospace Inc)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cAcceleration Event 2.7(e)(ii) Acquisition Engagement 9.19(a) Acquisition Proposal 5.17(j)(i5.3(c) Actual Cash Royalty Revenue 2.7(a)(v) Actual Cash Royalty Revenue Calculation 2.7(c)(i) Affected Employees 5.11(a) Agreement Preamble Alternative Acquisition Recovery 8.5(b) Assigned Consulting Agreements 5.19(c) Business Recitals Business Registered IP 3.15(a) Buyer Preamble Buyer Basket 8.5(a)(ii) Buyer Basket Tipping Point 8.5(a)(ii) Buyer Cap 8.5(a)(iii) Buyer Losses 8.1 Buyer Mini Basket 8.5(a)(i) Buyer Severance Payment 1.1 Calculation Period 2.7(a)(i) Calculation Period 1 2.7(a)(ii) Calculation Period 2 2.7(a)(iii) Calculation Period 3 2.7(a)(iv) Closing 2.4(a) Closing Aggregate Deferred Revenue 2.6(a) Closing Cash 2.6(a) Closing Date 2.4(a) Closing Indebtedness 2.6(a) Closing Prepaid Expenses 2.6(a) Closing Transaction Expenses 2.6(a) Company GP Interests Recitals Company LP Interests Recitals Confidentiality Agreement 5.17(a)(ii)(E5.7(a) Alternative Financing 5.21(bContribution Recitals Conversion Recitals Data Handling 3.15(j) Applicable Debt Payee 2.3(b) Disclosure Schedules Article III Earn-Out Payment 2.7(b)(i) Earn-Out Payments 2.7(b)(i) Emeril Termination Election 5.18 Employee Plans 3.11(a) Environmental Laws 3.18(d)(i) Environmental Permits 3.18(d)(ii) ERISA 3.11(a) Estimated Aggregate Deferred Revenue 2.5 Estimated Cash 2.5 Estimated Indebtedness 2.5 Estimated Prepaid Expenses 2.5 Estimated Transaction Expenses 2.5 Final Closing Statement 2.6(a) Final True-Up Amount 2.8(c) Final True-Up Date 3.6(d2.8(c) Assumed Liabilities 2.3 Balance Sheet 3.6(bFinancial Statements 3.7(a)
(a) Business GP Holdco Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 GP Interests Recitals Holdco Recitals HSR Act 3.3(b) Indemnified Party 7.4(a) 1.1 Indemnifying Party 7.4(a8.3(a) Independent Accounting Firm 2.8(a2.6(c) Initial Allocation 2.1 Interim Financial Statements 3.5(aPost-Period 3 True-Up Payment 2.7(d) Intervening Event 5.17(j)(iiiInsurance Policies 3.13 Interests Recitals IT Transition 5.23 Leases 3.14(b) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hLicensee Contracts 3.19(b) Losses 7.2 Marks 8.2 Master Agreement 1.1 Material Contracts 3.19(a) Membership Interests Recitals Net Adjustment Amount 2.6(f)(i) Notice Period 5.17(d)(i)(Dof Disagreement 2.6(b) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(aPermits 3.9(b) Post-Closing Claims 5.13(aPeriod 3 Actual Cash Royalty Revenue 2.7(d) Post-Period 3 Actual Cash Royalty Revenue Calculation 2.7(d) Pre-Closing Contract Liabilities 2.4(fPeriod Fraction 1.1 Preliminary Closing Statement 2.5 Proprietary Information 5.7(b) Privacy Laws 3.26(aReceived Payments 2.7(a)(v) Proxy Statement 3.29Reorganization Recitals Reverse IT Transition 5.23 Second Post-Period 3 True-Up Payment 2.7(d) Seller Preamble Seller Guarantees 5.13 Seller Losses 8.2 Seller Receivables 2.8(a) Seller Retained Employees 5.11(b) Shares Recitals
Appears in 1 contract
Samples: Equity Purchase Agreement (Sequential Brands Group, Inc.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) Definition Location Aggregate Closing Transaction Expenses 2.3 Aggregate Units 2.1 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Allocation 6.9 Alternative Financing 5.21(b5.14(a) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a3.7(b) Business Recitals 5.4(a)(i) Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii3.17(b)(ii) Claim Notice 7.4(a8.4(a) Closing 2.6 Closing Balance Sheet 2.7 2.2(a) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(i3.11(b) Commitment Letter 4.4 Company Recitals Company Group Employees 5.4(a)(ii) Company Released Parties 5.7(a) Confidential Information 5.8(b5.10(b) Confidentiality Agreement 5.10(a) Contribution 3.4(b) Contribution Date 3.4(b) Conversion 3.4(d) Conversion Date 3.4(d) Copyrights 1.1 Customer 5.3(a)(iiiD&O Insurance 5.15(c) Debt Financing 5.21(a5.14(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DPayoff Letter 7.3(j) DGCL 4.6 Designated Representative Preamble Direct Claim 7.4(c8.4(c) Effect 1.1 Disclosure Schedules Article III Due-At-Closing Transaction Expenses 2.3 Environmental Laws 3.17(d)(iLaw 3.17(b)(i) Equity Financing 5.21(aERISA 3.11(a)(i) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a3.7(a) Financing 5.21(aSources 10.19 Fundamental Representations 8.1(a)(i) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aGeneral Cut-Off Date 8.1(a) Group Health Plan 5.7(d) General Indemnity Cap 8.5 Hazardous Substances 3.17(d)(ii3.17(b)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HoldCo Preamble HSR Act 3.3(b) Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Accountant 6.10 Definition Location Intended Tax Treatment 6.8 Interim Financial Statements 3.5(a3.7(a) Intervening Event 5.17(j)(iiiIRS 3.11(b) Intervening Event Change of Recommendation 5.17(d)(iiIT Systems 3.15(i) Licensed Excluded IP 3.13(hLLC Agreement 3.4(d) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DMaterial Contracts 3.18(a) Outside Date 8.1(b)(iMBS Parties Preamble P&P Materials 3.22(e) Patents 1.1 Payoff Indebtedness 2.2(b)(iii) PCI DSS 3.21(e) Permits 3.9(b) Permitted Encumbrances 3.13(a) Personal Information 3.26(a3.21(a) Post-Closing Claims 5.13(aPlans 3.11(a)(ii) Pre-Closing Contract Liabilities 2.4(fActions 5.16 Pre-Closing Transaction Expenses 2.3 Premium Cap 5.15(c) Privacy Laws 3.26(a3.21(a) Proxy Statement 3.29Registered IP 3.15(a) Release 3.17(b)(iii) Released Claims 5.7(a) Released Party 10.12(a) Releasing Parties 5.7(a) Restricted Payment Recovery Amount 5.6(b) S Corporation 3.16(n) Schedule of Expenses 2.3 Subsidiary Conversion 3.4(a) Tax Claim 6.4(a) Third Party Claim 8.4(a) Top Direct Customer 3.22(a) Top Supplier 3.22(c) Top Wholesale Customer 3.22(b) Trade Secrets 1.1 Unitholders Preamble
Appears in 1 contract
Samples: Purchase Agreement (Barnes & Noble Education, Inc.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cAAA 11.9(a) Acquisition Proposal 5.17(j)(i) ADA 3.20 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EBank of America Definition of 555 Mezzanine Debt Agreements Base Purchase Price 2.1 Basket Amount 9.5(b)(i) Alternative Financing 5.21(bBrokerage Commissions Definition of Other Liabilities Buyer Preamble Buyer Adjustment Statement Objection 2.7(b) Applicable Buyer Indemnified Parties 9.2 Casualty Termination Notice 7.1(c) Closing 2.3(a) Closing Date 3.6(d2.3(a) Assumed Liabilities 2.3 Balance Sheet 3.6(b)Continuing Entities 2.5(i) Covered Person 5.10 Deposit 2.2 Employee Plans 3.11(a) Environmental Laws 3.15 Environmental Permits 3.15 Equity Interests 3.6(a) ERISA 3.11(a) ERISA Affiliate 3.11(d) Escrow Agent 2.2 Escrow Fund 2.2 Estoppel Certificate 5.13 Excess Amount 5.16(b) Extell 5.2(b)(i) Financial Statements 3.7(a) Hazardous Substances 3.15 HWA Extell Note 5.2(b)(i) HWA I Tax Returns 6.2 Indemnified Party 9.4(a) Indemnifying Party 9.4(a) Independent Accounting Firm 2.7(c) Insurance Policies 3.12 Lease 3.16(a)(iii) Leases 3.16(a)(iii) Losses 9.2 Major Casualty 7.1(a) Material Contracts 3.16(a) Material Portion 7.1(a) Minimum Loss Amount 9.5(b)(i) Non-Consolidation Opinion 5.8(c) OFAC List 3.17
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiOrganizational Documents 3.1(c) Buyer Expenses 8.4(cOriginal Intercompany Notes 5.2(b)(iii) Buyer Welfare Plans 5.7(ePartnership Intercompany Notes 5.2(b)(iv)(A) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a3.9(b) Post-Closing Claims 5.13(aTax Period 6.3(a) Potential Contributor 9.8 Pre-Closing Contract Tax Period 6.3(a) Properties Recitals Property Recitals Purchase Price 2.1 Rent Rolls 3.19 Restoration Costs 7.1(a) Rules 11.9(a) Securities Act 4.6 Seller Indemnified Parties 9.3 Shares Recitals Straddle Period 6.3(b) Target Recitals Targets Recitals Tenant Improvement Allowances Definition of Other Liabilities 2.4(fTenant's Encumbrance Definition of Permitted Encumbrance Third Party Claim 9.4(a) Privacy Laws 3.26(aTransaction Costs 2.8 Xxxxx Definition of Partner Priority Return Xxxxx Intercompany Notes 5.2(b)(iv)(C) Proxy Statement 3.29Westside II Partnership 5.2(b)(i)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(iAffected Employees 5.8(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EBook-Entry Shares 2.12(d) Alternative Financing 5.21(bBylaws 2.4 Certificate of Incorporation 2.4 Certificate of Merger 2.2(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(aCertificates 2.12(d) Closing 2.6 Closing Balance Sheet 2.7 2.2(a) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(iCompany Preamble Company Board Recitals Company Recommendation Change 5.15(b) Confidential Information 5.8(bCompany Recommendation Change Notice 5.15(b) Copyrights 1.1 Customer 5.3(a)(iiiCompany Registered Intellectual Property 3.14(a) Debt Financing 5.21(aCompany Stockholder Approval 3.2(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DConfidentiality Agreement 5.9 D&O Indemnified Liabilities 5.12(a) D&O Indemnified Parties 5.12(a) DGCL 4.6 Direct Claim 7.4(cRecitals Disclosure Schedules Article III Dissenting Shares 2.8 Effective Time 2.2(b) Effect 1.1 Employee Plans 3.10(a) Environmental Laws 3.17(d)(i3.16(i) Equity Financing 5.21(aEnvironmental Permits 3.16(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cERISA 3.10(a) Excluded Liabilities 2.4 Existing Stock 5.14(bERISA Affiliate 3.10(d) Fairness Opinion 3.2(bForeign Plans 3.10(f) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(aMaterial Contracts 3.17 Material IP Contracts 3.14(e) Indemnifying Party 7.4(aMerger Recitals Merger Sub Preamble Open Source Code 3.14(g) Independent Accounting Firm 2.8(aOption Plans 3.4(b) Initial Allocation 2.1 Interim Financial Statements Parent Preamble Parent Nominee 8.1 Paying Agent 2.12(a) Payment Fund 2.12(a) Policies 3.12 Proxy Statement 3.6 Representatives 5.2(a) Restricted Stock 2.10(a) SEC Reports 3.5(a) Intervening Event 5.17(j)(iiiStockholder 2.12(a) Intervening Event Change of Recommendation 5.17(d)(iiStockholders’ Meeting 5.3(a) Licensed Excluded IP 3.13(hSurviving Corporation 2.1 Termination Date 7.1(b)(i) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.29Termination Fee 7.3 U.S.-Controlled Entity 4.8
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(dAssignment of Intellectual Property 2.7(b)(iii) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(aAssumption Agreement 2.7(b)(ii) Xxxx of Sale 2.7(b)(i) Business Recitals Business Patent 3.13(e) Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e5.8(e) CERCLA 3.17(d)(ii3.16(e)(iii) Claim Notice 7.4(a8.4(a) Closing 2.6 Closing Balance Sheet 2.7 2.7(a) Closing Date 2.6 2.7(a) COBRA 5.7(d5.8(d) Code 1.1 Co-Marketing Agreement 5.17 Commitments 3.13(h) Competing Business 5.3(a)(i5.9(a) Confidential Information 5.8(b5.10(b) Copyrights 1.1 Customer 5.3(a)(iiiConfidentiality Agreement 5.10(a) Debt Financing 5.21(aDesignated Seller Contracts 5.18(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c8.4(c) Effect 1.1 Disclosure Schedules Article III DivX Consumer Business 3.5(c) Dolby Audit 5.16 Environmental Laws 3.17(d)(i3.16(b)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aFundamental Representations 8.1(a)(i) Group Health Plan 5.7(d5.8(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b3.16(b)(ii) Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(aLosses 8.2 Material Contracts 3.17(a) Initial Non-Solicit Period 5.9(b) Permits 3.7(b) Permitted Encumbrances 3.4 Purchase Price 2.6 Purchase Price Allocation 2.9 Purchased Assets 2.1 Interim Financial Statements 3.5(aRelease 3.16(b)(iii) Intervening Event 5.17(j)(iiiScheduled IP 3.13(a) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP Seller Preamble Standards Body 3.13(h) Losses 7.2 Marks 1.1 Notice Straddle Payables 2.3(a) Straddle Payables Period 5.17(d)(i)(D2.3(a) Outside Date 8.1(b)(iTax Claim 6.3(a) Patents 1.1 Personal Information 3.26(aTerminated Subsidiary Employees 5.8(b) PostThird-Closing Claims 5.13(aParty Claim 8.4(a) Pre-Closing Contract Liabilities 2.4(fTransferring Employees 5.8(b) Privacy Laws 3.26(a) Proxy Statement 3.29WARN Act 3.10(f)
Appears in 1 contract
Samples: Purchase Agreement (Neulion, Inc.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) Acquiror Preamble Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EArticles of Merger 2.2(b) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a3.6(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiBankruptcy and Equity Exception 3.2(a) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(eBB&T 3.26 BB&T Fee Amount 3.26 Bid 3.18(a) CERCLA 3.17(d)(ii3.16(f)(iii) Claim Notice 7.4(aCertificates 2.10(c) Closing 2.6 2.2(a) Closing Balance Sheet 2.7 Accounts Payable 3.6(h)(iv) Closing Accounts Receivable 3.6(h)(iii) Closing Cash 3.6(h)(ii) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(iClosing Date Equity Consideration 2.10(h)(ii) Confidential Information 5.8(bClosing Date Merger Consideration 2.10(h)(iii) Copyrights 1.1 Customer 5.3(a)(iiiClosing Date Per Share Merger Consideration 2.10(h)(iv) Debt Financing 5.21(aClosing Working Capital 3.6(h)(v) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DCompany Preamble Company Board Approval 3.2(a) DGCL 4.6 Direct Claim 7.4(cCompany Equity Plans 2.9(a) Effect 1.1 Company Government Contract 3.18(a) Company Government Subcontract 3.18(a) Company Plans 3.10(a) Company Registered IP 3.14(b) Company Stockholder Approval 3.2(a) Company Stockholder Ratification 3.2(b) Core Representations 9.1(a) Disclosure 3.27 Disclosure Schedules Article III Dissenting Holder 2.8 Dissenting Shares 2.8 Effective Time 2.2(b) Environmental Laws 3.17(d)(i3.16(f)(i) Equity Financing 5.21(aEnvironmental Permits 3.16(f)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cERISA 3.10(a) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a3.6(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(dFormer Government Employee 3.18(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b3.16(f)(iii) Indemnified Party 7.4(a9.3(a) Indemnifying Party 7.4(a9.3(a) Independent Accounting Firm 2.8(aInterim Balance Sheet 3.6(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a3.6(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hIRS 3.10(a) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D9.2(a) Outside Date 8.1(b)(iMajority Holders 2.12(c) Patents 1.1 Personal Information 3.26(aMaterial Contracts 3.17(a) Post-Closing Claims 5.13(aMerger Recitals Merger Consideration 2.10(h)(i) Pre-Closing Contract Liabilities 2.4(fMerger Sub Preamble Nonqualified Deferred Compensation Plan 3.10(c) Privacy Laws 3.26(aOption 2.9(a) Proxy Statement 3.29Option Payment Amount 2.10(b) Owned Intellectual Property 3.14(c) Paying Agent 2.10(a) PBGC 3.10(b)(iii) Permits 3.8(b) Permitted Encumbrances 3.12(a) Plan of Merger 2.2(b) Release 3.16(f)(iv) Shares 2.7 Stockholder 2.10(a) Stockholder Loan Repayment Amount 2.10(b) Stockholder Representative 2.12(a) Surviving Corporation 2.1 Target Working Capital 3.6(h)(i) Tax Claim 7.4 Third Party Claim 9.3(a) Virginia Law Recitals VSCA Recitals
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) Definition Location Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
3.6 (a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) Indemnified Parties 9.2 Business Recitals CERCLA 3.17(d)(ii) Definition of Haz. Substances Claim Notice 7.4(a9.5 (a) Closing 2.6 2.4 (a) Closing Balance Sheet 2.7 2.6 (a) Closing Date 2.4 (a) Closing Working Capital 2.6 COBRA 5.7(d(a) Code 1.1 Competing Business 5.3(a)(iClosing Transaction Expenses 2.6 (a) Company Preamble Company Registered IP 3.14 (e) Confidential Information 5.8(b6.5 (b) Confidentiality Agreement 6.5 (a) Contributed Shares Recitals Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Definition of Int. Property Direct Claim 7.4(c9.5 (c) Effect 1.1 Environmental Laws 3.17(d)(iDisclosure Schedules Article III Escrow Agreement 2.4 (b)(ii) Equity Financing 5.21(aEscrow Release Date 2.8 Estimated Working Capital 2.5 Estimates Transaction Expenses 2.5 Final Closing Statement 2.6 (a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a3.6 (a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bFundamental Representations 8.3 (a)(i) Indemnified Party 7.4(a9.5 (a) Indemnifying Party 7.4(a9.5 (a) Independent Accounting Firm 2.8(a2.6 (c) Initial Allocation 2.1 Interim Financial Statements 3.5(a3.6 (a) Intervening Event 5.17(j)(iiiIT Systems 3.14 (j) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hJAMS 11.9 (a) Losses 7.2 9.2 Marks 1.1 Definition of Int. Property Material Contracts 3.19 (a) Net Adjustment Amount 2.6 (f)(i) Notice Period 5.17(d)(i)(Dof Disagreement 2.6 (b) Outside Date 8.1(b)(i10.1 (b) Party-Appointed Arbitrators 11.9 (a) Patents 1.1 Personal Definition of Int. Property Permitted Encumbrances 3.5 (a) Preliminary Closing Statement 2.5 Preliminary Notice of Disagreement 2.5 Purchased Shares Recitals Required Bank Information 3.26(a6.11 (b) Post-Closing Claims 5.13(aSeller Indemnified Parties 9.4 Seller Party or Seller Parties Preamble Sellers Preamble Sellers’ Representative 11.13 (a) Pre-Closing Contract Liabilities 2.4(fShares Recitals Straddle Period 7.3 Tax Claim 7.4 Third Party Claim 9.5 (a) Privacy Laws 3.26(aTrade Secrets Definition of Int. Property Transaction Recitals WARN Act 3.11 (f) Proxy Statement 3.29Working Capital Principles 2.5
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cDefinition Location 8-K Financial Information 5.22 Acquiror Preamble Acquiror Indemnified Parties 8.1 Acquiror SEC Documents 4.11(a) Acquisition Proposal 5.17(j)(iEngagement 9.19(b) Agreed Amount 8.2(e) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EFinancing 5.18(a) Alternative Financing 5.21(bAntitrust Action 5.10(a) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(bAntitrust Authorizations Schedule 3.3(b)
(a) Business CA Code Recitals Buyer Preamble Buyer Employees 5.3(a)(iiCancelled Shares 2.7(a)(iii) Buyer Expenses 8.4(cCARES Act 3.11(g) Buyer Welfare Plans 5.7(eCertificates 2.10(d) CERCLA 3.17(d)(iiCharges 2.13(b) Claim Notice 7.4(a8.2(d) Closing 2.6 2.2(a) Closing Balance Sheet 2.7 Cash 2.12(b) Closing Date 2.6 COBRA 5.7(d2.2(a) Closing Net Working Capital 2.12(b) Closing Net Working Capital Adjustment 2.12(b) Closing Payoff Debt 2.12(b) Closing Transaction Expenses 2.12(b) Closing Unpaid Pre-Closing Income Taxes 2.12(b) Commitment Letter 4.6 Company Preamble Company Intellectual Property 3.14(c) Company Real Property 3.13(b) Company Registered Intellectual Property 3.14(a) Company Representative 3.8(e) Company Source Code 1.1 Competing Business 5.3(a)(i3.14(g) Confidential Information 5.8(bDefinition Location Company Stockholder Approval 3.2 Contracting Parties 9.11(a) Copyrights 1.1 Customer 5.3(a)(iiiData Privacy Obligations 3.19(a) Debt Financing 5.21(a) 4.6 Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D4.6 Disclosure Schedules Article III Dispute Resolution Auditor 2.12(c) DGCL 4.6 Direct Claim 7.4(cDissenting Shares 2.8 DOJ 5.10(b) Effect 1.1 Effective Time 2.2(b) Environmental Laws 3.17(d)(i3.16(d)(i) Environmental Permits 3.16(d)(ii) Equity Financing 5.21(aInvestment 3.5(b) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cPlans 3.4(f) Excluded Liabilities 2.4 Existing Stock 5.14(bERISA 3.10(a)(i) Fairness Opinion 3.2(bEstimated Cash 2.12(a)(i) FDA 1.1 Estimated Net Working Capital 2.12(a)(i) Estimated Net Working Capital Adjustment 2.12(a)(i) Estimated Payoff Debt 2.12(a)(i) Estimated Transaction Expenses 2.12(a)(i) Estimated Unpaid Pre-Closing Income Taxes 2.12(a)(i) Express Indemnification Limits 8.4(a) Fee Letter 4.6 Final Closing Statement 2.12(b) Financial Statements 3.5(a3.6(a) Financing 5.21(aSources 5.18(b) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aFirst Certificate of Merger 2.2(b) Group Health First Merger Recitals First Step Surviving Corporation 2.1 Foreign Plan 5.7(d3.10(m) Forward-Looking Data 9.22(b) FTC 5.10(b) Hazardous Substances 3.17(d)(ii3.16(d)(iii) Health Care Permits 3.27(cHolder of Registrable Securities 5.17(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(aInformation Statement 5.16(a) Indemnifying Party 7.4(aIntended Tax Treatment Recitals Letter of Transmittal 2.10(d) Independent Accounting Firm 2.8(aMajority Holders 2.13(c) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Material Contracts 3.17(a) Material Customers 3.20(a) Material Suppliers 3.20(a) Merger Recitals Definition Location Net Adjustment Amount 2.12(e)(i) New Debt Commitment Letter 5.18(a) New Fee Letter 5.18(a) New Plans 5.8(a) Non-Disclosure Agreement 5.9 Notice Period 5.17(d)(i)(D8.2(b) Outside Date 8.1(b)(iObjections Statement 2.12(c) Patents 1.1 Personal Information 3.26(aPaying Agent 2.10(a) Post-Closing Claims 5.13(aPayment Fund 2.10(a) Payment Schedule 2.12(a)(ii) Payoff Letters 5.20 PDF 9.18 Permits 3.8(b) Permitted Transfer 5.17(a)(ii) Permitted Transferee 5.17(a)(ii)
(a) Plans 3.10(a)(i) Pre-Closing Contract Liabilities 2.4(fPeriod 5.1(a) Privacy Laws 3.26(aPreliminary Calculations 2.12(b) Proxy Preliminary Closing Statement 3.292.12(a)(i) Prospectus 5.17(b) Prospectus Supplement 5.17(b) Recipient 1.1 Registration Period 5.17(b) Registrable Securities 5.17(a)(i) Registration Statement 5.17(b) Related Person 3.18 Release 3.16(d)(iv) Response 8.2(e) Sample Statement 2.12(a) Xxxxxxxx-Xxxxx Act 4.11(a) Second Certificate of Merger 2.2(b) Second Effective Time 2.2(b) Second Merger Recitals Securities Act 4.5 Seller Transfer Taxes 5.12 Significant Stockholder Agreements Recitals Solvent 4.7 Specified Matter 9.19(a) Stockholder 2.10(a) Stockholder Parties 9.22(a) Stockholder Representative 2.13(a) Sub I Preamble Sub II Preamble Definition Location Subs Preamble Surviving Corporation 2.1 Termination Date 7.1(c) Third-Party Action Notice 8.2(a) Trade Secrets 1.1 Transfer Taxes 5.12 WARN Act 3.11(c)
Appears in 1 contract
Samples: Merger Agreement (Perkinelmer Inc)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cAccounts Receivable 3.7(c) Acquisition Engagement 9.20(a) Acquisition Proposal 5.17(j)(i5.15 Affected Employees 5.12(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EApplicable Accounting Principles 2.3(a) Alternative Financing 5.21(bBasket Amount 7.5(a)(ii) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(iiIndemnified Parties 7.2 Cap 7.5(a)(i) Claim Notice Information 7.4(a) Closing 2.6 2.2(a) Closing Balance Sheet 2.7 Cash 2.3(b) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(iClosing Indebtedness 2.3(b) Confidential Information 5.8(bClosing Net Working Capital 2.3(b) Closing Transaction Expenses 2.3(b) Company Recitals Company Registered IP 3.15(a) Confidentiality Agreement 5.6 Copyrights 1.1 Customer 5.3(a)(iiiDisclosure Schedules 9.10 Employee Plans 3.11(a) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i3.17(f)(i) Equity Financing 5.21(aEnvironmental Permits 3.17(f)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cERISA 3.11(a) Excluded Liabilities 2.4 Existing Stock 5.14(bEstimated Cash 2.3(a) Fairness Opinion 3.2(bEstimated Indebtedness 2.3(a) FDA 1.1 Estimated Net Working Capital 2.3(a) Estimated Transaction Expenses 2.3(a) Final Closing Statement 2.3(b) Financial Statements 3.5(a3.7(a) Financing 5.21(aFundamental Representations 7.1(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aXxxxxx Xxxx 9.20(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 Guarantees 5.9 HSR Act 3.3(b) Imagitas Plan 3.11(a) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h2.3(d) Losses 7.2 Marks 1.1 Master License Agreement 5.4(b)(ii) Material Contracts 3.18(a) Net Adjustment Amount 2.3(g)(i) Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(iof Disagreement 2.3(c) Patents 1.1 Personal Information 3.26(aPermits 3.9(b) Post-Closing Claims 5.13(aPollutant 3.17(f)(iii) Potential Contributor 7.6 Pre-Closing Contract Liabilities 2.4(fTax Periods 5.14(g) Privacy Laws 3.26(aPreliminary Closing Statement 2.3(a) Proxy Related Party 3.21 Related Party Transaction 3.21 Release 3.17(f)(iv) Sample Statement 3.292.3(a) Securities Act 4.6 Seller Preamble Seller Indemnified Parties 7.3 Seller Prepared Return 5.14(f) Shares Recitals Short Closing Year 5.14(f) Straddle Period 5.14(h) Tax Benefit 5.14(m) Tax Proceeding 5.14(n)(i) Third Party Claim 7.4(a) Trade Secrets 1.1 Transfer Taxes 5.14(c) Transition Services Agreement 5.4(b)(i) USPS 1.1 USPS Alliance Agreement 1.1
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c280G Waiver 6.8(c) ACA 4.13(i) Acquisition Proposal 5.17(j)(iEngagement 11.19(a) Adjustment Escrow Shortage Amount 2.7(g)(iii) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EFinancing 6.11(a) Alternative Financing 5.21(bRecovery 9.3(d) Applicable Date 3.6(dAccounting Principles 2.7(a) Assumed Liabilities 2.3 Audited Financial Statements 4.6(a) Balance Sheet 3.6(b)
(a4.6(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiIndemnified Parties 9.1 Carryback Returns 6.1(s) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Certificate of Merger 2.1 Claim Notice 7.4(aInformation 9.4(a) Closing 2.6 2.6(a) Closing Balance Sheet 2.7 Cash 2.7(b) Closing Date 2.6 COBRA 5.7(d2.6(a) Code 1.1 Competing Business 5.3(a)(iClosing Indebtedness 2.7(b) Confidential Information 5.8(bClosing Net Working Capital 2.7(b) Copyrights 1.1 Customer 5.3(a)(iiiClosing Transaction Expenses 2.7(b) Debt Financing 5.21(aCommon Stock Recitals Company Preamble Company Employee 6.8(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DCompany Permits 4.11(b) DGCL 4.6 Direct Claim 7.4(cConfidentiality Agreement 6.3(a) Effect 1.1 Construction Services Separation 6.10 CS Separation Tax Indemnity Escrow Account 2.6(b)(iv) DOJ 6.4(a) Effective Time 2.2(a) Environmental Laws 3.17(d)(i4.21(h)(i) Equity Financing 5.21(aEnvironmental Permits 4.22(h)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cEstimated Cash 2.7(a) Excluded Liabilities 2.4 Existing Stock 5.14(bEstimated Indebtedness 2.7(a) Fairness Opinion 3.2(bEstimated Net Working Capital 2.7(a) FDA 1.1 Estimated Transaction Expenses 2.7(a) Final Closing Statement 2.7(b) Financial Statements 3.5(a4.6(a) Financing 5.21(aFTC 6.4(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(dXxxxxx Xxxx 11.19(a) Hazardous Substances 3.17(d)(iiSubstance 4.22(h)(iii) Health Care Permits 3.27(cReform Laws 4.13(i) HIPAA 1.1 Health Plan 4.13(i) HSR Act 3.3(b) Indemnified Party 7.4(aHSR Filing 6.4(a) Indemnifying Party 7.4(aIndemnity Cap 9.3(b)(i) Indemnity Escrow Account 2.6(b)(iv) Independent Accounting Firm 2.8(a2.7(d) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii4.6(a) Licensed Excluded IP 3.13(hIntellectual Property 4.20(a) Losses 7.2 Marks 1.1 Material Contracts 4.22(a) Materiality Qualifier 8.2(a) Maximum Amount 6.6(b) Merger Recitals Merger Sub Preamble Net Adjustment Amount 2.7(g)(i) New Benefit Plans 6.8(b) Notice Period 5.17(d)(i)(Dof Disagreement 2.7(c) Outside Date 8.1(b)(iOld Benefit Plans 6.8(b) Patents 1.1 Personal Information 3.26(aOwned Intellectual Property 4.20(a) Post-Closing Claims 5.13(aPortfolio Companies 6.3(b) Pre-Closing Contract Liabilities 2.4(fIncome Return 7.1(a) Privacy Laws 3.26(aPre-Closing Return 7.1(b) Proxy Preliminary Closing Statement 3.292.7(a) Purchase Price Adjustment Escrow Account 2.6(b)(iv) Real Property Lease 4.18(b) Registered IP 4.20(b) Related Funds 6.3(b) Release 4.22(h)(iv) Remedial Action 4.22(h)(v) Replacement Instrument 9.5(c) Residual Information 6.3(b) Sample Statement 2.7(a) Securities Act 5.7 Seller Preamble Seller Indemnified Parties 9.2
Appears in 1 contract
Samples: Merger Agreement (TopBuild Corp)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Definition Location Acquisition Proposal 5.17(j)(i5.3(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(dPeriod 3.18(a)(i) Assumed Liabilities 2.3 2.2(a) Balance Sheet 3.6(b)
(a3.5(a) Balance Sheet Date 3.5(a) Bankruptcy Exception 3.2 Basket Amount 7.5(b)(ii) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiIndemnified Parties 7.2 Buyer Obligations 5.16(a) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(aCap 7.5(b)(i) Closing 2.6 Closing Balance Sheet 2.7 2.4 Closing Date 2.6 COBRA 5.7(d2.4 Confidentiality Agreement 5.6(a) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iiiDebt Commitment Letter 4.4(a) Debt Financing 5.21(a4.4(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination 4.4(a) Disclosure Schedules Article III Dispute Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c2.3(b)(iii) Effect 1.1 Environmental Laws 3.17(d)(i3.17(e)(i) Equity Financing 5.21(aEnvironmental Permits 3.17(e)(ii) Equity Financing Commitment 4.4 Estimated Closing Statement 2.3(b)(i) Definition Location Excluded Assets 2.2 Excluded Intellectual Property 2.2(c2.1(b) Excluded Liabilities 2.4 2.2(b) Excluded Willow Court Assets 2.1(b)(iv) Existing Stock 5.14(bCollaboration Agreement Recitals Existing Grifols Liabilities 2.2 FCPA 1.1 Fee Letter 4.4(b) Fairness Opinion 3.2(bFinal Allocation Schedule 2.6(a) FDA 1.1 Final Closing Statement 2.3(b)(v) Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) 5.17 Fundamental Representations 7.1 Xxxxxx Xxxx 9.21 Grifols Preamble Hazardous Substances 3.17(d)(ii3.17(e)(iii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(aSchedule 2.6(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hInsurance Policies 3.13 Lenders 4.4(a) Losses 7.2 Marks 1.1 Notice Material Contracts 3.18(a) Material Suppliers 3.12 Objection Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a2.6(b) Post-Closing Claims 5.13(a5.14(b) Pre-Proposed Final Closing Contract Statement 2.3(b)(ii) Purchase Price 2.3(a) Resolution Period 2.3(b)(iv) Seller Preamble Seller Indemnified Parties 7.3 Shared Liabilities 2.4(f2.2(c)(i) Privacy Laws 3.26(aTermination Date 8.1(c) Proxy Statement 3.29Third Party Claim 7.4(a) Transferred Assets 2.1(a) Transferred Contracts 2.1(a)(iii)
(a) Transferred Product Registrations 2.1(a)(vii) Transferred Real Property 2.1(a)(iv) Withholding Agent 2.8
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cDefinition Location Actual Current Liabilities 2.7(d) Acquisition Proposal 5.17(j)(iActual Working Capital 2.7(b) Adjustment Statement 2.7(f) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAlleged Obsolete Unit 2.8(a) Alternative Financing 5.21(bAlleged Obsolete Units Notice Schedule 2.8(a) Applicable Date 3.6(d) Allocation Schedule 2.9 Assumed Liabilities 2.3 Balance Sheet 3.6(bAudited Financial Statements 5.9(a) Basket Amount 8.4(b)(iii) Books and Records 2.1(h) Business Recitals Business Patents 3.21(a) Business Permits 2.1(g) Business Registered Copyrights 3.21(a) Business Registered IP 3.21(a)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiEmployee Plans 5.1(c) Buyer Expenses 8.4(cIndemnified Parties 8.1 Buyer Savings Plan 5.1(e) Buyer Welfare Plans 5.7(eBuyer’s Value 2.8(a) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Definition Location Cleanup 1.1 Closing 2.6 Closing Balance Sheet 2.7 Date 2.6 Closing Date Payment 2.5(a) COBRA Obligations 5.1(g) Confidentiality Agreement 5.2 Copyright Registrations 2.1(k) Core Reps 8.4(b)(iii) Disclosure Schedules Article III Effective Time 2.6 COBRA 5.7(dEngagement Letter 5.9(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cContracts 2.2(k) Excluded Inventory 2.2(m) Excluded Liabilities 2.4 Existing Stock 5.14(bExcluded Purchase Orders 2.2(l) Fairness Opinion 3.2(bFinancial Statement Deadline 5.9(a) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 3.7 Finished Goods Inventory Amount 2.8(aCredit 2.8(c) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bHouston Aldine Property Sublease 2.5(b) Indemnified Party 7.4(a8.3(a) Indemnifying Party 7.4(a8.3(a) Independent Accounting Firm Accountants 2.7(g) Intellectual Property 2.1(k) Inventions 2.1(k) Leased Real Property 3.11(c) Losses 8.1 Marks 2.1(k) Minimum Loss Amount 8.4(b)(iii) Notice of Disagreement 2.7(g) Other Financial Materials 5.9(b) Owned Real Property 3.11(a) Parent Preamble Patents 2.1(k) Pre Close Default 2.3(c) Production Equipment 3.6 Purchase Price 2.7(h) Purchase Price Reduction 5.9(e) Receivables 2.2(b) SEC 5.9(a) Seller Preamble Seller Indemnified Parties 8.2 Seller Note 2.5(a) Seller Savings Plan 5.1(e) Seller’s Value 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(aSeverance Cap 5.1(b)(ii) Intervening Event 5.17(j)(iiiDefinition Location Sundry Payables 2.4(o) Intervening Event Change Tampa Assets 2.1(e) Tampa Welding Production Assets 2.1(e) Tangible Personal Property 2.1(d) Target Working Capital 2.7(a) Third Party Claim 8.3(a) Title Company 1.1 Trade Secrets 2.1(k) Trademark Registrations 2.1(k) Transfer Taxes 6.2 Transferred Assets 2.1
(a) Transferred Contracts 2.1(a) Transferred Employee 5.1(a) Transferred Inventory 2.1(f) Transferred Inventory Value 2.7(c) Transferred Purchase Orders 2.1(b) transition period 5.1(d) Unit Count 2.7(e) Unit Inventory Schedule 2.7(c) WARN Act 2.4(b) Works of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.29Authorship 2.1(k)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) Accounting Principles 1.1 Action 1.1 Affiliate 1.1 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Transaction 1.1 Ancillary Agreements 1.1 Antitrust Law 1.1 Applicable Date 3.6(dNet Product Working Capital Forecast Amount 1.1 Apportioned Taxes 6.4 Approved Budget 1.1 Asset Class 1.1 Assumed Liabilities 2.3(a) Assumed Liabilities 2.3 Plan 1.1 Auction 1.1 Avoidance Actions 1.1 Balance Sheet 3.6(b)
(a3.5(e) Bankruptcy Case 1.1 Bankruptcy Code 1.1 Bankruptcy Court Recitals Xxxx of Sale 2.9(b)(i) Books and Records 1.1 Breaches 3.15(c) Business 1.1, Recitals Business Day 1.1 Business Employee 1.1 Business Permits 2.1(a)(xiv) Buyer Preamble Buyer Employees 5.3(a)(iiMaterial Adverse Effect 1.1 Buyer Plans 5.4(j) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(iiTaxes 1.1 Cash Component 2.7(a) Claim Notice 7.4(a1.1 Closing 2.9(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 2.9(a) COBRA 5.7(d) 1.1 Code 1.1 Collateral 1.1 Commitment Letter 4.4 Commitment Parties 4.4 Commitment Party Related Person 9.13 Company Group 1.1 Company SEC Documents 3.5(a) Competing Business 5.3(a)(iBid 1.1 Competing Bid Obligations 5.8(f) Confidential Information 5.8(b) Contract 1.1
1.1 controlled by 1.1 Copyrights 1.1 Customer 5.3(a)(iiiCredit Bid Consideration 2.9(c)(i)(A) Debt Financing 5.21(aCure Claims 1.1 Current Representation 9.25(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DXxxxx Xxxx 9.25(a) DGCL 4.6 Direct Claim 7.4(cDesignated Buyer 2.11(a) Effect Designated Contract Make-Whole Amount 1.1 Designated Contracts 1.1 Designated Person 9.25(a) DIP Credit Agreement 1.1 DIP Loan Document 1.1 DIP Loan Parties 1.1 DIP Obligations 1.1 DIP Secured Parties 1.1 DIP Superpriority Claims 1.1 Disclosure Letter III Disputed Cure Claims 2.6(c) Employee Census 3.10(a) Employee Incentive Plan 5.4(g) Employee Plans 1.1 Encumbrance 1.1 Environmental Laws 3.17(d)(iClaim 1.1 Environmental Law 1.1 Environmental Permit 1.1 ERISA 1.1 ERISA Affiliate 1.1 Excess Cash Amount 1.1 Exchange Act 3.5(a) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cInsurance 2.1(a)(xv) Excluded Liabilities 2.4 Existing Stock 5.14(bExecutory Contract 2.6(a) Fairness Opinion 3.2(bExecutory Contract List 2.6(a) Expense Reimbursement Amount 8.3(a) FDA 1.1 Financial Statements 3.5(a) FFDCA 1.1 Final DIP Order 1.1 Final Order 1.1 Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Fraud 1.1 GAAP 1.1 GDPR 1.1 Goodwill 1.1 Governmental Authority 1.1 Designated Contract 1.1 Hazardous Substances 3.17(d)(ii) Materials 1.1 Health Care Permits 3.27(c) Laws 1.1 HIPAA 1.1 HSR Act 3.3(b1.1 IND 1.1 Indebtedness 1.1 Information Privacy and Security Laws 1.1 Infringe 1.1 Intellectual Property 1.1 Interests 1.1 Interim DIP Order 1.1 Inventory 1.1 IP Assignment Agreement 2.9(b)(ii) Indemnified IP License Agreement 2.9(b)(iii) IRS 1.1 Knowledge 1.1 Law 1.1 Lease 1.1 Leased Real Property 1.1 Liability 1.1 Lockbox Accounts 1.1 Material Adverse Effect 1.1 Material Contract 3.17(a) Material Contracts 3.17(a) Milestones 1.1 Morristown Facility 1.1 Morristown Lease 1.1 Nalpropion 1.1 Nalpropion Loan Documents 1.1 Nalpropion Loan Indebtedness 1.1 Nalpropion Shares 1.1 Nasdaq 3.5(b) NDAs 1.1 Net Product Working Capital 1.1 Order 1.1 Ordinary Course of Business 1.1 Organizational Documents 1.1 Original Agreement Recitals Outside Date 8.1(a)(iii)(C) Parties 1.1 Party 7.4(a1.1 Patents 1.1 Permits 3.7(b) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Permitted Encumbrance 1.1 Pernix Ireland DAC 1.1 Pernix Ireland DAC Cash 1.1 Pernix Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents Person 1.1 Personal Information 3.26(a) Data 1.1 Petition Date 1.1 Petitions Recitals Positive Product Working Capital 1.1 Positive Product Working Capital Credit Bid Consideration 1.1 Post-Closing Claims 5.13(aTax Period 6.4 Pre-Auction Designation Date 2.6(d) Pre-Closing Statement 2.8 Pre-Closing Tax Period 6.4 Prepetition DDTL Agreement 1.1 Prepetition DDTL Loan Documents 1.1 Prepetition DDTL Obligations 1.1 Product Approvals 1.1 Product Intellectual Property 1.1 Product Marketing Materials 1.1 Product Regulatory Materials 1.1 Product Working Capital Assets 1.1 Product Working Capital Liabilities 1.1 Products 1.1 Purchase Price 2.7(a) Purchase Price Allocation 2.10 Qualified Bidder 1.1 Qualified Leave Recipient 1.1 Real Property 1.1 Reference Statement 1.1 Regulatory Approvals 1.1 Release 1.1 Representatives 1.1 Sale Hearing 1.1 Sale Motion 5.8(a) Sale Order 1.1 Sale Procedures 1.1 Sale Procedures Order 1.1 SEC 3.5(a) Securities Act 3.5(a) Seller Preamble Seller Financial Statements 3.5(c) Seller Parent Preamble Seller Taxes 1.1 Seller Unaudited Financial Statements 3.5(c) Seller-Paid Buyer Taxes 2.7(a) Sellers Preamble Sellers Plans 5.4(j) Sensitive Data 1.1 Services Agreement 1.1 Shared GTN Contracts 1.1 Software 1.1 Specified Cure Claims 1.1 Specified DIP Credit Bid Consideration 1.1 Specified Interests 1.1 Specified Prepetition Credit Bid Consideration 1.1 Subsidiary 1.1 Successful Bidder 1.1 Tax Return 1.1 Taxes 1.1 Term Sheet 1.1 Termination Date 8.1(a) Trade Secrets 1.1 Trademarks 1.1 Transfer Taxes 6.1 Transferred Assets 2.1(a) Transferred Contracts 1.1 Transferred Employee 5.4(b) Transition Services Agreement 1.1 Treximet Assets 1.1 Treximet Bid 1.1 Treximet Business 1.1 Treximet Indenture 1.1 Treximet Intellectual Property 1.1 Treximet Letter of Credit 1.1 Treximet Products 1.1 Treximet Sale 1.1 Treximet Working Capital Liabilities 1.1 Treximet-Related Shared Contract Liabilities 2.4(f5.17(a) Privacy Laws 3.26(aunder common control with 1.1 Undisputed Cure Claims 2.6(a) Proxy Statement 3.29Unpaid Seller Taxes 2.7(a)
Appears in 1 contract
Samples: Asset Purchase Agreement (Pernix Therapeutics Holdings, Inc.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i5.3(a) Aggregate Option Consideration 2.9(a) Aggregate Share Consideration 2.7(a) Aggregate Warrant Consideration 2.9(c) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EApplicable Accounting Principles 2.12(a) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b) Cancelled Shares 2.7(c) Cashed-Out Options 2.9(a) CERCLA 3.16(f)(ii) Certificate of Merger 2.2(b) Certificates 2.10(b) Charter 1.1 Closing 2.2(a) Closing Cash 2.13(a) Closing Date 2.2(a) Closing Indebtedness 2.13(a) Closing Net Working Capital 2.13(a) Closing Transaction Expenses 2.13(a) Company Preamble Company 401(k) Plan 5.14 Company IT Systems 3.21(f) Company Related Materials 9.19 Confidentiality Agreement 5.8 Consideration Schedule 2.12(b) Contest 5.11(c) Debt Payoff Letter 6.3(h) Delaware Law Recitals Disclosure Schedules Article III Dissenting Shares 2.8 Effective Time 2.2(b)
(a) Business Employment Arrangements Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i3.16(f)(i) Equity Financing 5.21(aERISA 3.10(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cERISA Affiliates 3.10(a) Excluded Liabilities 2.4 Existing Stock 5.14(bERISA Affiliates 2.12(a) Fairness Opinion 3.2(bEstimated Indebtedness 2.12(a) FDA 1.1 Estimated Net Working Capital 2.12(a) Estimated Transaction Expenses 2.12(a) Final Closing Statement 2.13(a) Financial Projections 3.6(c) Financial Statements 3.5(a3.6(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Firm 9.19 Fundamental Representations 7.1 Hazardous Substances 3.17(d)(ii3.16(f)(ii) Health Care Permits 3.27(c) HIPAA 1.1 Holders Recitals HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a2.13(c) Initial Allocation 2.1 Information Statement 3.23 Infringe 3.14(e) Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h3.6(a) Losses 7.2 Marks 1.1 Majority Holders 2.15(a) Material Contracts 3.17(a) Merger Recitals Merger Sub Preamble Net Adjustment Amount 2.13(f) Notice Period 5.17(d)(i)(Dof Disagreement 2.13(b) Open Source License 3.14(g) Outside Date 8.1(b)(i8.1(c) Patents 1.1 Parent Preamble Paying Agent 2.10(a) Permits 3.8(b) Personal Information 3.26(a3.21(a) Post-Preferred Stockholder Written Consent Recitals Preferred Stockholders Recitals Preliminary Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(fStatement 2.12(a) Privacy Laws 3.26(a3.21(a) Proxy Statement 3.29Release 3.16(f)(iii) Representative Losses 2.15(c) Schedule Supplement 5.6 Securityholder Representative 2.15(a) Shares 2.7 Stockholder Written Consent Recitals Stockholders Recitals Straddle Period 5.11(a) Surviving Corporation 2.1 Third Party Claim 7.4(a) Transfer Taxes 5.11(f) Written Consents Recitals
Appears in 1 contract
Samples: Merger Agreement (NICE Ltd.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cAffected Employees 6.11(a) Acquisition Proposal 5.17(j)(i) Agent 6.15 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(Eof Merger 2.3(a) Alternative Financing 5.21(bAuthorization 3.3(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b4.6(a) Business Combination 6.16 Buyer Preamble Buyer Indemnified Parties 7.2 Buyer Stockholders’ Meeting 4.26 Certificate of Merger 2.3(c) Claims 6.16 Closing 2.2(a) Closing Date 2.2(a) Closing Statement 2.4(a) Closing Working Capital 2.4(a) Common Stock Recitals Company Preamble Company Employee Plans 4.10(a) Company Intellectual Property 4.14 Company Financial Statements 4.6(a) Company Xxxx 6.22 Confidentiality Agreement 6.5(a) D&O Indemnified Liabilities 6.10(a)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiDeficit Amount 2.5(a) Buyer Expenses 8.4(cDelivery Fee 12.1(b) Buyer Welfare Disclosure Schedules Article IV Effective Time 2.3(c) Employee Plans 5.7(e4.10(a) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i4.16(g) Equity Financing 5.21(aEnvironmental Permits 4.16(g)
(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cFacility Fee 12.1(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(aFiling Deadline 6.18 Final Working Capital 2.5(a) Financing 5.21(a5.5 Fundamental Buyer Representations 7.1 Fundamental Company Representations 7.1 Fundamental Representations 7.1 Guarantees 6.9 Hazardous Material 4.16(g) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(aExpert 2.4(c) Initial Allocation 2.1 Interim Financial Statements 3.5(a4.6(a) Intervening Event 5.17(j)(iiiLease(s) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h4.13(b) Losses 7.2 Marks 1.1 Material Contracts 4.17(a) Merger 2.3(b) Michigan Use Tax Reserve 8.1(a) Noncompetition Period 6.12(a) Notice Period 5.17(d)(i)(Dof Objection 2.4(b) Outside Date 8.1(b)(iPermits 4.8(b) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Potential Contributor 7.7 Products 4.21 Promissory Note 2.1 Proposal 6.15 Proxy Statement 3.294.26 Purchase Price 2.1 Release 4.16(g) Representatives 6.2 Restricted Entities 6.12(a) Review Period 2.4(b) SEC 6.18 Section 338 Forms 8.3(c) Section 338(h)(10) Election 8.3(a) Securities Act 5.7 Seller Preamble Seller Employee Plans 4.10(a) Seller Indemnified Parties 7.3
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cAccess Agreement 4.7(a) Acquisition Proposal 5.17(j)(i) Adjustment Escrow Amount 2.6 Affiliated Sellers Preamble Affiliated Transferred Assets 2.1 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(dAHBMS Preamble AHC California Preamble Assumed Contacts 2.1(b) Assumed Liabilities 2.3 Balance Sheet 3.6(b3.5(a) Balance Sheet Date 3.5(a) Basket Amount 8.5(b)(iii) Books and Records 2.1(i) Business Domain Names 3.13(a) Business Intellectual Property 2.1(d) Business Patents 3.13(a) Business Permits 2.1(h) Business Registered Copyrights 3.13(a) Business Registered IP 3.13(a) Business Registered Marks 3.13(a) Buyer Preamble Buyer Indemnified Parties 8.2 Buyer Savings Plan 5.5(d) Buyer Welfare Benefit Plans 5.5(e)(i) Cap 8.5(b)(i) Classified Ventures 2.2(k)(ii) Closing 2.7 Closing Net Working Capital 2.9(a) Closing Statement 2.9(a) COBRA Obligations 5.5(e)(ii) Confidential Information 5.6(b) Confidentiality Agreements 5.6 Construction Obligations 2.4(f) Disclosure Schedules Article III Environmental Laws 3.15(b)(i) Environmental Permits 3.15(b)(ii) Excluded Assets 2.2 Excluded Liabilities 2.4 Financial Statements 3.5(a) Fundamental Representations 8.1 Indemnified Party 8.4(a) Indemnifying Party 8.4(a) Independent Accounting Firm 2.9(c) Interim Financial Statements 3.5(a) Inventory 2.1(g) Kaiser Employees 5.5(e)(iii) Leased Premises 3.12(c) Leased Real Property 3.12(b) Losses 8.2 Material Contracts 3.16(a) Minimum Loss Amount 8.5(b)(iii) Net Adjustment Amount 2.9(d)(i) North County Times Business 2.2(m) Notice of Disagreement 2.9(b) Permits 3.7(b) Post-Closing Tax Period 6.1 Pre-Closing Tax Period 6.1 Pre-Deed Recordable Documents 7.3(d) Preliminary Closing Statement 2.9(a) Preliminary Net Working Capital 2.9(a)
(a) Purchase Price 2.6 Real Property 2.1(c) Real Property Leases 3.12(b) Receivables 2.1(e) Seller Preamble Seller Assumed Contracts 2.1(b) Seller Business Recitals Buyer Preamble Buyer Permits 2.1(h) Seller Indemnified Parties 8.3 Seller Real Property 2.1(c) Seller Savings Plan 5.5(d) Seller Tangible Personal Property 2.1(f) Seller Transferred Assets 2.1 SoCal Printing Real Estate 2.2(k)(i) Tangible Personal Property 2.1(f) Tax Representations 8.1 Termination Date 9.1(c) Third Party Claim 8.4(a) Title Policy 7.3(d) Transferred Assets 2.1 Transferred Employees 5.3(a)(ii5.5(a) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR WARN Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.295.5(g)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c2013 Audited Annual Company Financial Statements 4.7(a) 2014 Audited Annual Company Financial Statements 4.7(a) Accounting Firm 8.1(d) Acquisition Recitals Acquisition Proposal 5.17(j)(i) 7.3 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAllocation Objection Notice 2.6 Audited Annual Company Financial Statements 4.7(a) Alternative Financing 5.21(bBasket 10.4(a)(i) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Business Blocker Corporation Shares Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(aIndemnitees 10.2(a) Closing 2.6 2.2 Closing Balance Sheet 2.7 Capitalization Schedule 2.3(a)(viii) Closing Date 2.6 COBRA 5.7(d2.2 Closing Estimates and Calculations 2.4 Closing Statement 2.9(a) Code 1.1 Competing Business 5.3(a)(iCommitment Letter 6.4 Company Preamble Company IP 4.15(c) Company-Standard PIIAAs 7.13 Confidential Information 5.8(b7.6(b) Copyrights 1.1 Customer 5.3(a)(iiiConfidentiality Agreement 7.6(a) Debt Financing 5.21(a) 6.4 Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) 6.4 DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 2.12 Disclosure Schedules Article IV Environmental Laws 3.17(d)(i4.17(e)(i) Equity Financing 5.21(aEnvironmental Permits 4.17(e)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cEPU Holder Release 2.7(d) Excluded Liabilities 2.4 Estimated Purchase Price 2.3(a)(viii) Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Representation 7.12 Fee Letter 6.4 Financial Statements 3.5(a4.7(c) Financing 5.21(aFounder Restricted Shares 2.7(b)(i) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aFundamental Reps 9.3(a) Group Health Plan 5.7(dGoverning Documents 7.9(a) Government Official 4.26(a) Hazardous Substances 3.17(d)(ii4.17(e)(iii) Health Care Permits 3.27(cHolder Group 7.12(b) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a10.6(a) Indemnifying Party 7.4(a10.6(a) Independent Accounting Firm 2.8(aIssue Price 2.7(b)(i) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hKey Employee 9.3(f) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D10.2(a) Majority Holders 2.11(b) Material Contracts 4.18(a) Minimum Amount 10.4(b)(i) MoFo 7.12(a) Xxxxxx Xxxxxxx 4.27 Non-Competition Agreements Recitals NYSE 2.7(b)(i) Outside Date 8.1(b)(i11.1(b) Patents 1.1 Personal Paying Agent 2.3(a) Payment Fund 2.3(a) Permitted Encumbrances 4.6 Personally Identifiable Information 3.26(a4.25(b) Post-Closing Claims 5.13(aEPU Obligations 2.8(a) PrePost-Closing Contract Liabilities 2.4(fRepresentation 7.12(b) Privacy Laws 3.26(aRights 4.25(b) Proxy Statement 3.29Pro Forma Financials 7.10(b) Proposed Purchase Price Allocation 2.6 Release 4.17(e)(iv) Representative Losses 2.11(c) Required Information 7.11(c)(iii) Restructuring Recitals SEC 4.7(a) Seller Preamble Seller Person 7.8(a) Seller Released Matters 7.8(b) Seller Released Party 7.8(b) Seller Releasing Party 7.8(b) Sellers Preamble Sellers Representative 2.11(a) September 2015 Balance Sheet 4.7(c) September 2015 SAS Financials 4.7(b) Surviving Agreements 7.8(a)(i) Tax Controversies 8.2(a) Tax Reps 10.1(a) Terminated Agreements 7.8(a)(i) Third Party Claim 10.6(a) Top 20 Supplier 4.19(b) Top 30 Customer 4.19(a) Transferred Companies Recitals Units Recitals Unresolved Objections 2.9(c)(iii)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections sections referenced below: 510(k)s 3.27(cAcceptable Transferee 5.12(b) Acquisition Proposal 5.17(j)(iEngagement 9.21(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EFinancing 5.22(c) Alternative Financing 5.21(bAnti-Corruption Laws 3.8(c) Applicable Date 3.6(dAnti-Money Laundering Laws 4.8 APBHH 3.6(f) Assumed Liabilities 2.3 APBHH Balance Sheet 3.6(b)
(a3.6(f) APBHH Business Financial Statements 3.6(f) Balance Sheet 3.6(a) Business Recitals Cash Flow Statements 3.6(j) Business Financial Statements 3.6(a) Buyer Preamble Buyer Employees 5.3(a)(iiCredit Support Cap 5.11(a) Buyer Expenses 8.4(cIndemnified Party 7.1 Buyer Letter of Credit 5.11(b) Buyer Welfare Plans 5.7(eParties 5.15(b) CERCLA 3.17(d)(iiBuyer Releasees 9.25(b) Claim Notice 7.4(aBuyer Releasors 9.25(a) Buyer Termination Fee 8.3(a) Carvers Creek TE Shortfall Amount 2.3(j)(i) Clearview Tax Equity Documents 5.25(c)(i) Closing 2.6 2.2(a) Closing Balance Sheet 2.7 Carvers Creek Tax Equity Amount 2.3(b) Closing Cash 2.3(b) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(iClosing Development Projects 2025 Pre-Locked Box Spending Amount 2.3(b) Closing Development Projects Adjustment Amount 2.3(b) Closing Xxxxxx RNG Sale-Leaseback Amount 2.3(b) Closing Indebtedness 2.3(b) Closing Leakage Amount 2.3(b) Closing Locked Box Period Capital Expenditure Amount 2.3(b) Closing Net Working Capital 2.3(b) Closing Property Tax Amount 2.3(b) Closing Specified Funded Indebtedness 2.3(b) Closing Transaction Expenses 2.3(b) Company Recitals Company Partnership 5.13(b)(iv)(1) Company Trusts 5.13(b)(iv)(2) Condemnation Value 5.29(b) Confidential Information 5.8(b5.4 Construction 1.1 Continuing Credit Support Obligations 5.11(b) Copyrights 1.1 Customer 5.3(a)(iiiContinuing Employee 5.20(a) Counsel Communications 9.21(b) CRA 5.13(b)(iv)(1) Cross-Currency Swaps 5.36 Debt Financing 5.21(a4.4(d) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DDefinitive Agreements 5.22(a) DGCL 4.6 Direct Claim 7.4(cDisclosed Personal Information 5.10 Disqualified Transferee 5.12(b) Effect 1.1 Environmental Laws 3.17(d)(iDPA 4.12 EBR 3.6(d) EBR Balance Sheet 3.6(d) EBR Business Financial Statements 3.6(d) Electronic Data Room 9.7 Employee Plans 3.10(a) Equity Financing 5.21(a4.4(c) Estimated Carvers Creek Tax Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Amount 2.3(a) Estimated Cash 2.3(a) Estimated Construction Projects Outstanding Obligations Amount 2.3(a) Estimated Development Projects 2025 Pre-Locked Box Spending Amount 2.3(a) Estimated Development Projects Adjustment Amount 2.3(a) Estimated Xxxxxx RNG Sale-Leaseback Amount 2.3(a) Estimated Indebtedness 2.3(a) Estimated Leakage Amount 2.3(a) Estimated Locked Box Period Capital Expenditure Amount 2.3(a) Estimated Net Working Capital 2.3(a) Estimated Property 2.2(cTax Amount 2.3(a) Excluded Liabilities 2.4 Estimated Specified Funded Indebtedness 2.3(a) Estimated Transaction Expenses 2.3(a) Event of Loss 5.29(a) Excess Credit Support Obligations 5.11(a) Existing Stock 5.14(bCredit Support Obligations 5.11(a) Fairness Opinion 3.2(bFC Adjustment Amount 2.3(i) FDA 1.1 Financial Statements 3.5(aFC Construction Projects Outstanding Obligations Amount 2.3(i) FC Notice of Disagreement 2.3(i) Final Closing Statement 2.3(b) Final Completion Statement 2.3(i) Financing 5.21(aAmounts 4.4(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aGolden Share 5.9(b) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a7.2(a) Indemnifying Party 7.4(a7.2(a) Indemnified Taxes 5.13(b)(vii) Independent Accounting Firm 2.8(a2.3(d) Independent Expert 5.29(b) Initial Allocation 2.1 Extended Termination Date 8.1(c) Initial Termination Date 8.1(c) Insurance Policies 3.12 Interim Financial Statements 3.5(aDevelopment Credit Support Obligation 5.11(b) Intervening Event 5.17(j)(iiiInterim Period 5.13(b)(iv)(5)(c) Intervening Event Change Intragroup Balances 5.15(a) Joint Venture 9.7 Lost Profits 5.29(b) Major Loss 5.29(c) Mandatory Reporting Rules 5.13(b)(i) [Redacted – Confidential Information] 5.18(a) [Redacted – Confidential Information] 5.18(a) Material Adverse Effect 6.2(a) Material Contracts 3.18(a) Net Pre-FC Adjustment Amount 2.3(g)(i) New Preferred Shares 5.9(a) Non-Party Affiliate 9.24(a) Notice of Recommendation 5.17(d)(iiClaim 7.2(e) Licensed Excluded IP 3.13(hNotice of Disagreement 2.3(c) Losses 7.2 Marks OFAC 1.1 Notice Period 5.17(d)(i)(DOther Transaction FERC 203 Application 5.5(h) Outside Date 8.1(b)(iPermits 3.8(b) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(aPotential Contributor 7.3 Power Generation Company 3.20(e) Pre-Consummation Warning Letter 5.5(i) Preliminary Closing Contract Liabilities 2.4(fStatement 2.3(a) Privacy Laws 3.26(aPRH 3.6(e) Proxy Statement 3.29PRH Balance Sheet 3.6(e) PRH Business Financial Statements 3.6(e) Proceeds 5.29(b) Project Power 9.7 Property Taxes 5.13(b)(iv) Purchased Interests Recitals Qualified Transferee 3.18(a)(xiii) Recipient 1.1 Renewable Energy Credit Generator 3.20(e) Resource Entity 3.20(e) Restoration Costs 5.29(b) Retained Names and Marks 5.14(a) RLWEP 3.6(c) RLWEP Balance Sheet 3.6(c) RLWEP Business Financial Statements 3.6(c) RNG Partnership Flip Documents 5.25(f) RNG Sale-Leaseback Documents 5.25(e) Second Extended Termination Date 8.1(c) Seller Preamble Seller Credit Support Cap 5.11(b) Seller Credit Support Continuing Documents 5.11(b) Seller Credit Support Obligations 5.11(b) Seller Parties 5.15(b) Seller Releasees 9.25(a) Seller Releasors 9.25(b) Seller/Company Acquisition Counsel 9.21(a) Shady Oaks II Tax Equity Documents 5.25(d) Specified Funded Indebtedness 2.2(b)(ii) [Redacted – Commercially Sensitive Information – Negotiations with Third Party] 5.18(a) [Redacted – Commercially Sensitive Information – Negotiations with Third Party] 5.30 Stub Company Partnership Year Ends 5.13(b)(iv)(1) Subject Employees 3.11(b) Subsidiary 9.7 Taking 5.29(a) Tax Audit 5.13(b)(vii) Tax Equity Company 5.25(c)(iv Tax Equity Documents 5.25(c)(iv) Termination Date 8.1(c) Third Party Claim 7.2(a) Transfer Taxes 5.13(a) ULC Conversions 5.1(i) VWH 3.6(g) VWH Balance Sheet 3.6(g)
Appears in 1 contract
Samples: Securities Purchase Agreement (Algonquin Power & Utilities Corp.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Assets 3.13 Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiDisclosure Letter Article IV Buyer SEC Reports 4.6 Buyer Subsidiary(ies) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) 2.1 Claim Notice 7.4(a8.4(a) Chanel Limited DB Pension Plan 5.16 Chanel Limited DC Pension Plan 5.16 Closing 2.2(a) Closing 2.6 Accounts 2.4(a) Closing Balance Sheet 2.7 Cash 2.4(a) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(iClosing Indebtedness 2.4(a) Closing Prepaid Payables 2.4(a) Closing Transaction Expenses 2.4(a) Company Group Recitals Company Group Employees 5.4 Company Registered IP 3.15(e) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iiiConfidentiality Agreement 5.8(a) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c8.4(e) Effect 1.1 Environmental Laws 3.17(d)(iDirect Claim Notice 8.4(e) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Disclosure Letter Article III Employer Debt Regulations 5.16 Estimated Cash 2.3 Estimated Indebtedness 2.3 Estimated Prepaid Payables 2.3 Estimated Transaction Expenses 2.3 Exchange Act 4.6 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c5.14 Exempted Obligations 3.7(b) Excluded Liabilities 2.4 Existing Stock 5.14(bFinal Closing Statement 2.4(a) Fairness Opinion 3.2(bFrench Tax Sharing Termination Agreement 6.8 Fundamental Representations 8.1(a)(i) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) General Cap 8.5 Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(a2.4(c) Initial Allocation 2.1 Interim Financial Statements 3.5(aLocal GAAP 3.7(a) Intervening Event 5.17(j)(iiiMaterial Leased Real Property 3.14(b) Intervening Event Change Net Adjustment Amount 2.4(f) Notice of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DDisagreement 2.4(b) Outside Date 8.1(b)(i9.1(b) Patents 1.1 Overall Cap 8.5 Pensionable Employees 5.16(b) Permits 3.9(b) Personal Information 3.26(a3.23(a) Post-Preliminary Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Statement 2.3 Privacy Laws 3.26(a3.23(a) Proxy Statement 3.29Products Recitals Remote Employees 3.11(a) SEC 3.27(b) Securities Act 3.24 Seller Preamble Seller Insurance 5.17 Seller Subsidiary 2.1 Senior Employee 3.11(g) Shares 2.1 Specific Third Party Contracts 3.18(b) Statutory Accounts 3.7(a) Tax Benefit 8.5(b) Tax Contest 6.4 Tax Representations 8.1(a)(ii) Third Party Approvals 5.9(f) Third Party Claim 8.4(a) Third Party Contracts 3.18(a) Transition Services Agreements 5.20 TUPE Regulations 5.18
Appears in 1 contract
Samples: Stock Purchase Agreement (Coty Inc.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) 1060 Form 2.10 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Allocation Schedule 2.10 Assumed Liabilities 2.3 Audited Financial Statements 5.22(a)(i) Balance Sheet 3.6(b)
(a3.5 Base Purchase Price 2.6 Books and Records 2.1(g) Business Recitals Permits 2.1(f) Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Indemnified Parties 7.2 Buyer Welfare Benefit Plans 5.7(e5.5(e)(i) CERCLA 3.17(d)(iiClosing 2.8(a) Closing Date 2.8(a) COBRA Obligations 5.5(e)(ii) Asset Purchase Agreement Confidentiality Agreement 5.6 Contracts 2.1(a) Debt Commitment 4.4 Deposit 2.7 Direct Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(iDisclosure Schedules Article III dollars, $, US$ 9.14 Easements 3.11(e) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Escrow Agent 2.7 Escrow Fund 2.7 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(bFinal Purchase Price Adjustment Amount 2.9(h)(i) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) 3.5 Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aFranchise Transfer Resolution 5.7(c)(i) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Guarantees 5.8 including 9.5 Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(aIP Addresses 2.1(k) Initial Allocation 2.1 Interim Financial Statements 3.5(aLeased Real Property 3.11(c) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Liquidity Transaction 2.7 Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DMaterial Contracts 3.15(a) Outside Date 8.1(b)(iNames 5.9 New Properties 5.3 Owned Real Property 3.11(a) Patents 1.1 Personal Information 3.26(aPermits 3.7(b) Post-Closing Claims 5.13(aPhase I Assessment 5.2(d) Pre-Closing Contract Liabilities 2.4(fPole Attachment Agreement 3.15(a)(i) Privacy Laws 3.26(aPotential Contributor 7.6 Programming Services 5.14(a) Proxy Statement 3.29Purchase Price 2.6 Qualified Intermediary 9.12 Real Property 2.1(b) Representatives 5.2(a) Retained Assets 2.5(b) Retained Employees 5.5(a) Retained Franchise 2.5(b) Retained Shares 2.5(b) Securities Act 4.9 Seller Preamble Seller Indemnified Parties 7.3 Seller RGU Objection 2.9(e)(ii) Asset Purchase Agreement Seller Working Capital Objection 2.9(d)(ii) Seller’s Required Consent Letter 5.7(c)(i)
Appears in 1 contract
Samples: Asset Purchase Agreement (Charter Communications Inc /Mo/)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cAcquisition Engagement 11.20(a) Acquisition Proposal 5.17(j)(iAffected Employees 6.7(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(bAllocation Schedule 7.7(b) Applicable Date 3.6(dAccounting Principles 2.3(a) Assumed Liabilities 2.3 Assignment Agreement 6.5(b) Balance Sheet 3.6(b)
(a4.6(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Indemnified Parties 9.2 Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(eTermination Fee 10.3(a) CERCLA 3.17(d)(ii4.16(e)(iv) Claim Notice 7.4(aInformation 9.4(b) Closing 2.6 2.2(a) Closing Balance Sheet 2.7 Cash 2.3(b) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(iClosing Indebtedness 2.3(b) Confidential Information 5.8(bClosing Net Working Capital 2.3(b) Copyrights 1.1 Customer 5.3(a)(iiiCommon Stock Recitals Company Preamble Confidentiality Agreement 6.8 D&O Indemnified Parties 6.12(a) Debt Financing 5.21(aDeductible Amount 9.5(a)(iii) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DDeposit Recitals Disclosure Schedules Article III Ducommun Credit Agreement 2.2(b)(iii) DGCL 4.6 Direct Claim 7.4(cElection Forms 7.7(a) Effect 1.1 Employee Plans 4.10(a) Environmental Laws 3.17(d)(i4.16(e)(i) Equity Financing 5.21(aEnvironmental Permits 4.16(e)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cERISA 4.10(a) Excluded Liabilities 2.4 Existing Stock 5.14(bEstimated Cash 2.3(a) Fairness Opinion 3.2(bEstimated Indebtedness 2.3(a) FDA 1.1 Estimated Net Working Capital 2.3(a) Facilities 4.16(e)(iii) FCPA 4.20 Final Closing Statement 2.3(b) Financial Statements 3.5(a4.6(a) Financing 5.21(aXxxxxx Xxxx 11.20(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Guarantees 6.11 Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b4.16(e)(iv) Indemnified Party 7.4(a9.4(a) Indemnifying Party 7.4(a9.4(a) Independent Accounting Firm 2.8(a2.3(d) Initial Allocation 2.1 Interim Financial Statements 3.5(a4.6(a) Intervening Event 5.17(j)(iiiMaterial Contracts 4.15(a) Intervening Event Change Material Customers 4.18 Material Vendors 4.18 Net Adjustment Amount 2.3(g)(i) Notice of Recommendation 5.17(d)(iiDisagreement 2.3(c) Licensed Excluded IP 3.13(hParent Preamble Permits 4.8(c) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DPotential Contributor 9.6 Preliminary Closing Statement 2.3(a) Outside Release 4.16(e)(v) Remediation 4.16(e)(vi) Restricted Customer 6.14 Restricted Part Numbers 6.14 Sample Statement 2.3(a) Section 336(e) Consideration 7.7(b) Section 336(e) Election 7.7(a) Seller Preamble Seller Indemnified Parties 9.3 Shares Recitals Strata 6.14 Termination Date 8.1(b)(i10.1(c) Patents 1.1 Personal Information 3.26(aThird Party Claim 9.4(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.29Varian 6.14
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cDefinition Location ACA 4.15(e) Acquisition Proposal 5.17(j)(iAcceleration Event 2.6(e) Aggregate Consideration 2.5(a) Agreement Preamble Alternative Acquisition Annual Financial Statements 4.5(a) Assigned Contracts 2.1(b) Assignment and Assumption Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d3.2(a)(ii) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(aAzunia Note 3.2(a)(x) Bxxx of Sale 3.2(a)(i) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Indemnitees 8.2 Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Releasees 7.12 Closing 2.6 Closing Balance Sheet 2.7 3.1 Closing Date 2.6 3.1 Definition Location COBRA 5.7(d4.15(c) Code 1.1 Competing Business 5.3(a)(iCompany Preamble Company Indemnitees 8.3 Company Products 4.20(a) Confidential Information 5.8(bCompany Related Party 4.23 Earnout Consideration 2.6(b) Copyrights 1.1 Customer 5.3(a)(iiiEarnout Dispute Notice 2.6(c)(iii) Debt Financing 5.21(aEarnout Statement 2.6(c)(ii) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DEmployee Assignment Agreement 4.11(f) DGCL 4.6 Direct Claim 7.4(cEmployment Laws 4.16(b) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a4.5(a) Financing 5.21(aFixed Number of Shares 2.6(a)(i) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(iiFundamental Representations 8.1 HCERA 4.15(e) Health Care Permits 3.27(cReform Laws 4.15(e) HIPAA 1.1 HSR Act 3.3(bHealth Plan 4.15(e) Indemnified Party 7.4(a8.5(a) Indemnifying Party 7.4(a8.5(a) Indemnity Threshold 8.5(d) Independent Accounting Firm 2.8(a2.6(c)(iii) Information Systems 4.11(h) Initial Allocation 2.1 Consideration 2.5(a) Initial Earnout Consideration 2.6(a)(ii) Initial Earnout Payment Date 2.6(d)(i) Initial Purchase Price for Assets 2.6(a)(ii) Inventory 2.1(a) IP Representations 8.5(d) Key Customer 4.19(a) Key Vendor 4.19(b) Last Balance Sheet 4.5(a) Last Balance Sheet Date 4.5(a) Last Interim Financial Statements 3.5(a4.5(a) Intervening Event 5.17(j)(iiiM&A Qualified Beneficiary 4.15(g) Intervening Event Change of Recommendation 5.17(d)(iiPer-Claim Threshold 8.5(d) Licensed Permitted Encumbrances 4.8 Personal Data Obligations 4.11(k) Process 4.11(k) Processing 4.11(k) Promissory Note 2.5(b) Purchased Assets 2.1 Releasing Parties 7.12 Resale Shelf 7.2(a) Restricted Period 7.13(a) Securities Act 3.2(a)(vi) Selling Group 7.1(d) Specified Excluded IP 3.13(hLiabilities 2.4 Subsequent Earnout Consideration 2.6(b) Losses 7.2 Marks 1.1 Notice Substitute Payment 2.5(b) Suspension Period 5.17(d)(i)(D7.2(b) Outside Date 8.1(b)(iTangible Personal Property 2.1(d) Patents 1.1 Personal Information 3.26(aTransaction Recitals Transfer Taxes 7.8 Transferring Employees 7.1(b) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.29WARN Act 7.1(c)
Appears in 1 contract
Samples: Asset Purchase Agreement (Eastside Distilling, Inc.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c401(k) Acquisition Proposal 5.17(j)(iPlan 5.7(a) Adjustment Statement 2.4(a) Adverse Disclosure Annex a Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EDate Preamble AI 3.18(c) Alternative Financing 5.21(bAI Inputs 3.18(c) Applicable Date 3.6(dAI Technology 3.18(c) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(aAnnex A Indemnified Party Annex A Annex A Indemnifying Party Annex A Annex A Losses Annex a Anti-Money Laundering Laws 3.20(m) Business Recitals Antitrust Order 5.3(b) Block Trade Annex A Buyer Financial Statements 4.7(b) Buyer Preferred Stock 4.3(a) Buyer Sub Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(iiSub 1 Recitals Buyer-Prepared Returns 5.8(c)(ii) Claim Notice 7.4(a8.4(a) Claims Period 8.4(a) Closing 2.6 Closing Balance Sheet 2.7 2.2 Closing Date 2.6 COBRA 5.7(d2.2 -Closing Tax Period Tax Return 5.8(c)(i) Code 1.1 Competing Business 5.3(a)(iCommercialization 3.17(a)(i) Confidential Information 5.8(bCompany Recitals Company Disclosure Schedule Article III Company Indemnified Parties Section 5.10(a) Copyrights 1.1 Customer 5.3(a)(iiiCompany Insurance Policies 3.11 Company IP 3.17(a)(ii) Debt Financing 5.21(aCompany Products 3.17(a)(iii) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Company Registered Intellectual Property 2.2(c3.17(a)(iv) Excluded Liabilities 2.4 Existing Stock 5.14(bCompany Trademarks 5.15(b) Fairness Opinion 3.2(bCompany-Owned IP 3.17(a)(v) FDA 1.1 Contaminants 3.17(k) Contributor 3.17(f) Controlling Party 5.8(d)(ii) D&O Tail Policy 4.5(b) Data Protection Program 3.18(b) Deductible Amount 8.3(b) Determination Date 2.4(e) Dispute Period 8.5(b) Effectiveness Period Annex A Employment Agreement Recitals Enforceability Exceptions 3.2(a) Escrow Agreement 6.2(e)(vi) Estimated Closing Cash 2.3(i) Estimated Closing Debt 2.3(i) Estimated Closing Transaction Expenses 2.3(i) Estimated Working Capital 2.3(i) Estimated Working Capital Shortfall 2.3(i) Estimated Working Capital Surplus 2.3(i) Extended Termination Date 7.1(a)(i) Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aGovernmental Consent 5.3(a) Group Health Company Plan 5.7(d3.14(a) Hazardous Substances 3.17(d)(iiIndemnifiable Losses 8.2 Indemnifiable Matters 8.2 Indemnified Parties 8.2 Independent Accountant 2.4(d) Health Care Permits 3.27(cInsurance Policies 3.11 Intellectual Property 3.17(a)(vi) HIPAA 1.1 HSR Act 3.3(bIntended Tax Treatment 5.8(j) Indemnified Intercompany Balances 5.18 Interruption Period Annex A Material Contract 3.10(a) Material Customers 3.10(a)(i) Material Distributor 3.21(a) Material Suppliers 3.10(a)(i) Multiemployer Plan 3.14(f) Negative Adjustment Amount 2.4(e) Non-Controlling Party 7.4(a5.8(d)(i) Indemnifying Party 7.4(aNon-Public Information 3.17(h) Independent Accounting Firm 2.8(aObjection Deadline 8.4(b) Initial Allocation 2.1 Interim Financial Statements 3.5(aObjection Notice 8.4(b) Intervening Event 5.17(j)(iiiObjections Statement 2.4(c) Intervening Event Change of Recommendation 5.17(d)(iiOpen Source Materials 3.17(a)(vii) Licensed Excluded IP 3.13(hParent Preamble Positive Adjustment Amount 2.4(e) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) PostPreamble 1 Pre-Closing Claims 5.13(aActions 5.9 Pre-Closing Period 5.1(a) Pre-Closing Tax Audit 5.8(d)(i) Privileged Communications 9.11 Proprietary Software 3.17(a)(viii) R&W Policy Recitals Related Party Contract Liabilities 2.4(f3.16 Related Person 3.16 Releasing Parties 5.14 Representation Matters 8.2 Resale Prospectus Supplement Annex A Resale Registration Statement Annex A Rights of Publicity 3.17(a)(ix) Privacy Laws 3.26(aSelected Courts 9.8(b) Proxy Statement 3.29Seller Preamble Seller Confidentiality Agreement 5.5(b) Seller Group 9.11 Seller Insurance Policies 3.11 Seller Plans 3.14(a) Share Purchase Recitals Software 3.17(a)(x) Specified Employee 5.13(a) Stockholder Information Annex A Survival Date 8.1 Termination Date Annex A, 7.1(a)(i) Third-Party Claim 8.5(a) Third-Party IP 3.17(a)(xi) Trademarks 3.17(a)(vi) Transfer Taxes 5.8(a) WARN 3.15(c) WKSI 4.7(d)
Appears in 1 contract
Samples: Share Purchase Agreement (Take Two Interactive Software Inc)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) ACF Preamble ACM Preamble Agency Transfer Costs 10.1 Agreement Preamble Alternative Asset Acquisition Statement 2.9 Assignment and Assumption Agreement 5.17(a)(ii)(E2.7(b)(ii) Alternative Financing 5.21(b) Applicable Date 3.6(dAssumed Benefit Plans 5.7(a) Assumed Liabilities 2.3 Balance Sheet 3.6(bA&R Management Agreement 2.7(b)(xv) Bankruptcy and Equity Exception 3.2 Xxxx of Sale 2.7(b)(i) Board Recitals Buyer Preamble Buyer Fundamental Representations 7.2(a) Buyer Indemnified Person 8.2(a) CERCLA 3.15(f)(iii) Change in Recommendation 5.11(c) Claim Notice 8.4(a) Claimed Amount 8.4(a)(ii) Closing 2.7(a) Closing Acquired Servicing Portfolio 2.8(a) Closing Date 2.7(a) Closing Purchase Price 2.8(a) Closing Statement 2.8(b) Collateral Source 8.3(b) Conclusive Closing Statement 2.8(d) Confidential Information 5.8(b) Confidentiality Agreement 5.8(a) Covenant Support Letter 2.7(b)(x) Copyrights 1.1 Deductible 8.3(a) Disputed Items 2.8(c) End Date 9.1(c) Environmental Claim 3.15(f)(i) Environmental Laws 3.15(f)(ii) Estimated Closing Acquired Servicing Portfolio 2.8(a) Estimated Closing Excess Servicing Strip and Xxxxxxx Mac I/O Strip 2.8(a)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiEstimated Closing Weighted Average Servicing Fee 2.8(a) Buyer Expenses 8.4(cEstimated Deficit Amount 2.6(c)(i) Buyer Welfare Plans 5.7(eEstimated Excess Amount 2.6(c)(ii)
(a) CERCLA 3.17(d)(iiEstimated Net Working Capital Deficiency Amount 2.8(a) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(bFinal Closing Acquired Servicing Portfolio 2.8(e)(ii)(E) Fairness Opinion 3.2(bFinal Closing Excess Servicing Strip and Xxxxxxx Mac I/O Strip 2.8(e)(ii)(G) FDA 1.1 Financial Statements 3.5(aFinal Closing Weighted Average Servicing Fee 2.8(e)(ii)(F) Financing 5.21(aFinal Deficit Amount 2.8(h)(i) Financing Commitments 4.4 Finished Goods Inventory Final Excess Amount 2.8(a2.8(h)(ii) Group Health Plan 5.7(dFinal Net Working Capital 2.8(e)(ii)(B) Final Net Working Capital Deficiency Amount 2.8(e)(ii)(D) Final Net Working Capital Excess Amount 2.8(e)(ii)(C) Final Purchase Price 2.8(e)(ii)(A) Xxxxxxx Mac I/O Strip Assignment Agreement 2.7(b)(xiv) Fundamental Representations 8.1 Hazardous Substances 3.17(d)(ii3.15(f)(iii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Hunton 2.7(b)(xxiv) Indemnifiable Damages 8.2(a) Indemnified Party 7.4(aPersons 8.2(b) Indemnifying Party 7.4(aIndemnity Termination Date 8.1 Intellectual Property Assignment Agreement 2.7(b)(xiii) Independent Accounting Firm 2.8(aLeased Property Assignments 2.7(b)(xxiii) Initial Allocation 2.1 Interim Financial Statements 3.5(aLoan Documents 3.18(f) Intervening Event 5.17(j)(iiiLoan Files 3.18(f) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Master Participation Agreement 2.7(b)(xii) Material Contracts 3.16(a) Mini-Basket 8.3(a) Non-Compete Agreement 2.7(b)(v) Non-Dispute Notice Period 5.17(d)(i)(D2.8(f)(i) Outside Date 8.1(b)(iNon-Unit Consideration 2.6(b) Obligations Article III Option Agreement 2.7(b)(iv) Offering Documents 5.13(a) Parent Preamble Parent Offering 5.13(a) Parent Preferred Stock 4.8(a) Parent Stockholders 5.11(c) Parent Stockholder Approval 4.6 Partnership Preamble Party Preamble Patents 1.1 Personal Information 3.26(aPCBs 3.15(a) Post-Closing Claims 5.13(aPension Plan 3.9(e) Permitted Encumbrances 3.4(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(aPeriod 6.1 Preferred Equity Amount 5.14 Preferred Equity Documentation 5.14 Proprietary Software 3.12(a) Proxy Statement 3.295.11(a) Purchase Price Adjustment Amount 2.8(e)(ii) Purchased Assets 2.1 Real Property Leases 3.11(a) Reference Market Value 2.6(b) Release 3.15(f)(iv) Required Information 5.13(a) Resolution Period 2.8(c) Revised Statements 2.9 SEC 5.11(a) Seller Preamble Seller Benefit Plans 3.9(b) Seller Closing Statement 2.8(a) Seller Dispute Notice 2.8(c) Seller Fundamental Representations 7.3(a) Seller Indemnified Person 8.2(b) Seller Registered IP 3.12(a) Servicing Advance Schedule 3.18(r) Stockholders Meeting 5.11(c) Straddle Period 6.2 Support Agreement 2.7(b)(iii) Termination Fee 9.2(c)(i) Third Party Claim 8.5(a) Trademark License Agreement 2.7(b)(xi) TRS Preamble Unit Consideration 2.6(b)(ii) Voting and Standstill Agreement Recitals
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(iDefinition Location Accounting Firm 5.8(e) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a3.5(a) Balance Sheet Date 3.5(a) Binder 5.15 Books and Records 2.1(i) Business Recitals Domain Names 3.13(a) Business Intellectual Property 2.1(d) Business Patents 3.13(a) Business Permits 2.1(h) Business Registered Copyrights 3.13(a) Business Registered IP 3.13(a) Business Registered Marks 3.13(a) Buyer Preamble Buyer Employees 5.3(a)(ii) Indemnified Parties 8.2 Buyer Expenses 8.4(cParent Recitals Buyer Savings Plan 5.6(d) Buyer Welfare Benefit Plans 5.7(e5.6(e)(i) CERCLA 3.17(d)(iiCap 8.5(a)(i) Claim Notice 7.4(aCBAs 3.16(a)(v) Classified Ventures Business 2.2(j) Closing 2.6 Date 2.7(a) Closing Balance Sheet 2.7 Net Working Capital 2.9(a) Closing Date 2.6 Statement 2.9(a) COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(iObligations 5.6(e)(ii) Confidential Information 5.8(b5.7(b) Definition Location Confidentiality Agreement 5.7(a) Contracts 2.1(b) Copyrights 1.1 Customer 5.3(a)(iiiCurrent Assets 1.1 Current Liabilities 1.1 Deductible Amount 8.5(a)(ii) Debt Financing 5.21(aDisclosure Schedules Article III Domain Names 1.1 Employment Laws 3.10(b) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Insurance Policy 5.15 Environmental Laws 3.17(d)(i3.15(c)(i) Equity Financing 5.21(aEnvironmental Permits 3.15(c)(ii) Equity Financing Commitment 4.4 ERM 5.18 ERM Phase I Investigation 5.18 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cEmployees 5.6(a) Excluded Liabilities 2.4 Existing Stock 5.14(bExcluded Real Property 2.2(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(aFundamental Representations 8.1 Guarantees 5.9 Hazardous Materials 3.15(c)(iii) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Hydraulic Lift Remedial Actions 5.18 Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(a2.9(c) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iiiInventory 2.1(g) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hLeased Real Property 2.1(c) Losses 7.2 8.2 Marks 1.1 Material Contracts 3.16(a) Minimum Loss Amount 8.5(a)(ii) Net Adjustment Amount 2.9(d)(i) Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(iof Disagreement 2.9(b) Patents 1.1 Personal Information 3.26(aPermits 3.7(b) Post-Closing Claims 5.13(a) Tax Period 6.1 Potential Contributor 8.6 Pre-Closing Contract Liabilities 2.4(fTax Period 6.1 Preliminary Closing Statement 2.8(a) Privacy Laws 3.26(aPreliminary Net Working Capital 2.8(a) Proxy Statement 3.29Price Allocation 2.10(a) Publications 2.1(l) Real Property 2.1(c) Definition Location Receivables 2.1(e) Schedule Supplement 5.3 Seller Preamble Seller Indemnified Parties 8.3 Seller Savings Plan 5.6(d) Tangible Personal Property 2.1(f) Tax Representations 8.1 Termination Date 9.1(c) Third Party Claim 8.4(a) Title Policy 7.3(d) Transferred Assets 2.1 Transferred Employees 5.6(a) Wanderful Media Business 2.2(j) WARN Act 5.6(h)
Appears in 1 contract
Samples: Asset Purchase Agreement (New Media Investment Group Inc.)
Table of Definitions. The following Capitalized terms have the meanings set forth are defined in the Sections referenced belowfollowing sections of this Agreement: 510(k)s 3.27(cAccountants 9(o)(iii) Acquisition Proposal 5.17(j)(iAffiliate 8(e)(ii) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EArbitrating Accountant 5(b) Alternative Financing 5.21(bBenefit Plans 9(q)(i)(c) Applicable Date 3.6(dBusiness Recital A Business Day 4 Cash Equivalents 2(b) Assumed Liabilities 2.3 CERCLA 9(u)(i) Claims 1 Closing 7 Closing Balance Sheet 3.6(b4 Closing Date 7 Closing Estimate 6(a) Code 9(m)(i)(C) Company Preamble Control 8(e)(iii) Damages 15(x) Xxxxx 2(f) Xxxxx Amount 2(f) Xxxxxx Agreement 2(c) Xxxxxx Amount 2(e) Deductible 16(a) Delivery Date 4 Disclosure Schedule 9 Dispute 5(a) Dispute Notice 5(a) Dispute Period 5(a) Xxxxx XX 14(f) Employee Benefit Plan 9(q)(i)(c) Environmental Claim 9(u)(ii) Environmental Laws 9(u)(ii)(B) Environmental Permits 9(u)(ii)(C) ERISA 9(q)(i)(A) ERISA Affiliate 9(q)(i) Escrow Agreement 6(a)(i) Escrow Deposit 6(a)(i) Escrowee 6(a)(i) Facility 9(u)(ii)(D) Financial Statements 9(h) GAAP 3 Hazardous Activity 15(e) Hazardous Substances 9(u)(ii)(D) Indebtedness 2(d) Indemnified Employee 14(b)(i) Indemnified Employee Liability 14(b)(i) Indemnified Employees 14(b)(i) Indemnitee 19(a)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c9(x)(ix)(A) Excluded Liabilities 2.4 Existing Stock 5.14(bIntellectual Property Licenses 9(x)(i)(C) Fairness Opinion 3.2(bInterim Financial Statement Date 9(h) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a9(h) Intervening Event 5.17(j)(iiiIRS 6(c) Intervening Event Change of Recommendation 5.17(d)(iiLeased Real Property 9(v) Licensed Excluded IP 3.13(hLiabilities 9(i) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DMass Mutual Entities 9(g)(i) Outside Date 8.1(b)(iMaterial Adverse Effect 9(a) Patents 1.1 Personal Information 3.26(aMaterial Contracts 9(o)(ii) PostOffsite Facility 9(u)(ii)(E) Permits 9(p) Person 8(e)(i) Plan 9(q)(i)(A) Proprietary Software 9(x)(i)(B) Purchase Price 2 Purchaser Preamble Purchaser Indemnitee 15 Purchaser Indemnitees 15 Related Parties 9(cc) Release 9(u)(ii)(F) Return 9(m)(i)(B) Returns 9(m)(i)(B) Seller Preamble Seller Entity 10(b) Seller Indemnitees 17 Seller Releases 14(b)(iii) Sellers Preamble Shares Recital A Software 9(x)(ix)(B) Stockholders' Committee 22 Subsidiary Recital A Tax 9(m)(i)(A) Tax Savings 2(c) Taxes 9(m)(i)(A) Taxing Authority 9(m)(i)(D) Telemotive Industrial Controls Recital A TIC Brazil 9(gg) Third-Closing Claims 5.13(aParty Claim 15(y) Pre-Closing Contract Liabilities 2.4(fTitle IV Plan 9(q)(i)(c) Privacy Laws 3.26(aWelfare Plan 9(q)(i)(B) Proxy Statement 3.29Wenglor Heads 4 Working Capital Adjustment 3
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i5.3(g)(i) Adverse Recommendation Change 5.3(c) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E5.3(c) Alternative Financing 5.21(bAsset Acquisition Statement 2.6(b) Applicable Date 3.6(dAssignment and Assumption Agreement 2.7(b)(ii) Assignment of Purchased Intellectual Property 2.7(b)(iii) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a3.5(a) Bangalore Employees 5.9(c) Xxxx of Sale 2.7(b)(i) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Indemnified Parties 8.2 Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(eTermination Fee 9.3(e) CERCLA 3.17(d)(ii3.15(d)(iii) Claim Notice 7.4(a8.4(e) Closing 2.6 2.7(a) Closing Balance Sheet 2.7 2.8(a) Closing Date 2.6 2.7(a) Closing Working Capital 2.8(a) COBRA 5.7(d5.9(e) Code 1.1 Competing Business 5.3(a)(i5.5(a)(i) Confidential Information 5.8(b5.10(b)
(a) Copyrights 1.1 Core Representations 8.1(a)(i) Customer 5.3(a)(iii5.5(a)(iii) Debt Financing 5.21(aDenver Sublease Agreement 2.7(b)(iv) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DDisclosure Schedule Update 5.6(b) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Disclosure Schedules Article III Environmental Laws 3.17(d)(i3.15(d)(i) Equity Financing 5.21(aEnvironmental Permits 3.15(d)(ii) Equity Financing Commitment 4.4 Estimated Closing Balance Sheet 7.3(f) Estimated Closing Working Capital 7.3(f) Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(bGroup Health Plan 5.9(e) Fairness Opinion 3.2(bHazardous Substances 3.15(d)(iii) FDA 1.1 High Termination Fee 9.3(b) Inbound License Agreements 3.12(g) Indemnified Party 8.4(a) Indemnifying Party 8.4(a) Independent Accounting Firm 2.8(c) IP License Agreement 2.7(b)(v) Low Termination Fee 9.3(c) Master Reseller Agreement 5.14(a) Master Reseller Agreement Term Sheet 5.14(a) Material Business Contracts 3.16(a) Material Development Update 5.6(c) Minimum Loss Amount 8.5(b)(iii) Notice of Disagreement 2.8(b) Open Source License 3.12(i) Outbound License Agreements 3.12(g) Permits 3.7(b) Permitted Business 5.5(a)(i) Permitted Encumbrances 3.4(a) Prime Rate 2.8(e) Proxy Statement 5.4(a) Purchase Price 2.6(a) Purchased Assets 2.1 Release 3.15(d)(iv) Representatives 5.2(a) Revised Statements 2.6(b) Rights Agreement 3.27 Schedule Article III Scheduled IP 3.12(a) Seller Preamble Seller Board 2.7(b)(x) Seller Financial Statements 3.5(a) Financing 5.21(aSeller Indemnified Parties 8.3 Seller Products 3.12(i) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aSeller Review Period 2.8(b) Group Health Plan 5.7(dSeller’s Service Activation/Mediation Product and Services 5.5(a)(i) Hazardous Substances 3.17(d)(iiShared Confidential Information 5.10(b) Health Care Permits 3.27(cStockholder Approval 3.2 Stockholders Meeting 5.4(b) HIPAA 1.1 HSR Superior Proposal 5.3(g)(ii) Third-Party Claim 8.4(a) Third-Party Claim Notice 8.4(a) Transfer Taxes 6.2 Transferring Employees 5.9(b) WARN Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.293.10(e)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced set forth below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) 1999 Agreement 1.1 Adjusted Purchase Price 3.1 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAlternate Assignment 2.1(c) Alternative Financing 5.21(b) Applicable Date 3.6(dAlternate Target Sale 2.1(a) Assumed Liabilities 2.3 2.1(f) Balance Sheet 3.6(b)
(a5.6(a) Business Recitals Breach 12.12(b) Buyer Preamble Buyer Employees 5.3(a)(iiIndemnified Parties 10.2 Buyer’s Objections 9.1(a) Buyer Expenses 8.4(cCash True-Up 3.11(c)(iii) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Casualty Loss 7.3 Claim Notice 7.4(aDeadline 10.5(a) Closing 2.6 3.11(a) Closing Balance Sheet 2.7 Allocated Price 3.10(a) Closing Date 2.6 COBRA 5.7(d3.11(b) Code Closing Management Fee Statement 3.5 Closing Statements 3.3(a) Contest 8.5 CTF Preamble CTF Master Agreement 1.1 Competing Business 5.3(a)(iDe Minimis Amount 10.5(b) Confidential Information 5.8(bDesignee, Designees 12.12(a) Copyrights Dispute Notice 10.4(c) Dutch Pension Plan 22 Effective Date 3.11(c)(i) Emergency Event 1.1 Customer 5.3(a)(iiiEmployment Practices Liabilities 1.1 Estimated Foreign Capex 3.2(b)(ii) Debt Financing 5.21(aEstimated Management Fees 3.5 Estimated North American Capex 3.2(b)(i) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DEstimated PIP Expenditures 3.2(b)(iii) DGCL 4.6 Direct Claim 7.4(cEstimated Total Working Capital 3.2(a) Effect 1.1 Environmental Laws 3.17(d)(iEstoppel Certificates 7.9(e) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cGerman Hotels 2.3(b) Excluded Liabilities 2.4 Existing Stock 5.14(b5.6(b) Fairness Opinion 3.2(bFee Property 2.1(a) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aFee Sale 2.1(a) Group Health Plan 5.7(dA Hotels 7.3(a) Hazardous Substances 3.17(d)(iiGroup A Threshold Amount 7.3(a) Health Care Permits 3.27(cGroup B Hotels 7.3(b) HIPAA Group B Threshold Amount 7.3(b) Guarantee 7.12 Hotel Level Data 5.6(a) HPI Master Agreement 1.1 HSR Act 3.3(bIndemnification Limit 10.5(b) Indemnified Party 7.4(a10.4(a) Indemnifying Party 7.4(a10.4(a) Independent Accounting Firm 2.8(aInformation 7.8 Lease Assignment & Sale 2.1(b) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hLeasehold Property 2.1(b) Losses 7.2 Marks 1.1 Notice 10.2 Management Interest 2.1(d) Mandatory Consent Hotel 9.2(b) Mirror Claim 12.12(b)(i) New Title Matters 9.1(e) Non-U.S. Hotel Investigative Work 9.1(a) Objection Period 5.17(d)(i)(D9.1(a) Outside Date 8.1(b)(iOffer and Solicitation 4.1(b) Patents 1.1 Personal Information 3.26(aOptional Consent Hotel 9.2(a) Post-Closing Claims 5.13(a) Potential Contributor 10.7 Pre-Closing Contract Liabilities 2.4(fTax Period 8.2 Preliminary Allocated Price 2.2(a) Privacy Laws 3.26(aPro Forma 9.1(b) Proxy Statement 3.29Proposed Conveyance Documents 9.1(h) Real Properties 9.1(a) Related Transactions 2.1(h) Requirements 9.1(b) Seller Preamble Seller Indemnified Parties 10.3 Seller Level Data 5.6(a) Seller’s Representations 12.12(b) Execution Copy 13 Solicitation Costs 4.1(b) Straddle Period 8.4 Supported Hotels 2.3(a) Surveyor 9.1(a) Target Foreign Capex Amount 2.6(b) Target North American Capex Amount 2.6(a) Termination Date 11.1(c) Termination Fee 11.1(b)(B) Third Party Claim 10.4(a) Threshold Amount 10.5(b) Title Cure Period 9.1(c) Title Materials 9.1(a) Total Working Capital 3.3(a) Tradenames 5.12 Transaction 2.1 UK Hotels 14 Unadjusted Purchase Price 3.1
Appears in 1 contract
Samples: Purchase and Sale Agreement (Marriott International Inc /Md/)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cAcquisition Engagement 10.19(a) Acquisition Proposal 5.17(j)(i) Affiliate Agreement 3.21 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Audited Financial Statements 5.22 Available Insurance Policies 5.1 Balance Sheet 3.6(b3.6 Business Recitals Business Assets 3.18(b) Business Guarantees 5.8 Buyer Preamble Buyer 401(k) Plan 5.17(c) Buyer Designated Shared Contracts 5.13(c)(i) Buyer Indemnified Party 8.2 Buyer Related Parties 1.1 Buyer Replacement Contracts 5.13(c)(i) CA Buyer Preamble CA Company Recitals CA Seller Recitals CA Shares Recitals CFIA 3.20(b) Closing 2.2(a) Closing Cash 2.3(b) Closing Date 2.2(a) Closing Indebtedness 2.3(b) Closing Net Working Capital 2.3(b) Closing Transaction Expenses 2.3(b) Companies Recitals Company Recitals Competing Transaction 5.18 Confidentiality Agreement 5.5 Continuation Period 5.17(a) Continuing Employee 5.17(a) Contribution Agreement 5.11 Designated Assets 5.11(c) Designated Liabilities 5.11(c) Designated Shared Contracts 5.13(c)(ii) X.X. Xxxxx Marks 5.16 Employee Plans 3.10(a) Environmental Laws 3.16(g)(i) Environmental Permits 3.16(g)(ii) Equity Financing 4.4(a) Equity Financing Commitment Letter 4.4(a) Equity Investor 4.4(a) ERISA 4.10(a)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiEstimated Indebtedness 2.3(a) Buyer Estimated Net Working Capital 2.3(a) Estimated Transaction Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c2.3(a) Excluded Liabilities 2.4 Existing Stock 5.14(bBenefits 5.17(a) Fairness Opinion 3.2(bExcluded Employees 1.1 FDA 3.20(b) FDA 1.1 Final Closing Statement 2.3(b) Financial Statements 3.5(a3.6(a) Financing 5.21(aPurposes 4.4(f) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aXxxxxx Xxxx 10.19(a) Group Health Plan 5.7(dCompany Plans 3.10(a) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bMaterials 3.16(g)(iii) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) 8.3 Independent Accounting Firm 2.8(a2.3(d) Initial Allocation 2.1 In-Scope Requirement 3.11(a) Insurance Policies 3.12 Interim Financial Statements 3.5(a3.6(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(iiLeases 3.13(b) Licensed Excluded Buyer IP 3.13(h5.15(b) Licensed Seller IP 5.15(a) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 8.2 Material Contract Approvals 5.13(a) PreMaterial Contracts 3.17(a) Material Customers 3.24(a) Material Suppliers 3.24(b) Multiemployer Plans 3.10(d) Net Adjustment Amount 2.3(g)(i) New Plan 5.17(b) Newco 5.11(c) Non-US Plans 3.10(h) Notice of Disagreement 2.3(c) PBCG 3.10(f) Permits 3.8(c) Pickles and Refrigerated Dough Business 5.11 Pickles and Refrigerated Dough Transfer 5.11(c) Preliminary Closing Contract Liabilities 2.4(fStatement 2.3(a) Privacy Laws 3.26(aPrior Reorganization Recitals Real Property 3.13(c) Proxy Statement 3.29Registered Intellectual Property 3.14(a) Replacement Contracts 5.13(c)(ii) Restrictive Covenant Agreement Recitals Securities Act 4.6 Seller Indemnified Party 8.3 Seller Plans 4.10(a) Sellers Recitals Shared Procurement Contracts 5.13(b)(i) Shares Recitals Subject Courts 10.22 Subsequent Reorganization 5.11 Subsidiary Sellers Recitals Termination Date 9.1(c) Third Party Claim 8.4(b) Title Commitment 1.1 Title IV Plan 3.10(d) Trade Controls 3.25(b) Transferred Subsidiaries Recitals TreeHouse Preamble TreeHouse Designated Shared Contracts 5.13(c)(ii) TreeHouse Replacement Contracts 5.13(c)(ii) Union Members 5.17(e) US Buyer Preamble US Company Recitals US Sellers Recitals US Shares Recitals USDA 3.20(b) WARN Act 3.11(d)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EApproved Consultant 6.2(b) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a4.6(a) Business Recitals Buyer Bidder Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(aBidder Guarantor Preamble Closing 2.2(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(iCOFECO 3.3(b) Confidential Information 5.8(bCOFETEL 3.3(b) Copyrights 1.1 Customer 5.3(a)(iiiCompany Preamble Covered Parties 6.15(a) Debt Financing 5.21(aDBM Preamble Determination Date 8.1(i) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DDisclosure Schedules Article III Dispute 9.10 Employee Plans 4.10(a) DGCL 4.6 Direct Environmental Claim 7.4(c4.17(d)(i) Effect 1.1 Environmental Laws 3.17(d)(i4.17(d)(ii) Equity Financing 5.21(aEnvironmental Permits 4.17(d)(iii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Execution Date Preamble Financial Statements 3.5(a4.6(a) Financing 5.21(aFN Preamble Guaranteed Obligations 6.21 ICC Rules 9.10 Improvements 4.13(c) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a4.6(a) Intervening Event 5.17(j)(iiiIssuing Bank 6.13(a) Intervening Event Change ITU 4.15(b) Joinder Agreement Recitals Major Fuel Deficiency 6.2(b) *** Certain confidential portions of Recommendation 5.17(d)(iithis exhibit were omitted by means of redacting a portion of the text. Copies of the exhibit containing the redacted portions have been filed separately with the Securities and Exchange Commission subject to a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act. Material Contracts 4.18(a) Licensed Excluded IP 3.13(hME 3.3(b) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DMIFR 4.15(d) Outside MXJV Recitals MXJV Partner Recitals Permits 4.8(b) Potential Transaction 6.17 Projected Closing Date 8.1(b)(i8.1(i) Patents 1.1 Personal Information 3.26(aQualified Bank 6.13(a) Post-Closing Claims 5.13(aSatellite Health Data 4.15(a) Pre-Closing Contract Liabilities 2.4(fSCT 3.3(b) Privacy Laws 3.26(a) Proxy Statement 3.29Seller Preamble Sellers Preamble Termination Date 8.1(d)
Appears in 1 contract
Samples: Stock Purchase Agreement (Satelites Mexicanos Sa De Cv)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cACA 4.10(i) Acquisition Proposal 5.17(j)(iEngagement 10.20(a) Affected Employees 6.12(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(bRecovery 8.5(c) Applicable Date 3.6(dAccounting Principles 2.4 Applicable Survival Period 8.1(c) Assumed Liabilities 2.3 Balance Sheet 3.6(b4.6(a) Balance Sheet Date 4.6(a) Bankruptcy Code 6.11(b)(v) Benefits Period 6.12(b) Buyer Preamble Buyer FSA Plan 6.12(i) Buyer Indemnified Parties 8.2 Cap 8.2(a)(ii) Claim Information 8.4(a) Closing 2.2 Closing Cash 2.5(a) Closing Date 2.2 Closing Indebtedness 2.5(a) Closing Net Working Capital 2.5(a) Closing Transaction Expenses 2.5(a) COBRA 6.12(j) Company Preamble Confidentiality Agreement 6.6 Copyrights 1.1 Current FDD 4.18(f) Debt Commitment Letter 5.4(a) Debt Financing 5.4(a) Deductible 8.2(a)(ii) Derivative Software 6.11(b)(ii) Disclosure Schedules Article III Employee Plans 4.10(a) Environmental Reports 4.17(e) Equity Financing 5.4(a) Equity Financing Commitment 5.4(a) ERISA 4.10(a) Estimated Cash 2.3 Estimated Indebtedness 2.4 Estimated Net Working Capital 2.4 Estimated Transaction Expenses 2.4 Excluded Information 1.1 Final Closing Statement 2.5(a) Financial Statements 4.6(a) Financing 5.4(a) Financing Commitments 5.4(a) Former Franchisees 4.18(a) Franchisee Association 4.18(j) Franchisor FDDs 4.18(f) Franchisor Schedule Period 4.18(a) FTC Rule 1.1 Fundamental Representations 8.1(a)(ii)
(a) Business Guarantee Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 Guarantors Recitals HSR Act 3.3(b) 1.1 Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(a2.5(c) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hInsurance Policies 4.12 Liabilities 4.6(b) Losses 7.2 8.2 Marks 1.1 Material Contracts 4.19(a) Xxxxxx Xxxxxxx 3.5 Net Adjustment Amount 2.5(f)(i) Notice Period 5.17(d)(i)(Dof Disagreement 2.5(b) Outside Date 8.1(b)(i9.1(c) Outstanding Consents 6.8(d) Patents 1.1 Personal Information 3.26(aPCI 4.14(h) PCI-DSS 4.14(h) Permits 4.8(b) Post-Closing Claims 5.13(aPeriod Tax Contest 6.13(c)(ii) Potential Contributor 8.7 Pre-Closing Contract Liabilities 2.4(fIncome Tax Returns 6.13(a) Privacy Laws 3.26(aPreliminary Closing Statement 2.4 Proposal 6.6 Qdoba Business Registered IP 4.14(a) Proxy Real Property Lease 4.13(b) Redacted Fee Letter 5.4(a) Related Party 9.3(b) Required Amount 5.4(f) Retained Marks 6.11(a) Sample Statement 3.292.4 Secret Information 1.1 Securities Act 5.8 Seller Preamble Seller FSA Plan 6.12(i) Seller Guarantees 6.15 Seller Indemnified Parties 8.3 Severance Period 6.12(c)
Appears in 1 contract
Samples: Stock Purchase Agreement (Jack in the Box Inc /New/)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cActive Employee 5.5(a) Acquisition Proposal 5.17(j)(iActual Inventory Amount 2.8(a) Agreed Allocation 2.9 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(dAnti-Corruption Laws 3.7(c) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(aAudited Financial Statements 5.17(a) Business Recitals Business Intellectual Property 2.1(c) Business Permits 2.1(f) Business Registered IP 3.12(a) Buyer Preamble Buyer Employees 5.3(a)(ii) Group 8.2 Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(aLicensed Marks 5.9(c) Closing 2.6 Closing Balance Sheet 2.7 2.7(a) Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i2.7(a) Confidential Information 5.8(b5.6 Confidentiality Agreement 5.6 Deductible 8.4(c) Copyrights 1.1 Customer 5.3(a)(iiiDisclosure Schedules Article III Environmental Claim 3.14(d)(i) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i3.14(d)(ii) Equity Financing 5.21(aEnvironmental Permits 3.14(d)(iii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d3.19 FDCA 3.16 Xxxxxx Xxxx 2.2(q) Hazardous Substances 3.17(d)(ii3.14(d)(iv) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Inactive Employee 5.5(a) Indemnification Cap 8.4(a) Indemnified Party 7.4(a8.5(a) Indemnifying Party 7.4(a8.5(a) Independent Accounting Firm 2.8(aInventory 2.1(e) Initial Allocation 2.1 Interim Financial Statements 3.5(aKHC Licensed Marks 5.9(b) Intervening Event 5.17(j)(iiiKHC Marks 5.9(a) Intervening Event Change of Recommendation 5.17(d)(iiLeased Real Property 3.11(b) Licensed License Term 5.9(b) Material Contracts 3.15(a) Materials 5.9(a) Owned Real Property 3.11(a) P3 Excluded IP 3.13(hProducts 1.1 Per-Claim Test 8.4(b) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(aPermits 3.7(e) Pre-Closing Contract Liabilities 2.4(fCovenant 8.1(a) Privacy Laws 3.26(aPurchase Price 2.6 Real Property 2.1(b) Proxy Statement 3.29Real Property Lease 3.11(b) Seller Group 8.3 10 Seller Guarantees 5.8 Seller Parent Preamble Subject Action 5.24(a) Termination Date 7.1(c) Third-Party Claim 8.5(a) Transfer Taxes 5.15(a) Transferred Assets 2.1 Transferred Contracts 2.1(a) Transferred Employees 5.5(a) Transitional Period 5.9(a) UPC Codes and Prefixes 2.1(j)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cAAA 10.9(a) Acquisition Proposal 5.17(j)(i) Subs Preamble Adknowledge Preamble Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EB&B Preamble Business Patents 3.13(a) Alternative Financing 5.21(bBusiness Registered Copyrights 3.13(a) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(bBusiness Registered IP 3.13(a)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(aBuyers Preamble Cap 8.6(a)(i) Closing 2.6 Closing Balance Sheet 2.7 2.6(a) Closing Date 2.6 COBRA 5.7(d2.6(a) Code 1.1 Competing Business 5.3(a)(iClosing Net Working Capital Statements 2.7(a) Confidential Information 5.8(b5.3(a) Copyrights 1.1 Customer 5.3(a)(iii[***] 7.1(a) Debt Financing 5.21(aDisclosing Parties 10.9(c) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DDisclosure Schedules Article III European Acquisition Sub Preamble European Assumed Liabilities 2.3(b) DGCL 4.6 Direct Claim 7.4(cEuropean Balance Sheet 3.5(a) Effect 1.1 Environmental Laws 3.17(d)(iEuropean Carveout Procedures 3.5(a) Equity Financing 5.21(aEuropean Closing Net Working Capital Statement 2.7(a) Equity Financing Commitment 4.4 European Media Business Recitals European Purchase Price 2.5(b) Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a8.5(a) Indemnifying Party 7.4(a8.5(a) Independent Accounting Firm 2.8(a2.7(c) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iiiLosses 8.2 Material Contracts 3.15(a) Intervening Event Change Media Business Recitals MIVA Preamble [***] = Confidential treatment requested for redacted portion; redacted portion has been filed separately with the Securities and Exchange Commission. MIVA (UK) Preamble New York Convention 10.9(b) Notice of Recommendation 5.17(d)(iiDisagreement 2.7(b) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(aOrder 6.4 Permits 3.7(b) Post-Closing Claims 5.13(a) Tax Period 8.4 Pre-Closing Tax Period 8.4 Price Allocation 6.1 Proposed Expert 10.9(c) [***] 2.3(b) Restricted Contract 5.4(a) Restricted Period 5.10(a) Seller Solvency Certificate 2.6(b)(ii)(D) Seller(s) Preamble Third Party Claim 8.5(a) Transferring Employees 5.8(a) TUPE 5.8(d) U.S. Assumed Liabilities 2.4(f2.3(a) Privacy Laws 3.26(aU.S. Balance Sheet 3.5(a) Proxy U.S. Carveout Procedures 3.5(a) U.S. Closing Net Working Capital Statement 3.292.7(a) U.S. Media Business Recitals U.S. Purchase Price 2.5(a) US Acquisition Sub Preamble
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c1060 Forms 2.10 Acquisition Date 3.10(b) Acquisition Proposal 5.17(j)(iAdditional Unaudited Financial Statements 5.14(b) Adjustment Escrow 2.6(b) Adjustment Escrow Account 2.6(b) Adjustment Escrow Agent 2.6(b) Adjustment Escrow Agreement 2.6(b) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Allocation Schedule 2.10 Assumed Liabilities 2.3 Audited Financial Statements 3.5(a) Balance Sheet 3.6(b)
(a3.5(a) Balance Sheet Date 3.5(a) Base Purchase Price 2.6(a) Books and Records 2.1(g) Business Recitals Permits 2.1(f) Buyer Preamble Buyer Employees 5.3(a)(iiIndemnified Parties 7.2 Buyer’s Financing 5.16(a) Buyer Expenses 8.4(cCapital Project 5.1(b) Buyer Welfare Plans 5.7(eCapital Project Notice 5.1(b) CERCLA 3.17(d)(iiCash Purchase Price 2.6(b) Claim Notice 7.4(a) Closing 2.6 EBU Count 2.6(d) Closing Balance Sheet 2.7 2.8(a) Closing Date 2.6 COBRA 5.7(d2.8(a) Code 1.1 Competing Business 5.3(a)(iAcquisition 5.18 Compliance Costs 5.1(b) Confidential Information 5.6(b) Contracts 2.1(a) Deposit 2.7(a) Disclosure Schedules Article III Domain Name Agreement 5.8(b) Copyrights 1.1 Customer 5.3(a)(iiiEasements 3.11(d) Debt Financing 5.21(aEmployee List 5.5(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cEmployees 5.4(a) Excluded Liabilities 2.4 Existing Stock 5.14(bExcluded Marks 2.2(h) Fairness Opinion 3.2(bExcluded Representations 7.1 Financing Letter 4.4 Franchise Transfer Resolution 5.7(c)(i) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Guaranties 3.22 Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a5.14(d) Intervening Event 5.17(j)(iii) Intervening Event Change Letter of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hCredit 2.7(a) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DMaterial Adverse Effect 6.3(a) Outside Date 8.1(b)(iMaterial Contracts 3.15 Permits 3.7(b) Patents 1.1 Personal Information 3.26(aPhase I Assessment 5.2(d) Post-Closing Claims 5.13(aPole Attachment Agreement 3.15(i) Pre-Closing Contract Liabilities 2.4(fEscrow Agent 2.7(a)
(a) Privacy Laws 3.26(aPurchase Price 2.6(a) Proxy Statement 3.29Real Property 2.1(b) Representatives 5.2(a) Retained Franchise 2.5(b) Retained Franchise Management Agreement 2.5(b) Seller Preamble Seller Group 5.18 Seller Indemnified Parties 7.3 Seller Note 2.6(b) Seller’s Auditor 5.14(a) Seller’s Required Consent Letter 5.7(c)(i) Subscriber Objection 2.9(d)(ii) Systems Recitals Surveys 6.3(i) System Report 3.5(b) Systems Recitals Tangible Personal Property 2.1(e) Termination Date 8.1(c) Third Party Claim 7.4(a) Title Company 6.3(h) Title Policies 6.3(h) Transfer Tax Returns 5.17(b) Transfer Taxes 5.17(a) Transferred Assets 2.1 Transferred Employee 5.4(a) Transferred Intellectual Property 2.1(h) Updated Employee List 5.4(a) Working Capital Objection 2.9(c)(ii)
Appears in 1 contract
Samples: Asset Purchase Agreement (Atlantic Broadband Finance, LLC)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(iDefinition Location Adjustments Statement 2.3(c) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(bTransaction 5.3(a)(i) Applicable Date 3.6(dAnti-Corruption Laws 3.27(a) Assumed Liabilities 2.3 Balance Sheet 3.6(b3.7(b) Buyer Preamble Closing 2.2(a) Closing A/R Schedule 2.3(c) Closing Balance Sheet 2.3(c) Closing Date 2.2(a) Closing Working Capital 2.3(c) Company Preamble Company Group Employees 5.11 Company License Agreement 3.18(a)(xxvii) Company Scheduled IP 3.15(a) Confidential Information 5.7(b) Confidentiality Agreement 5.7(a) Contaminants 3.15(m) Disclosure Schedules Article III Dispute 10.8 Dispute Notice 10.9(b) Divestiture 5.8(b) Dollars 10.12 Environmental Laws 3.17(e)(i) Environmental Permits 3.17(e)(ii) Estimated A/R Schedule 2.3(a) Estimated Adjustments Statement 2.3(a) Estimated Closing Balance Sheet 2.3(a) Estimated Working Capital 2.3(a) Excluded Dispute 10.9(g) Exclusivity Fee 9.3(a) Final Adjusted Purchase Price 2.3(f) Final Closing Working Capital 2.3(f)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiFundamental Representations 8.1(a)(i) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(dGovernment Officials 3.27(b) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b3.17(e)(iii) Indemnified Party 7.4(a) Indemnifying Party 7.4(a8.3(a) Independent Accounting Firm 2.8(a2.3(e) Initial Allocation 2.1 Insurance Policies 3.20 Interim Financial Statements 3.5(a3.7(a) Intervening Event 5.17(j)(iiiJAMS Streamlined Rules 10.9(b) Intervening Event Change Material Contracts 3.18(a) Memorandum 10.9(b) Non-Disclosure Agreement 7.1(g) Notice of Recommendation 5.17(d)(iiDisagreement 2.3(d) Licensed Excluded IP 3.13(hNotifying Party 10.9(b) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DOverpayment 2.3(g) Outside Permits 3.9(b) Permitted Encumbrances 3.13(a) Responding Party 10.9(b) Plans 3.11(a)(ii) Recalculated Adjustment 2.3(f) Release Date 8.1(b)(i8.6(b) Patents 1.1 Personal Information 3.26(aRequired Approvals 3.3(b) Post-Closing Claims 5.13(aSeller Preamble Shares Recitals Spreadsheet 2.5 Systems 3.15(n) Pre-Closing Contract Liabilities 2.4(fThird Party Claim 8.3(a) Privacy Laws 3.26(aTop Customer 3.23(c) Proxy Statement 3.29Top Distributor 3.23(c) Top Supplier 3.23(c) Underpayment 2.3(g) US$ 10.12 USD 10.12 US Dollars 10.12 Working Capital Shortfall 2.3(b) Working Capital Surplus 2.3(b)
Appears in 1 contract
Samples: Asset Purchase Agreement (Applied Micro Circuits Corp)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Definition Location Acquisition Proposal 5.17(j)(i) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(dTransaction 5.4(b) Assumed Liabilities 2.3 Balance Sheet 3.6(bBusiness Data Processing Contract 3.17(p)(iv) Buyer Reports 4.4 Cash Consideration 2.6 Claim Notice 8.2(a) Closing 2.7(a) Closing Date 2.7(a) Commission 5.13 Confidential Information 5.1 Confidentiality Agreement 5.1 controlled foreign corporation 6.1(f) Counsel 9.2(d)(i) Direct Claim 8.2(c) Disclosure Schedule Article III domestic corporation 6.1(e) e-mail 11.6 Employees 3.13(a) Equity Transfer Agreement 2.7(b)(xii) Escrow Account 2.7(c)(ii) Escrow Agreement 2.7(b)(vii) Escrow Claim 9.2(c) Escrow Period 9.2(a) Estimated Liability 9.2(d) Exchange Act 3.20(j) Excluded Contracts 2.2(a) Excluded Liabilities 2.4 ASIA 34949044 19 Harmful Code 3.17(k) Higher Cap Amount 8.3(b)(i) HKCo Shares 3.3(a) HKIAC 11.11(b) Indemnified Parties 8.1(a) Indemnifying Parties 8.1(a) License Agreement 2.7(b)(viii) Material Contracts 3.21(a) Non-Buyer Party 3.1 Purchase Price 2.6 Purchased Assets 2.1(a) Registration Statement 5.13 Restricted Xxxx 3.17(g)(ii) Restructuring 5.2(a) Restructuring Plan 5.2(a) Retained Account Agent Agreement 2.7(b)(ix) SEC 4.4 Securities Act 2.10, 3.20(h) Share Purchase Agreement 2.7(b)(x)
(a) Stock Consideration 2.6 surrogate foreign corporation 6.1(e)
(a) Target Equity 2.1(a) Tax Indemnity 8.1(a)(iii) Third-Party Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiIP Licenses 3.17(b) Buyer Expenses 8.4(cThird-Party Claim 8.2(a) Buyer Welfare Plans 5.7(eTrade Control Laws 3.10(c) CERCLA 3.17(d)(iiTrademark Assignments 2.7(b)(v) Claim Notice 7.4(aTransfer Protocols 2.7(b)(iv) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(dTransferred Contracts 2.1(a)(i) Code 1.1 Competing Business 5.3(a)(iTransition Period 5.8(a) Confidential Information 5.8(bTransition Services Agreement 2.7(b)(vi) Copyrights 1.1 Customer 5.3(a)(iiiU.S. Person 3.20(c) Debt Financing 5.21(aUnited States real property interest 6.1(g) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.29ASIA 34949044 20
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i5.3 Aggregate Preference Amount 2.7(a)(iv)(A) Aggregate Preferred Earnout Amount 2.7(a)(iv)(B) Aggregate Series B Per Share Earnout Amount 2.7(a)(iv)(W) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EArbiter 2.8(b)(ii) Alternative Financing 5.21(bAssumption Agreements Section 2.7(b)(i) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiBalance Sheet Date 3.6(b) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(eCancelled Shares 2.7(e) CERCLA 3.17(d)(ii3.16(d)(ii) Certificate of Merger 2.2(b) Certificates 2.11(c) Charter Amendment Section 5.1(a) Claim Notice 7.4(a8.4(a) Closing 2.6 2.2(a) Closing Balance Sheet 2.7 Consideration 2.7(a)(iv)(C) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(i3.10(b) Confidential Information 5.8(bCommon Aggregate Closing Amount 2.7(a)(iv)(D) Copyrights 1.1 Customer 5.3(a)(iiiCommon Aggregate Earnout Amount 2.7(a)(iv)(E) Common Fair Value 2.7(a)(iv)(F) Common Per Share Earnout Amount 2.7(a)(iv)(H) Common Stock Per Share Amount 2.7(a)(iv)(G) Company Preamble Company Registered IP 3.14(e) Company Stock Plans 2.7(b)(i) Confidentiality Agreement 5.6 Consideration Spreadsheet 2.13(a) Continuing Employees 5.9 D&O Indemnification Provisions 5.11(b) D&O Indemnified Person 5.11(b) D&O Tail Policy 5.11(a) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DPayoff Letter 7.3(e) DGCL 4.6 Recitals Direct Claim 7.4(c8.4(c) Effect 1.1 Disclosure Schedules Article III Dissenting Shares 2.1 Earnout Amount 2.8, 2.7(a)(iv)(I) Earnout Average Price 2.7(a)(iv)(J) Earnout Consideration Statement 2.8(b)(i) Effective Time 2.2(b) Employee Offer Letters Recitals Environmental Laws 3.17(d)(iLaw 3.16(d)(i) Equity Financing 5.21(aERISA 3.10(a)(i) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cEstimated Closing Statement 2.9 Exchange Agent 2.11(a) Excluded Liabilities 2.4 Existing Stock 5.14(bExpense Fund 2.15(c) Fairness Opinion 3.2(b) FDA 1.1 Final Closing Statement 2.9 Financial Statements 3.5(a3.6(a) Financing 5.21(aFully Diluted Shares of Common Stock 2.7(a)(iv)(O) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(dFundamental Representations 8.1(a) Hazardous Substances 3.17(d)(ii3.16(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bHolder Representative 2.15(a) Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(aAccountant 6.5(a) Initial Allocation 2.1 Infringement Claim 5.4(b) Interim Financial Statements 3.5(a3.6(a) Intervening Event 5.17(j)(iiiIn-the-Money Option 2.7(a)(iv)(K) Intervening Event Change of Recommendation 5.17(d)(iiIP Assignment 5.4(b) Licensed Excluded IP 3.13(hIRS 3.10(b) IT 5.2(b) Joinder Agreements Recitals Key Employees Recitals Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D8.2 Majority Holders 2.15(c) Outside Date 8.1(b)(iMaterial Contracts 3.17(a) Patents 1.1 Merger Recitals Merger Consideration 2.7(a)(iv)(L) Merger Sub Preamble Milestone 1 2.8(a)(i) Milestone 1 Earnout Amount 2.8 Milestone 2 2.8(a)(ii) Milestone 2 Earnout Amount 2.8 Milestones 2.8(a)(iii) Multiemployer Plan 3.10(c) Offered Employees 5.9 Option Exchange Ratio 2.7(a)(iv)(M) Out-of-the-Money Option 2.7(a)(iv)(N) Parent Preamble Parent Fundamental Representations 8.1(a), 8.1(a) Parent SEC Documents 4.4(a) Permits 3.8(b) Permitted Encumbrances 3.12(a) Personal Information 3.26(a3.19(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(fPlans 3.10(a)(iv) Privacy Laws 3.26(a3.19(a) Proxy Statement 3.29Release 3.16(d)(iii) Representative Losses 2.15(e) Series A Aggregate Closing Amount 2.7(a)(iv)(P) Series A Aggregate Earnout Amount 2.7(a)(iv)(Q) Series A Per Share Closing Amount 2.7(a)(iv)(R) Series A Per Share Earnout Amount 2.7(a)(iv)(S) Series B Aggregate Closing Amount 2.7(a)(iv)(T) Series B Aggregate Earnout Amount 2.7(a)(iv)(U) Series B Per Share Closing Amount 2.7(a)(iv)(V) Stockholder Consent Recitals Surviving Corporation 2.1 Tax Attribute 3.15 Termination Date 9.1(c) Third Party Claim 8.4(a) Transaction Expenses Payoff Instructions 7.3(f)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Definition Location Acquisition Proposal 5.17(j)(iEngagement 10.19(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(bAllocation Certificate 6.9(f) Applicable Date 3.6(dAccounting Principles 2.8 ASC 855 2.9(a) Asset Sellers 2.2 Assumed Contract 2.2(a) Assumed Liabilities 2.3 2.4 Balance Sheet 3.6(b)
(aDate 4.6(a) Bank Accounts 4.23 Benefit Plan 4.11(a) Business Recitals Permits 2.2(e) Business Products 4.16(b) Business Registered IP 4.15(a) Buyer Preamble Buyer Employees 5.3(a)(iiU.S. DC Plans 7.14 Call Center 6.17 Canadian Bank Account 2.2(b) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(aCanadian Seller Preamble Closing 2.7 Closing Cash 2.9(a) Closing 2.6 Closing Balance Sheet Date 2.7 Closing Date 2.6 COBRA 5.7(dIndebtedness 2.9(a) Code 1.1 Competing Business 5.3(a)(iClosing Net Working Capital 2.9(a) Confidential Information 5.8(bClosing Transaction Expenses 2.9(a) Copyrights 1.1 Closing Year Cash Incentives 7.15 Collective Bargaining Agreement 4.12(a) Company Preamble Company Employee 7.1(a) Confidentiality Agreement 6.4 Connecticut Transfer Act 6.18 CT DEEP 6.18 Customer 5.3(a)(iiiContracts 4.19(b) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Disclosure Letters Article III Environmental Laws 3.17(d)(i4.18(d)(i) Equity Financing 5.21(aEnvironmental Permits 4.18(d)(ii) Equity Financing Commitment 4.4 ERISA 4.11(a) Estimated Cash 2.8 Estimated Indebtedness 2.8 Estimated Net Working Capital 2.8 Estimated Transaction Expenses 2.8 Excluded Assets 2.2 2.3 Excluded Intellectual Property 2.2(cBenefits 7.1(c)(ii) Excluded Liabilities 2.4 Existing Stock 5.14(b2.5 Final Closing Statement 2.9(a) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a4.6(a) Financing 5.21(aFailure Event 6.19(c) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aRelated Action 10.21(a) Group Health Plan 5.7(dXxxxxx Xxxx 10.19(a) Hazardous Substances 3.17(d)(iiMaterial 4.18(d)(iii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Coverage 7.4 Independent Accounting Firm 2.8(a2.9(c) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(iiInside Date 2.7 Insurance Policies 4.13 Interests Recitals Labor Obligations 7.12 Lease 4.14(b) Licensed Excluded Seller Intellectual Property 6.16 LTD Employee 7.1(d) Material Contracts 4.19(a) Multiemployer Plan 4.11(d) Net Adjustment Amount 2.9(f)(i) Notice of Disagreement 2.9(b) Occurrence-Based Policies 6.11(b) Offer Employee 7.1(c)(i) Owned Business IP 3.13(h4.15(b) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DPBGC 4.11(e) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(aPermits 4.8(b) Pre-Consummation Warning Letter 6.5(h) Preliminary Allocation Certificate 6.9(e) Preliminary Closing Contract Liabilities 2.4(fStatement 2.8 Property Transfer Forms 6.18 Purchased Assets 2.2 Quarter End Blackout Period 2.7 Reimbursement Obligations 6.19(a) Privacy Laws 3.26(aReleasing Party 6.15 Restricted Assets 2.2 Restricted Business 6.12(a) Proxy Statement 3.29Restricted Period 6.12(a) Seller Cafeteria Plan 7.18 Seller Releasing Party 6.15(b) Seller U.S. DC Plans 7.14 Sellers Preamble Solvent 5.5 Supplier Contracts 4.19(b) Surety Arrangements 6.7 Tax Contests 6.9(i) Trade Controls 4.9 Transfer Taxes 6.9(a) Transferred Business Employees 7.1(d) Transferred IP 2.2(i) US Seller Preamble WARN Act 7.9
Appears in 1 contract
Samples: Transaction Agreement (Allegion PLC)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i5.10(b)(i) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAlien Employees 5.5(h) Allocation Dispute Notice 6.1(c) Alternative Financing 5.21(bRecovery 8.5(b) Applicable Date 3.6(dArbiter 6.1(b) Assumed Contracts 2.1(a) Assumed Leases 2.1(b) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(aBasket Amount 8.5(a)(i) Business Recitals Information Systems 3.13(j) Business Statements 3.5(a) Buyer Preamble Buyer Employees 5.3(a)(iiIndemnified Parties 8.2 Buyer Materiality Qualifiers 7.2(a) Buyer Expenses 8.4(cParty Recitals Buyer Savings Plan 5.5(c) Buyer Welfare Benefit Plans 5.7(e5.5(d)(i) CERCLA 3.17(d)(iiCFIUS Notice 5.7(c)(ii) Claim Information 8.4(a) Claim Notice 7.4(a8.4(e) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 2.7 COBRA 5.7(dObligations 5.5(d)(ii) Code 1.1 Competing Business 5.3(a)(i5.10(a) Confidential Information 5.8(bConfidentiality Agreement 5.6(a) Copyrights 1.1 Customer 5.3(a)(iiiContributor 3.13(g) Debt Financing 5.21(aDisclosure Schedules III Discussion Period 6.1(c) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DDispute Statement 6.1(b) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Eligible Patents 5.16 Environmental Laws 3.17(d)(i3.15(b)(i) Equity Financing 5.21(aEnvironmental Permits 3.15(b)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(bExploitation 5.10(d) Fairness Opinion 3.2(bFinal Allocation 6.1(c) FDA 1.1 Financial Statements 3.5(aFinal Seller Allocation Schedule 6.1(b) Financing 5.21(aXxxxxx Xxxx 2.2(o) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aID Filed Applications 5.16(b) Group Health Plan 5.7(dIllegal Activities 3.7(c) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bIndemnification Ancillary Agreements 8.1(a) Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP Institution 3.13(h) Inventory 2.1(g) Losses 7.2 Marks 1.1 Notice 8.2 Material Contracts 3.16(a) Non-Competing Products 5.10(d) Non-Transferring Employee 5.9(a) Permits 3.7(b) PMIC 5.8(e) Proposed Allocation 6.1(c) Related Person 3.20 Required Filing 5.7(a) Restricted Benefits 3.7(c) Restricted Entities 5.10(a) Restriction Period 5.17(d)(i)(D5.10(a) Outside Seller Preamble Seller Allocation Schedule 6.1(b) Seller Continuing Confidential Information 5.6(a) Seller Employee 5.9(b) Seller Fundamental Representations 8.1(a) Seller Indemnified Parties 8.3 Seller Materiality Qualifiers 7.3(a) Seller Party Recitals Seller Savings Plan 5.5(c) Seller Welfare Benefit Plans 5.5(d)(i) Significant Customer 3.17(a) Significant Supplier 3.17(a) Tax Purchase Price 6.1(a) Termination Date 8.1(b)(i9.1(c) Third Party Claim 8.4(a) Trade Licenses 3.7(d) Transferred Assets 2.1 Transferred Confidential Information 5.6(a) Transferred Employees 5.5(a) Transferred Intellectual Property 2.1(d) Transferred Non-Patent Intellectual Property 2.1(d) Transferred Patents 1.1 2.1(c) Transferred Personal Information 3.26(aProperty 2.1(f) Post-Closing Claims 5.13(aTransferred Products 2.1(h) Pre-Closing Contract Liabilities 2.4(fTransferred Technology 2.1(e) Privacy Laws 3.26(a) Proxy Statement 3.29WARN Act 5.5(f)
Appears in 1 contract
Samples: Asset Purchase Agreement (Marvell Technology Group LTD)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cAcquisition Engagement 9.18(a) Acquisition Proposal 5.17(j)(iAffected Employees 5.14(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EApplicable Accounting Principles 2.3(a) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a3.7(a0 Buyer Indemnified Parties 7.2 Buyers Preamble Cap 7.5(a)(i) Business Recitals Buyer CCM 5.4(d) CH Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(aClosing 2.2(a) Closing 2.6 Closing Balance Sheet 2.7 Cash 2.3(b) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(iClosing Indebtedness 2.3(b) Confidential Information 5.8(bClosing Net Working Capital 2.3(b) Closing Unpaid Transaction Expenses 2.3(b) CMH Preamble Companies Preamble Company Patents 3.14(a) Company Registered Copyrights 3.14(a) Company Registered IP 3.14(a) Company Registered Marks 3.14(a) Confidentiality Agreement 5.6(a) Copyrights 1.1 Customer 5.3(a)(iii) Crown Preamble Crown Luxembourg Preamble Debt Financing 5.21(a) 5.18 Debt Financing Commitments 4.4 Debt Financing Source 4.4 Sources 9.20 Deductible 7.5(a)(ii) Determination Notice 5.17(d)(i)(DDate 5.15(e0 Disclosure Schedules Article III Dutch Holdings Recitals Dutch Holdings Shares Recitals Employee Plans 3.11(a) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i3.16(c)(i) Equity Financing 5.21(aEnvironmental Permits 3.16(c)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cEstimated Cash 2.3(a) Excluded Liabilities 2.4 Existing Stock 5.14(bEstimated Indebtedness 2.3(a) Fairness Opinion 3.2(bEstimated Net Working Capital 2.3(a) FDA 1.1 Estimated Unpaid Transaction Expenses 2.3(a) Famosa Recitals Famosa Pension Plan 3.11(d) Famosa Shares Recitals Final Closing Statement 2.3(b) Financial Statements 3.5(a3.7(a) Financing 5.21(aAgreements 9.20 FM Preamble Fundamental Representations 7.1(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aXxxxxx Xxxx 2.2(a) Group Health Plan 5.7(dGS Preamble Guarantees 5.9 Hazardous Materials 3.16(c)(iii) Hazardous Substances 3.17(d)(iiHeineken Preamble Heineken Mexico Preamble ICC 9.9(a) Health Care Permits 3.27(cICC Rules 9.9(a) HIPAA 1.1 HSR Act 3.3(bIFRS Management Accounts 3.7(b) IFRS Management Balance Sheet 3.7(b) Indemnified Party 7.4(a) Indemnifying Party P arty 7.4(a) Independent Accounting Firm 2.8(a2.3(d) Initial Allocation 2.1 Interim Financial Statements 3.5(aInterested Parties 5.19 Leases 3.13(b) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Lenders 9.20 Losses 7.2 Marks 1.1 Material Contracts 3.17(a) Mexican Antitrust Law 3.3(b) Net Adjustment Amount 2.3(g)(i) Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(iof Disagreement 2.3(c) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(aPermits 3.9(b) Pre-Closing Contract Liabilities 2.4(fCompany Insurance Policies 5.12(b) Privacy Laws 3.26(aPreliminary Closing Statement 2.3(a) Proxy Prolatamex Preamble Purchase Price 2.1 Release 3.16(c)(iv) Released Parties 5.19 Retained Sisa Share 5.4(d0 Sample Statement 3.292.3(a0 Sanctions Targets 6.3(e0 Securities Act 4.6 Seller Indemnified Parties 7.3 Sellers Preamble Sellers' Marks 5.11 Shared Expenses Agreement 5.16(a) Shares Recitals SI Preamble Sisa Recitals Sisa Shares Recitals Sivesa Recitals Sivesa Pension Plan 3.11(d) Sivesa Shares Recitals SV Preamble Target Shares Recitals Termination Date 8.1(c) Terrestrategicos Preamble Third Party Claim 7.4(a) Trade Secrets 1.1
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c401(k) Acquisition Proposal 5.17(j)(iPlan 2.12(b)(vi) Acquiror Preamble Acquiror Indemnifying Parties 6.3 Advisory Group 2.17(e) Aggregate Unaccredited Cash Consideration 2.18 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Preamble Balance Sheet 3.6(b) Bankruptcy and Equity Exception 3.2(a) Basket 6.5(a) Business IP 3.14(c) Cancelled Shares 2.7(d) Carta 2.11(b) Certificate of Merger 2.2(b) Certificates 2.11(b) Chosen Courts 7.11 Claim Notice 6.4(a) Closing 2.2(a) Closing Cash 2.14(a) Closing Date 2.2(a) Closing Indebtedness 2.14(a) Closing Net Working Capital 2.14(a) Closing Transaction Expenses 2.14(a) Code 3.10(b) Company Preamble Company Common Stock Recitals Company Registered IP 3.14(e) Confidentiality Agreement 5.2 Continuing Employees 5.5(a) Converted Unvested Options 2.9(b) Converted Vested Options 2.9(a) Copyrights 1.1 D&O Tail 5.5(e) De Minimis Claim 6.5(a) Debt Payoff Letter 2.12(b)(iii) DGCL Recitals Direct Claim 6.4(c) Disclosure Schedules Article III Dissenting Shares 2.8 Effective Time 2.2(b) ERISA 3.10(a)(i) Estimated Cash 2.13 Estimated Indebtedness 2.13 Estimated Net Working Capital 2.12 Estimated Transaction Expenses 2.13 Exchange Act 4.4(a) Exchange Agent 2.11(a) Fenwick 7.18 Filing Date 5.3(a) Final Closing Statement 2.14(a) Financial Statements 3.6(a) Form S-3 5.3(a) Fundamental Representations 6.1(a)(i) General Cap 6.5(b) HSR Act 3.3(b) Indemnification Cap 6.5(c) Indemnified Party 6.4(a) Indemnifying Party 6.4(a) Independent Accounting Firm 2.14(c) Interim Financial Statements 3.6(a) Investor Questionnaire 2.11(c) IRS 3.10(b) JPM 3.24 Letter of Transmittal 2.11(c) Letter of Undertaking 2.12(b)(x) Losses 6.2 Majority Holders 2.17(c) Marks 1.1 Material Contracts 3.17(a) Merger Recitals Merger Consideration Schedule 2.13(b) Multiemployer Plan 3.10(c) Multiple Employer Plan 3.10(c) Net Adjustment Amount 2.14(f)(i) Notice of Disagreement 2.14(b) Option Payment Amount 2.12(a)(iv) Parent Preamble Parent SEC Documents 4.4(a) Patents 1.1 Payoff Indebtedness 2.12(a)(v) PCI DSS 3.20(e) Permits 3.8(b)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiPermitted Transferee 1.1 Personal Information 3.20(a) Buyer Expenses 8.4(cPlans 3.10(a)(iv) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Preferred Stock Conversion 1.1 Preliminary Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) 2.13 Privacy Laws 3.26(a3.20(a) Proxy Statement 3.29Requisite Holders Recitals Restrictive Covenant Agreements Recitals Seller Indemnifying Parties 6.2 Significant Customer 3.21(a) Significant Supplier 3.21(b) Stockholder 2.11(a) Stockholder Representative 2.17(a) Stockholder Representative Engagement Agreement 2.17(e) Stockholder Representative Expenses 2.17(e) Stockholder Representative Group 2.17(e) Sub Preamble Surviving Corporation 2.1 Tax Contest 5.4(g) Third Party Claim 6.4(a) Trade Secrets 1.1 Transaction Expenses Payoff Instructions 2.12(b)(iv) Transfer Taxes 5.4(b) VDA 5.4(e)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Definition Location Acquiror Preamble Acquiror Financial Statements 4.7 Acquiror Indemnified Parties 8.2 Acquiror Indemnified Party 8.2 Acquiror SEC Reports 4.7 Acquiror Set-Off Rights 8.10 Acquisition Proposal 5.17(j)(i) 5.3 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Date Preamble Applicable Date 3.6(d) Assumed Liabilities 2.3 Accounting Principles 2.12 Balance Sheet 3.6(b)
(a3.6(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiBasket 8.5(a) Buyer Expenses 8.4(cBook-Entry Shares 2.10(b) Buyer Welfare Plans 5.7(eCancelled Shares 2.6(b)(i) Cause 2.16(g)(iii)(A) CERCLA 3.17(d)(ii3.16(f)(iii) Claim Notice 7.4(a8.4(a) Claim Objection 8.4(c) Claim Objection Period 8.4(c) Closing 2.6 2.3 Closing Balance Sheet 2.7 2.13(a) Closing Cash 2.13(a) Closing Date 2.6 COBRA 5.7(d2.3 Closing Indebtedness 2.13(a) Closing Net Working Capital 2.13(a) Closing Transaction Expenses 2.13(a) Code 1.1 Competing Business 5.3(a)(iRecitals Company Preamble Company Leases 3.13(a) Confidential Information 5.8(bCompany Party 10.20(a) Copyrights 1.1 Customer 5.3(a)(iiiCompany Registered IP 3.14(e) Debt Financing 5.21(aComparable Plan 5.15(b) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DConfidentiality Agreement 5.7 Consideration Spreadsheet 2.5(b) Continuing Employees 5.15(a) Conversion Amount 2.5(b)(ii) Customary Agreement 3.15(k) D&O Indemnified Persons 5.11(a) D&O Tail 5.11(b) DGCL 4.6 Recitals Direct Claim 7.4(c8.4(c) Effect 1.1 Disclosure Schedules Article III Dissenting Shares 2.7 DLLCA Recitals Enforceability Limitations 3.2(a) Environmental Laws 3.17(d)(i3.16(f)(i) Equity Financing 5.21(aEnvironmental Permits 3.16(f)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cERISA 3.10(a) Excluded Liabilities 2.4 Existing Stock 5.14(bEstimated Cash 2.12 Estimated Indebtedness 2.12 Estimated Milestone Shares 5.13(a) Fairness Opinion 3.2(bEstimated Net Working Capital 2.12 Estimated Transaction Expenses 2.12 Exchange Fund 2.10(a) FDA 1.1 Final Closing Statement 2.13(a) Financial Statements 3.5(a3.6(a) Financing 5.21(aFirst Certificate of Merger 2.3 First Effective Time 2.3 First Merger Recitals First Step Surviving Corporation 2.1(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aFundamental Representations 8.1(a)(i) Group Health Plan 5.7(dGood Reason 2.16(g)(iii)(B) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b3.16(f)(iii) Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(a2.13(c) Initial Allocation 2.1 Interim Financial Statements 3.5(aIntended Tax Treatment Recitals IRS 3.10(b) Intervening Event 5.17(j)(iiiJAMS 2.16(c)(iii)(B) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hJAMS Rules 2.16(c)(iii)(B) Losses 7.2 Marks 1.1 8.2 Majority Holders 2.17(c) Material Contracts 3.17(a) Merger Recitals Merger Engagement 10.20(a) Merger Sub I Preamble Merger Sub II Preamble Merger Subs Preamble Milestones 2.16(a)(i) Milestone Abandonment Notice Period 5.17(d)(i)(D2.16(b)(v) Outside Date 8.1(b)(iMilestone Achievement Claim 2.16(c)(ii) Patents 1.1 Milestone Achievement Notice 2.16(c)(i) Milestone Cash/Stock Mix Notice 2.16(a)(ii) Milestone Consideration 2.16(a)(i) Milestone Consideration Spreadsheet 2.16(a)(vi) Milestone Dispute 2.16(c)(ii) Milestone Dispute Notice 2.16(c)(ii) Milestone Dispute Parties 2.16(c)(iii)(A) Milestone Table. 2.16(d) Milestone Update Report 2.16(b)(ii) Net Adjustment Amount 2.13(f)(i) New Plans 5.15(b) Notice of Disagreement 2.13(b) Offset Amount 8.10 Old Plans 5.15(b) Permits 3.8(b) Permitted Encumbrances 3.12(a) Personal Information 3.26(a3.20(a) Post-Closing Claims 5.13(aPlans 3.10(a) Pre-Closing Contract Liabilities 2.4(fTax Period 6.1(a) Preliminary Closing Balance Sheet 2.12 Privacy Laws 3.26(a3.20(a) Proxy Registration Statement 3.295.13(a) Release 3.16(f)(iv) Remediation 3.16(f)(v) Representative Losses 2.17(d) Required Consents 7.3(b) Second Certificate of Merger 2.3 Second Effective Time 2.3 Second Merger Recitals Securityholder Indemnified Parties 8.3 Securityholder Indemnified Party 8.3 Securityholder Representative 2.17(a) Share 2.5(a) Shares 2.5(a) Stockholder 2.10(b) Stockholder Written Consent Recitals Surviving Company Recitals Systems 3.20(a) Tax Contest 6.2(a) Tax Proceeding 3.15(g) Tax Representations 8.1(a)(iii) Termination Date 9.1(d) Third Party Claim 8.4(a) Trading Volume Legend 2.18(c) Transaction Expenses 3.21 Transfer Taxes 6.4 Websites 3.20(a) WSGR 10.20(a)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c2018 Balance Sheet 3.7(a) Acquisition Proposal 5.17(j)(i280G Vote 5.15(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EFinancing 5.5(c) Alternative Financing 5.21(bBlocker Recitals Blocker Seller Preamble Blocker Shares Recitals Books and Records 5.14 Business Employees 3.12(g) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiArrangements 5.15(a) Buyer Expenses 8.4(c) Indemnified Parties 8.2 Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(iiPrepared Tax Returns 6.2(b) Claim 5.7 Claim Notice 7.4(a8.4(a) Claims 5.7 Closing 2.2(a) Closing 2.6 Date 2.2(a) Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(dNet Working Capital 2.4(a) Code 1.1 Competing Business 5.3(a)(i3.11(d) Company Preamble Confidential Information 5.8(b) Confidentiality Agreement 5.8(a) Copyrights 1.1 Customer 5.3(a)(iiiConsent 10.20 Data Protection Agreements 3.21(a) Debt Financing 5.21(a4.7(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c8.4(c) Effect 1.1 Environmental Laws 3.17(d)(iDisclosure Schedules Article III Encumbrance Instrument 3.13(c) Equity Financing 5.21(a4.7(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cInterests Schedule 2.1 Equity Purchase Agreement Recitals ERISA 3.11(b) Excluded Liabilities 2.4 Estimated Cash 2.3 Estimated Indebtedness 2.3 Estimated Net Working Capital 2.3 Estimated Transaction Expenses 2.3 Existing Stock 5.14(bPolicy 5.17(a) Fairness Opinion 3.2(bFinal Closing Statement 2.4(b) FDA 1.1 Finance Related Parties 10.19 Financial Statements 3.5(a3.7(a) Financing 5.21(a4.7(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Indemnity Policy 5.18 Independent Accounting Firm 2.8(a2.4(c) Initial Allocation 2.1 Closing Statement 2.4(a) Insurance Cap 5.17(a) Interim Financial Statements 3.5(a3.7(a) Intervening Event 5.17(j)(iiiInvestors 4.7(a) Intervening Event Change of Recommendation 5.17(d)(iiIRS 3.11(d) Licensed Excluded IP 3.13(hLook-Back Date 3.9(a) Losses 7.2 Material Contracts 3.18(a) Marks 1.1 Xxxxxx Seller Preamble MIU Seller Preamble Net Adjustment Amount 2.4(f)(i) Notice Period 5.17(d)(i)(Dof Disagreement 2.4(b) Objection Notice 8.4(c) Outside Date 8.1(b)(i9.1(c) Patents 1.1 Personal Information 3.26(aPayoff Indebtedness 2.2(b)(ii) Post-Closing Claims 5.13(aPCI DSS 3.21(c) Permits 3.9(b) Plans 3.11(b) Pre-Closing Contract Liabilities 2.4(fMonthly Financial Statements 5.12(a) Privacy Laws 3.26(aPre-Closing Reorganization Recitals Preliminary Closing Statement 2.3 Purchase Price Allocation 2.5 Qualified Plan 3.11(i) Proxy Statement 3.29Receivables 3.7(e) Released Matters 5.7 Released Persons 5.7 Required Audited Financial Statements 5.12(b) Required Bank Information 5.4 Restricted Parties 5.16(a) Restricted Party 5.16(a) Reviewable Buyer Tax Return 6.2(b) Rollover Seller Preamble Seller Preamble Seller Parties 10.21 Seller Related Parties 10.19 Seller Releasing Party 5.7 Sellers Preamble Sellers’ Representative Preamble Sellers’ Representative Expense Fund 5.19 Splitter Recitals Straddle Period Flow-Through Income Tax Returns 6.3 Tail Policy 5.17(a) Tax Claim 6.3 Termination Fee 9.3 Third-Party Claim 8.4(a) Trade Secrets 1.1 Transfer Taxes 6.6
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cDefinition Location Additional Acquisitions 3.6 Agreement Preamble Antitrust Authority 7.8(a) CERCLA 4.15(c)(iii) Closing 2.4(a) Closing Date 2.4(a) Closing Transactions 2.3 CMS 4.7(b) Confidentiality Agreement 7.7 Definitive Financing Agreements 7.14(b) Effective Time 2.4(a) Environmental Laws 4.15(c)(i) Environmental Permits 4.15(c)(ii) ERISA 4.9(a) Estimated Xxxxx Cash Consideration 3.2(a) Financing 7.14(a) Hazardous Substances 4.15(c)(iii) HSR Act 4.3(b) Independent Accounting Firm 3.3(c) IRS 4.9(a) Multiemployer Plan 4.9(e) Net Adjustment Amount 3.5(b) NewCo Preamble Notice of Disagreement 3.3(b) Payoff Letters 3.1(a)(i) Payout Spreadsheet 3.2(c) PBGC 4.9(b)(ii) Permits 4.7(b) Release 4.15(c)(iv) Remediation 4.15(c)(v) Shares Recitals Definition Location Xxxxx Preamble Xxxxx Acquisition Proposal 5.17(j)(i7.5(c) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Xxxxx Balance Sheet 3.6(b5.5(b) Xxxxx Closing Acquisition Pipeline EBITDA 3.4(a) Xxxxx Closing Cash 3.4(a) Xxxxx Closing Indebtedness 3.4(a) Xxxxx Closing Net Working Capital 3.4(a) Xxxxx Closing Transaction Expenses 3.4(a) Xxxxx Contributed Company Recitals Xxxxx Contribution Recitals Xxxxx Disclosure Schedules Article V
(a) Xxxxx Estimated Cash 3.2
(a) Xxxxx Estimated Facility Ownership Adjustment 3.2
(a) Xxxxx Estimated Indebtedness 3.2
(a) Xxxxx Estimated Net Working Capital 3.2(a) Xxxxx Estimated Transaction Expenses 3.2(a) Xxxxx Facility Ownership Adjustment 3.4(a) Xxxxx Final Closing Statement 3.4(a) Xxxxx Financial Statements 5.5(a) Xxxxx Interim Financial Statements 5.5(a) Xxxxx Management Contracts 5.16(b) Xxxxx Material Contracts 5.16(a)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Xxxxx Preliminary Closing Balance Sheet 2.7 3.2(a)
(a) Xxxxx Reorganization Recitals Termination Date 9.1(d) Xxxxxxx Acquisition Proposal 7.5(a) Xxxxxxx Balance Sheet 4.5(b) Xxxxxxx Closing Date 2.6 COBRA 5.7(dAcquisition Pipeline EBITDA 3.3(a) Code 1.1 Competing Business 5.3(a)(iXxxxxxx Closing Cash 3.3(a) Confidential Information 5.8(bXxxxxxx Closing Indebtedness 3.3(a) Copyrights 1.1 Customer 5.3(a)(iiiXxxxxxx Closing Net Working Capital 3.3(a) Debt Financing 5.21(aXxxxxxx Closing Transaction Expenses 3.3(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion Xxxxxxx Disclosure Schedules Article IV Xxxxxxx Estimated Cash 3.2(b) FDA 1.1 Xxxxxxx Estimated Facility Ownership Adjustment 3.2(b) Xxxxxxx Estimated Indebtedness 3.2(b) Xxxxxxx Estimated Net Working Capital 3.2(b) Xxxxxxx Estimated Transaction Expenses 3.2(b) Xxxxxxx Facility Ownership Adjustment 3.3(a) Xxxxxxx Final Closing Statement 3.3(a) Xxxxxxx Financial Statements 3.5(a4.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Xxxxxxx Holding I Preamble Definition Location Xxxxxxx Holding II Preamble Xxxxxxx Holdings Preamble Xxxxxxx Holdings Contribution Recitals Xxxxxxx Interim Financial Statements 3.5(a4.5(a) Intervening Event 5.17(j)(iiiXxxxxxx LLCs Preamble Xxxxxxx Management Contracts 4.16(b) Intervening Event Change of Recommendation 5.17(d)(iiXxxxxxx Material Contracts 4.16(a) Licensed Excluded IP 3.13(hXxxxxxx Pipeline Acquisition EBITDA 3.2(b) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DXxxxxxx Plans 4.9(a) Outside Date 8.1(b)(iXxxxxxx Preliminary Closing Balance Sheet 3.2(b) Patents 1.1 Personal Information 3.26(aXxxxxxx Preliminary Closing Statement 3.2(b) Post-Closing Claims 5.13(aXxxxxxx Public Filer 4.5(a) Pre-Closing Contract Liabilities 2.4(fXxxxxxx Reorganization Recitals Xxxxxxx SEC Documents 4.21(a) Privacy Laws 3.26(a) Proxy Statement 3.29Xxxxxxx Stockholder Consent 7.10
Appears in 1 contract
Samples: Contribution and Purchase Agreement (United Surgical Partners International Inc)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(iAdjusted Variable Future Purchase Price 5.12(h) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EArbitrator 10.9(a) Alternative Financing 5.21(bBalance Sheets 3.8(b) Applicable Date 3.6(dBrand Transferee 5.12(b)(ii)b. Business 5.4(a)(i) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiBuyer’s Policy 7.2(e) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(iiCap Amounts 7.2(a) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 2.2(a) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(iCompany Preamble Company Group Employees 5.4(a)(ii) Confidential Information 5.8(bCompany IP 3.16(e) Company Registered IP 3.16(e) Confidentiality Agreement 5.7 Copyrights 1.1 Country 5.12(b)(ii)b. Covered Parties 7.1 Customer 5.3(a)(iii5.4(a)(iii) Debt Financing 5.21(aDeductible 7.2(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Delivered Variable Purchase Price 5.12(f) Designated Lender 2.1(b) Dispute Notice 5.17(d)(i)(D7.4(b) DGCL 4.6 Direct Claim 7.4(cDisputed Matters 5.12(f) Effect 1.1 Disputing Parties 10.9(a) Disputing Party 10.9(a) EBITDA 5.12(c) Environmental Laws 3.17(d)(i3.18(e)(i) Environmental Permits 3.18(e)(ii) Equity Financing 5.21(aInterests Recitals Escrow 6.3(k) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cFinal Variable Purchase Price 5.12(f) Excluded Liabilities 2.4 Existing Stock 5.14(bFinal Variable Purchase Price Payment Date 5.12(f) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a3.8(a) Financing 5.21(aFixed Future Purchase Price 5.12(b)(i) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aFunding Date 2.1(b) Group Health Plan 5.7(dFuture Closing Date 5.12(b) Future Dispute Notice 5.12(f) Future Purchase 5.12(b) Future Purchase Price 5.12(b) Hazardous Substances 3.17(d)(ii3.18(e)(iii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(aICC 10.9(a) Independent Accounting Firm 2.8(a5.12(f) Initial Allocation 2.1 Interim Financial Statements 3.5(aLoan Agreement 2.1(b) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hLoan Amount 2.1(b) Losses 7.2 7.1 Marks 1.1 1.1
(a) Minority Shareholders 3.7(a) Notice Period 5.17(d)(i)(D5.12(f) Outside Date 8.1(b)(iOffset Amount 7.2(f) Patents 1.1 Personal Information 3.26(aOptions 3.7(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.29Other Shares Recitals Palladium Preamble Palladium Intellectual Property 5.13
Appears in 1 contract
Samples: Share Purchase and Shareholders’ Rights Agreement (K Swiss Inc)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cDefinition Location [* * *] 8.7 [* * *] 8.7 [* * *] Product Revenue Schedule 2.5(a)(v) Acquisition Proposal 5.17(j)(i[* * *] Revenue Opportunity Schedule 2.5(a)(v) Additional Consideration 2.5(a) Additional Consideration Milestones 2.5(a) Definition Location Additional Consideration Notice 2.5(b) Adjustments Statement 2.3(c) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b3.7(b) Business 2.5(a) Buyer Preamble Closing 2.2(a) Closing A/R Schedule 2.3(a) Closing Balance Sheet 2.3(c) Closing Date 2.2(a) Closing Working Capital 2.3(c) Company Preamble Company Group Employees 5.13 Company Scheduled IP 3.15(a) Confidential Information 5.8(b) Confidentiality Agreement 5.8(a) Current Lease Agreement 8.2(k) Disclosure Schedules Article III Dispute 10.8 Dispute Notice 10.9(b) Domain Registrations 3.15(a) Environmental Laws 3.17(e)(i) Environmental Permits 3.17(e)(ii) Estimated A/R Schedule 2.3(a) Estimated Adjustments Statement 2.3(a) Estimated Closing Balance Sheet 2.3(a) Estimated Transaction Costs 5.12 Estimated Working Capital 2.3(a) Excess Working Capital 2.3(b)(i) Excluded Dispute 10.9(g) Final Additional Consideration 2.5(e) Final Adjusted Purchase Price 2.3(f) Final Closing Working Capital 2.3(f)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bFundamental Representations 8.1(a) Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(a2.3(e) Initial Allocation 2.1 Interim Financial Statements 3.5(a3.7(a) Intervening Event 5.17(j)(iiiJAMS Streamlined Rules 10.9(b) Intervening Event Change Legal Matters Schedule 2.5(a)(iii) Marks 3.15(a) Material Contracts 3.18(a) Definition Location Memorandum 10.9(b) Notice of Recommendation 5.17(d)(iiDisagreement 2.3(d) Licensed Excluded IP 3.13(hNotice of Objection 2.5(c) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DNotifying Party 10.9(b) Outside Date 8.1(b)(iOpen Source Software 3.15(i) Overpayment 2.3(g) Patents 1.1 Personal Information 3.26(a3.15(a) Post-Closing Claims 5.13(aPermits 3.9(b) Pre-Closing Contract Liabilities 2.4(fPermitted Encumbrances 3.13(a) Privacy Laws 3.26(aPlans 3.11(a)(ii) Proxy Statement 3.29Recalculated Adjustment 2.3(f) Registered Copyrights 3.15(a) Release Amount 8.7 Release Date 8.7 Responding Party 10.9(b) Schedule of Expenses 5.12 Sellers Preamble Sellers’ Representative 2.4(a) Shares Recitals Spreadsheet 2.7 Third Party Claim 8.4(a) Underpayment 2.3(g) Updated Spreadsheet 2.7 Working Capital Shortfall 2.3(b)(ii)
Appears in 1 contract
Samples: Stock Purchase Agreement (Applied Micro Circuits Corp)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Definition Location Acquisition Proposal 5.17(j)(i5.3 Aggregate Cap 7.3(b)(i) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EApproving Holders Preamble Articles of Merger 2.2(b) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) Cashless Exercise Loans 5.13 CERCLA 3.17(d)(ii) Claim Notice 7.4(a3.19 Certificates 2.10(c) Closing 2.6 2.2(a) Closing Balance Sheet 2.7 2.11(a) Closing Balance Sheet Costs 2.11(c) Closing Date 2.6 COBRA 5.7(d2.2(a) Closing Working Capital 2.11(a) Code 1.1 Competing Business 5.3(a)(i3.13(d) Confidential Information 5.8(bCompany Preamble Company Stockholder Approval 3.2(a) Copyrights 1.1 Customer 5.3(a)(iiiCompany Stockholders’ Meeting 3.29(b) Debt Financing 5.21(aCore Representations 7.1(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DDeficit Amount 5.15 Disclosure Schedules Article III Dissenting Shares 2.8 Effective Time 2.2(b) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i3.19 Environmental Permits 3.19 Environmental Representations 7.1(c) Equity Financing 5.21(aERISA 3.13(a)(i) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a3.6(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Flow of Funds Statement 5.15 Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) 3.19 Indemnified Party 7.4(a7.5(a) Indemnifying Party 7.4(a7.5(a) Independent Accounting Firm 2.8(a2.11(c) Initial Allocation 2.1 Information Statement 3.29(b) Interim Financial Statements 3.5(a3.6(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hIRS 3.13(b) Losses 7.2 Marks 1.1 Majority Holders 2.13(b) Material Contracts 3.20(a) Medline 6.3(p) Merger Recitals Multiemployer Plan 3.13(c) Multiple Employer Plan 3.13(c) Definition Location Noncompetition Agreement 6.3(d) Notice Period 5.17(d)(i)(Dof Disagreement 2.11(b) Outside Date 8.1(b)(iOption Withholding Amount 5.13 Oregon Law Recitals Parent Preamble Permits 3.11(b) Patents 1.1 Personal Information 3.26(aPermitted Encumbrances 3.15(a) Post-Closing Claims 5.13(aPlans 3.13(a)(iv) Pre-Closing Contract Liabilities 2.4(fTax Period 5.12(c) Privacy Laws 3.26(aPre-Closing Taxes 5.12(a) Proxy Statement 3.29Release 3.19 Repayment Agreements 5.14 Representatives 5.2 Schedule of Expenses 2.10(g) Shares Recitals Special Representations 7.1(c) Stockholder 2.10(a) Stockholder Representative 2.13(a) Stradle Period 5.12(a) Sub Preamble Surviving Corporation 2.1 Tax Claim 5.12(i) Tax Representations 7.1(b) Third Party Claim 7.5(a) Title Commitment 3.16(c) Unpaid Expenses 2.10(g)
Appears in 1 contract
Samples: Merger Agreement (I Flow Corp /De/)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i5.3(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(dPeriod 3.18(a)(i) Assumed Liabilities 2.3 2.2(a) Balance Sheet 3.6(b)
(a3.5(a) Balance Sheet Date 3.5(a) Bankruptcy Exception 3.2 Basket Amount 7.5(b)(ii) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiIndemnified Parties 7.2 Buyer Obligations 5.16(a) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(aCap 7.5(b)(i) Closing 2.6 Closing Balance Sheet 2.7 2.4 Closing Date 2.6 COBRA 5.7(d2.4 Confidentiality Agreement 5.6(a) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iiiDebt Commitment Letter 4.4(a) Debt Financing 5.21(a4.4(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination 4.4(a) Disclosure Schedules Article III Dispute Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c2.3(b)(iii) Effect 1.1 Environmental Laws 3.17(d)(i3.17(e)(i) Equity Financing 5.21(aEnvironmental Permits 3.17(e)(ii) Equity Financing Commitment 4.4 Estimated Closing Statement 2.3(b)(i) Excluded Assets 2.2 Excluded Intellectual Property 2.2(c2.1(b) Excluded Liabilities 2.4 2.2(b) Excluded Willow Court Assets 2.1(b)(iv) Existing Stock 5.14(bCollaboration Agreement Recitals Existing Grifols Liabilities 2.2 FCPA 1.1 Fee Letter 4.4(b) Fairness Opinion 3.2(bFinal Allocation Schedule 2.6(a) FDA 1.1 Final Closing Statement 2.3(b)(v) Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) 5.17 Fundamental Representations 7.1 Xxxxxx Xxxx 9.21 Grifols Preamble Hazardous Substances 3.17(d)(ii3.17(e)(iii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(aSchedule 2.6(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hInsurance Policies 3.13 Lenders 4.4(a) Losses 7.2 Marks 1.1 Notice Material Contracts 3.18(a) Material Suppliers 3.12 Objection Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a2.6(b) Post-Closing Claims 5.13(a5.14(b) Pre-Proposed Final Closing Contract Statement 2.3(b)(ii) Purchase Price 2.3(a) Resolution Period 2.3(b)(iv) Seller Preamble Seller Indemnified Parties 7.3 Shared Liabilities 2.4(f2.2(c)(i) Privacy Laws 3.26(aTermination Date 8.1(c) Proxy Statement 3.29Third Party Claim 7.4(a) Transferred Assets 2.1(a) Transferred Contracts 2.1(a)(iii) Transferred Employees 5.11(a) Transferred Product Registrations 2.1(a)(vii) Transferred Real Property 2.1(a)(iv) Withholding Agent 2.8
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i5 Adjustment Date 2.13(a) Advisory Group 2.15(b) Aggregate Closing Option Consideration 2.9(b) Aggregate Closing Share Consideration 2.7(a) Aggregate Converted Option Restricted Share Value 2.9(e) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Accounting Principles 2 Balance Sheet 3.6(b)
(a) Business Bonus Plan 5.9(g) California Law Recitals Buyer Preamble Buyer Employees 5.3(a)(iiCancelled Shares 2.7(c) Buyer Expenses 8.4(cCertificate of Merger 2.2(b) Buyer Welfare Plans 5.7(eCertificates 2.10(b) CERCLA 3.17(d)(ii) Claim Notice 7.4(aCharter 1 Closing 2.2(a) Closing 2.6 Closing Balance Sheet 2.7 Cash 2.13(a) Closing Date 2.6 2.2(a) Closing Indebtedness 2.13(a) Closing Option Consideration 2.9(b) Closing Pass-Through Amount 2.13(a) Closing Share Consideration 2.7(a) Closing Transaction Expenses 2.13(a) Closing Warrant Consideration 2.9(h) COBRA 5.7(dCoverage 3.10(f) Code 1.1 Competing Business 5.3(a)(iCompany Preamble Company Holders Meeting 3 Company Indemnified Parties 5.14(a) Confidential Information 5.8(bCompany Indemnifying Parties 8.2(a) Copyrights 1.1 Customer 5.3(a)(iiiConfidentiality Agreement 5 Consideration Schedule 2 Continuing Employees 5.9(a) Continuing Individuals 5.9(a) Debt Financing 5.21(aPayoff Letter 7.3(e) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DDelaware Law Recitals Developed 3.16(v) DGCL 4.6 Direct Claim 7.4(cDisclosure Schedules Article III Dissenting Shares 3 Effective Time 2.2(b) Effect 1.1 Employee Plans 3.10(a) Environmental Laws 3.17(d)(i3.16(d) Equity Financing 5.21(aEnvironmental Permits 3.16(d) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cERISA 3.10(a) Excluded Liabilities 2.4 Existing Stock 5.14(bERISA Affiliates 3.10(a) Fairness Opinion 3.2(bEstimated Cash 2 Estimated Indebtedness 2 Estimated Pass-Through Amount 2 Estimated Transaction Expenses 2 Final Closing Statement 2.13(a) FDA 1.1 Financial Statements 3.5(a3.6(a) Financing 5.21(aFundamental Claims 8.5(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Fundamental Representations 8 Hazardous Substances 3.17(d)(ii3.16(d) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Holders Recitals Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(a2.13(c) Initial Allocation 2.1 Information Statement 3 Infringe 3.14(f)(i) Interim Financial Statements 3.5(a3.6(a) Intervening Event 5.17(j)(iiiInterim Options Tax Ruling 5.15(b) Intervening Event Change of Recommendation 5.17(d)(iiIRS 3.10(c) Licensed Excluded IP 3.13(hIsraeli 102 Tax Ruling 5.15(a) Israeli Funds Ruling 5.15(a) Israeli Severance Pay Law 3.11(l) Israeli Tax Certificate 2.14(b) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D8.2(a) Outside Date 8.1(b)(iMaterial Contracts 3.17(a) Patents 1.1 Merger Recitals Merger Sub Preamble Net Adjustment Amount 2.13(f) Non-Personal Information 3.26(a3.21(a) Post-Notice of Disagreement 2.13(b) OCS 3.14(l) Open Source License 3.14(h) Option Consideration 2.9(b) Optionholder 2.9(b), 2.9(b) Optionholders 2.9(b) Parent Preamble Parent Indemnified Party 8.5(b) Paying and Exchange Agent 2.10(a) Permits 3.8(b) Personal Information 3.21(a) Preferred Stockholders Recitals Preliminary Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Statement 2 Privacy Laws 3.26(a3.21(a) Proxy Statement 3.29Representative Expenses 2.15(b) Representative Group 2.15(b) SEC 5 SEC Filings 5 Second Anniversary Option 2.9(a) Section 14 Arrangement 3.11(l) Securityholder Representative 2.15(a) Seller Group 10 Share Consideration 2.7(a) Shares 3 Specified Employee Release Amounts 8.7(b) Stockholders Recitals Surviving Corporation 2 Tail Policy 5.14(b) Third Party Claim 8.4(a) Title IV Plan 3.10(e) Transaction Expenses Payoff Instructions 7.3(f) Transfer Taxes 6 WARN 3.11(k), 3.11(d) Warrant Consideration 2.9(h) Written Consents Recitals
Appears in 1 contract
Samples: Merger Agreement (AOL Inc.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(iDefinition Location Agreed Closing Statement 2.4(b) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a3.7(b) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a6.3(a) Closing 2.6 Closing Balance Sheet 2.7 2.2(a) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(iCompany Preamble Company Registered IP 3.15(e) Confidential Information 5.8(bConsideration Shares 2.2(b)(i) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Designs 1.1 Direct Claim 7.4(c6.3(e) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Enforceability Exceptions 3.2 Financial Statements 3.5(a3.7(a) Financing 5.21(aFundamental Representations 6.1 ICC 7.11(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bICC Rules 7.11(a) Indemnified Party 7.4(a6.3(a) Indemnifying Party 7.4(a6.3(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h3.7(a) Losses 7.2 6.2 Marks 1.1 Notice Period 5.17(d)(i)(DMaterial Contracts 3.18(a) Outside Date 8.1(b)(iMinority Shareholders Recitals Parent Preamble Parent Common Stock Recitals Parent Preferred Stock 4.6(a) Parent Reports 4.4 Patents 1.1 Permits 3.9(b) Permitted Encumbrances 3.13(a) Personal Information 3.26(a3.21(a) Post-Plans 3.11(a) Preliminary Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(fStatement 2.4(a) Privacy Laws 3.26(a3.21(a) Proxy Statement 3.29Restrictive Covenant Agreements 2.3(b)(iii) Seller Counsel 7.20 Sellers Preamble Sellers’ Representative Preamble Shares Recitals Third Party Claim 6.3(a) Trade Secrets 1.1 Warrants 2.2(b)(i)
Appears in 1 contract
Samples: Purchase Agreement
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c401(k) Plan(s) 5.7(c) Acquiror Preamble Acquiror Fundamental Representations 6.2(a) Acquiror Releasees 8.21(b) Acquisition Proposal 5.17(j)(iEngagement 8.20(b) Affected Employees 5.7(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EPreamble
(a) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b3.6(a) Cancelled Shares 2.7(c) Certificate of Merger 2.2(b) Certificates 2.10(d) Charges 2.13(b) Closing 2.2(a) Closing Cash 2.12(b) Closing Date 2.2(a) Closing Date Payment Schedule 5.15 Closing Indebtedness 2.12(b) Closing Net Working Capital 2.12(b) Closing Transaction Expenses 2.12(b) Company Preamble Company Fundamental Representations 6.3(a) Company Patents 3.14(a) Company Personnel 3.10(a) Company Registered Copyrights 3.14(a) Company Registered IP 3.14(a) Company Registered Marks 3.14(a) Company Stockholder Approval 3.2(a) Copyrights 1.1 DGCL Recitals Disclosure Schedules Article III Dissenting Shares 2.8 DOL 3.10(a) Effective Time 2.2(b)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i3.16(c)(i) Equity Financing 5.21(aEnvironmental Permits 3.16(c)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cERISA 3.10(a)
(a) Estimated Indebtedness 2.12(a) Estimated Net Working Capital 2.12(a) Estimated Transaction Expenses 2.12(a) Excluded Liabilities 2.4 Existing Stock 5.14(bCash Accounts 1.1 Final Closing Statement 2.12(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d3.6(a)
(a) Hazardous Substances 3.17(d)(iiMaterials 3.16(c)(iii) Health Care Permits 3.27(cHighly-Compensated Employee 3.7(k) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(aIn-bound License 3.14(d) Independent Accounting Firm 2.8(a2.12(d) Initial Allocation 2.1 Interim Financial Statements 3.5(a3.6(a) Intervening Event 5.17(j)(iiiLetter of Transmittal 2.10(d) Intervening Event Change of Recommendation 5.17(d)(iiLiabilities 3.6(b) Licensed Excluded IP 3.13(hXxxxxxxxxx Fund 1.1 Majority Holders 2.13(c) Losses 7.2 Marks 1.1 Material Contracts 3.17(a) Merger Recitals Net Adjustment Amount 2.12(g)(i) Non-Disclosure Agreement 5.8 Non-U.S. Employee Plan 3.10(c) Notice Period 5.17(d)(i)(Dof Disagreement 2.12(c) Outside Date 8.1(b)(iOFAC 3.8(d) Patents 1.1 Paying Agent 2.10(a) Payment Fund 2.10(a) Permits 3.8(b) Personal Information 3.26(aData 3.14(h) Post-Preliminary Closing Claims 5.13(aStatement 2.12(a) Pre-Closing Contract Liabilities 2.4(fRelease 3.16(c)(iv) Privacy Laws 3.26(aSample Statement 2.12(a) Proxy Statement 3.29Stockholder 2.10(a) Stockholder Notice 5.3(b) Stockholder Releasors 8.21(b) Stockholder Representative 2.13(a) Sub Preamble Sub Stockholder Approval 4.2 Surviving Corporation 2.1 Takeover Statute 3.2(a) Termination Date 7.1(c)
(a) Top Suppliers 3.19(b) Trade Secrets 1.1 Transfer Taxes 5.13
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(iAgreed Principles 2.4(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAllocation Exhibit 2.5 Approval 3.5(b) Alternative Financing 5.21(bAudited Consolidated Annual Financial Statements 3.6(a) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Balance Sheet Date 3.6(b) breaching party 5.3(c) Business Recitals Business Documents 5.8(a) Buyer Preamble Buyer Employees 5.3(a)(iiCore Representations 8.1(a) Buyer Expenses 8.4(cBuyer’s Proposed Closing Financial Statements 2.4(b) Buyer Welfare Plans Buyer’s Proposed Purchase Price Adjustment 2.4(b) Cap 8.4(a) Closing 2.3(a) Closing Date 2.3(a) Closing Date Purchase Price 2.3(b)(i)(A) Closing Payment 2.3(b)(i)(A) COBRA 5.7(e) CERCLA 3.17(d)(iiCode 3.9(a) Claim Notice 7.4(aCompany Recitals Company Benefit Plans 3.9(a) Closing 2.6 Closing Balance Sheet Confidentiality Agreement 5.3(a) Continuing Employees 5.7(b) Corporate Subsidiary 2.7 Closing Date 2.6 COBRA 5.7(dD&O Indemnified Liabilities 5.11(a) Code 1.1 Competing Business 5.3(a)(iD&O Indemnified Parties 5.11(a) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Dataroom 10.3 Debt Financing 5.21(a) Commitment Letter 4.7 Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Sources 10.14 Deductible 8.4(b) Delivery Notice 5.17(d)(i)(D5.14 Deposit 2.2 Disclosure Schedules Article III Disqualified Individual 3.9(c) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Divestitures Recitals Environmental Laws 3.17(d)(i3.14 ERISA 3.9(a) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Estimated Closing Financial Statements 3.5(a2.4(a) Financing 5.21(aExisting D&O Policy 5.11(b) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aExpiration Date 8.1(c) Group Health Plan 5.7(dFinal Purchase Price 2.4(b)(iv) Hazardous Substances 3.17(d)(iiFinancial Statements 3.6(a) Health Care Permits 3.27(c) HIPAA 1.1 FKC Minority Corporate Subsidiary 2.7 HSR Act 3.3(b4.3(a)(iii) Indemnified Party 7.4(a8.6(a) Indemnifying Party 7.4(a8.6(a) Independent Accounting Firm 2.8(aAccountant 2.4(b)(ii) Initial Allocation 2.1 Insurance Policies 3.18 Intellectual Property 3.12(a) Interim Consolidated Financial Statements 3.5(a3.6(a) Intervening Event 5.17(j)(iiiLeased Real Property 3.10(b) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hLiberty Minority Corporate Subsidiary 2.7, 2.7 LLC Conversions 5.15) Losses 7.2 Marks 1.1 8.2 Material Contracts 3.16(a) Minority Interest 2.7 Nonassignable Excluded Assets 5.4(c) Notice Period 5.17(d)(i)(Dof Disagreement 2.4(b)(i) Offering Memorandum 4.6(a) Organizational Documents 3.5(a)(i) Outside Date 8.1(b)(i9.1(c) Patents 1.1 Personal Owned Real Property 3.10(a) Permits 3.8(b) Permitted Lien 3.10(a) Purchase Price 2.1 Real Property Leases 3.10(b) Required Information 3.26(a5.14 Residential Mortgages 3.20 Restricted Business 5.12(a) PostS Corporation Returns 6.4(a) Section 280G Payments 5.7(h) Seller Preamble Seller Core Representations 8.1(a) Seller’s Estimated Purchase Price Adjustment 2.4(a) Shares Recitals Tax Purchase Price 2.5 Tax-Closing Claims 5.13(arelated Actions 6.2 Termination Time 2.6 Third Party Claim 8.6(b) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.29Transaction 2.1 waiving party 5.3(c)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquiror Preamble Acquiror Indemnified Parties 8.2 Acquisition Proposal 5.17(j)(i5.2 April Financial Statements 3.6(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAllocation 2.10 Antitrust Authority 5.5(a) Alternative Financing 5.21(bAntitrust Filings 5.5(a) Applicable Date 3.6(dAudit Practice Recitals Basket Limitation 8.6(a) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(aBirchtree Financial 1.1 Broker-Dealer Activities 3.22(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiCertificate of Merger 2.3(b) Buyer Expenses 8.4(cChange in Control Participants 5.7(c) Buyer Welfare Plans 5.7(eChange in Control Schedule 5.7(c) CERCLA 3.17(d)(iiChange in Control Participant Payments 5.7(c) Claim Notice 7.4(aClient Agreements 3.20(a) Closing 2.6 Closing Balance Sheet 2.7 2.3(a) Closing Date 2.6 COBRA 5.7(d2.3(a) Company Conversion Recitals Contribution Recitals Conversion Recitals Code 1.1 Competing Business 5.3(a)(i3.10(b) Confidential Information 5.8(b) Company Preamble Copyrights 1.1 Customer 5.3(a)(iiiDecember Closing Schedule 2.14 Disclosure Schedule Article III DOJ 5.5(a) Debt Financing 5.21(aEffective Time 2.3(b) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cERISA 3.10(a)(i) Excluded Liabilities 2.4 Existing Stock 5.14(bAsset Call Letter 5.10 Excluded Asset Transfer 5.10 Excluded Plans 3.10 Executive Potential Terminees 5.7(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a3.6(a) Financing 5.21(a5.15 FINRA 3.22(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aFINRA Rules 3.22(a) Group Health Plan 5.7(dFIRPTA 3.16(a) Hazardous Substances 3.17(d)(iiFM Business 1.1 Forward Looking Statements 4.8 FTC 5.5(a) Health Care Permits 3.27(cHRB Deferred Compensation Plans 5.7(c) HIPAA 1.1 HRB Preamble HRB Indemnified Parties 8.3 HSR Act 3.3(b) Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(aAccountants 2.9(b) Initial Allocation 2.1 Interim Investment Advisory Contract 1.1 IRS 3.10(b) IT Systems 3.15(a) July Financial Statements 3.5(a3.6(a) Intervening Event 5.17(j)(iiiLeases 3.13(b) Intervening Event Change of Recommendation 5.17(d)(iiLegal Privilege 5.5(b) Licensed Excluded IP 3.13(h) LLC Interest 2.1 Losses 7.2 8.2 Marks 1.1 Notice Period 5.17(d)(i)(DMerger Recitals Negative Consent Contracts 5.20 Officer’s Certificate 8.4(a) Outside Date 8.1(b)(i9.1(c) Owned Software 3.14(g) Parent Preamble Patents 1.1 Personal Information 3.26(aPermitted Encumbrances 3.12(a) Post-Closing Claims 5.13(aPlans 3.10(a)(i) Pre-Closing Contract Tax Returns 6.5 Producer 3.23(a) PSB Assets 2.11 PSB Liabilities 2.4(f2.11 PSB Netting Process 2.11 Reserves 3.6(d) Privacy Laws 3.26(aRetained Employees 5.7(a) Proxy Statement 3.29Service Providers 3.24(f) Severance Obligations 1.1 Solutions Recitals Solutions Conversion Recitals Straddle Period 6.4 Sub Preamble Surviving Company 2.2 Target Data 3.15(b) Target Agreements 3.21(a) Target Insurance Policies 3.18 Third Party Claim 8.5(a) Trade Secrets 1.1
Appears in 1 contract
Samples: Merger Agreement (H&r Block Inc)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cDefinition Location 409A 3.10(n) Acquiror Preamble Acquiror Indemnification Claim 8.4(a) Acquiror Indemnified Parties 8.2 Acquisition Proposal 5.17(j)(i) 5.2 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAntitrust Authority 5.6(a) Alternative Financing 5.21(bAntitrust Filings 5.6(a) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(eAudited Financial Statements 3.6(a) CERCLA 3.17(d)(ii1.1 Certificate of Merger 2.2(b) Claim Notice 7.4(aCertificates 2.9(c) Class A Common Stock Recitals Class B Common Stock Recitals Closing 2.2(a) Closing 2.6 Date 2.2(a) Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(dSchedules 2.9(g) Code 1.1 Competing Business 5.3(a)(i3.10(b) Confidential Information 5.8(bCompany Preamble Company 401(a) Plan 3.10(o) Company Common Stock Recitals Company Indemnified Parties 8.3 Company IP 3.14(a) Confidentiality Agreement 5.5 Contractors 3.22 Copyrights 1.1 Customer 5.3(a)(iiiCounsel 5.12 Delaware Law Recitals Disclosure Schedules Article III Dissenting Shares 2.8 Divestiture 5.6(d) Debt Financing 5.21(aDOJ 5.6(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DEffective Time 2.2(b) DGCL 4.6 Direct Claim 7.4(cEmployment Agreements Recitals ERISA 3.10(a)(i) Effect 1.1 Environmental Laws 3.17(d)(iEstimated Net Working Capital Amount 2.9(g) Equity Financing 5.21(aExpiration Date 8.1 Expiration Time 5.10 Final Net Working Capital Amount 2.9(h) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a3.6(a) Financing 5.21(aFTC 5.6(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Definition Location Inbound License Agreements 3.14(e) Indemnified Party 7.4(a8.5(a) Indemnifying Party 7.4(a8.5(a) Independent Accounting Firm 2.8(aAccountants 2.9(h) Initial Allocation 2.1 Interim Financial Statements 3.5(aIRS 3.10(b) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hLegal Privilege 5.6(b) Losses 7.2 8.2 Marks 1.1 Notice Period 5.17(d)(i)(DMaterial Contracts 3.17(a) Material Supplier 3.23(b) Merger Recitals Multiemployer Plan 3.10(c) Multiple Employer Plan 3.10(c) Net Working Capital Amount Schedule 2.9(g) Non-Competition Agreements 7.3(f) Non-Solicitation Agreements 7.3(g) Officer’s Certificate 8.4(c) Open Source License 3.14(g) Option Payment 2.7(e) Outbound License Agreements 3.14(e) Outside Date 8.1(b)(i9.1(c) Patents 1.1 Personal Information 3.26(aPayment Agent 2.9(c) Post-Closing Claims 5.13(aPermits 3.8(b) Permitted Encumbrances 3.12(a) Plans 3.10(a)(iv) Pre-Closing Contract Liabilities 2.4(fStraddle Amount 6.2 Pre-Closing Tax Return 6.3 Principal Stockholders 7.3(g) Privacy Laws 3.26(aPro Rata Share 2.11(b) Proxy Statement 3.29Reduced Tax Liability 6.4 Representatives 5.10 Schedule of Expenses 2.9(g) Second Request 5.6(b) Shares 2.7 Stockholder Representative 2.11(a) Stockholders Agreement Recitals Straddle Period 6.2 Sub Preamble Surviving Corporation 2.1 Systems 3.14(i) Tax Benefit 8.6(b) Tax Cost 8.6(b) Tax Losses 8.4(b) Tax Matters Expiration Date 8.1 Third Party Claim 8.5(a) Definition Location Trade Secrets 1.1 Unaudited Financial Statements 3.6(a) Voting Agreements Recitals
Appears in 1 contract
Samples: Merger Agreement (H&r Block Inc)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(iAffected Employees 6.9(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(dAllocation Statement 2.5(a) Assumed Liabilities 2.3 2.1(c)(i) Balance Sheet 3.6(b)
(a4.6(a) Basket Amount 8.6(b)(ii) Business Recitals Registered IP 4.14(a) Buyer Preamble Buyer Employees 5.3(a)(iiIndemnified Parties 8.2 Buyer Restricted Territory 6.12(b) Buyer Expenses 8.4(cTermination Fee 9.3(a) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(aCap 8.6(b)(i) Closing 2.6 Closing Balance Sheet 2.7 2.3 Closing Date 2.6 COBRA 5.7(d2.3 Closing Statement 2.4(a) Code 1.1 Competing Business 5.3(a)(iCollective Bargaining Agreement 4.11(a) Confidential Information 5.8(bCompanies Preamble Company Plans 4.10(a) Copyrights 1.1 Customer 5.3(a)(iiiConfidentiality Agreement 6.5 Debt Financing 5.4(b) Debt Financing 5.21(aCommitment 5.4(b) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DDisclosure Schedules Article IV DOD 6.6(c) DGCL 4.6 Direct Claim 7.4(cDomestic Leasehold Shared Spaces 4.14(d) Effect 1.1 DSS 6.6(c) Employee Plans 4.10(a) Environmental Laws 3.17(d)(i4.17(c)(i) Equity Financing 5.21(a5.4(b) Equity Financing Commitment 4.4 5.4(b) ERISA 4.10(a) Estimated Purchase Price 2.4(a) Excluded Assets 2.2 Excluded Intellectual Property 2.2(c2.1(b)(ii) Excluded Liabilities 2.4 Existing Stock 5.14(b2.1(c)(ii) Fairness Opinion 3.2(bFinal Adjustment Schedule 2.4(b) FDA 1.1 Financial Statements 3.5(a4.6(a) Financing 5.21(a5.4(b) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a5.4(b) Group Health FLSA 4.11(c) Foreign Plan 5.7(d4.10(i) FTCA 4.8(a) Fundamental Representations 8.1 Guarantors Recitals Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(cMaterials 4.17(c)(ii) HIPAA 1.1 4.8(a) HSR Act 3.3(b) 1.1 Indemnified Party 7.4(a8.5(a) Indemnifying Party 7.4(a8.5(a) Independent Accounting Firm 2.8(aAccountant 2.4(d) Initial Allocation 2.1 Insurance Claim Amounts 6.14(a) Insurance Policies 4.12 Interim Financial Statements 3.5(a4.6(a) Intervening Event 5.17(j)(iiiInternational Leasehold Shared Spaces 4.14(d) Intervening Event Change of Recommendation 5.17(d)(iiJune Financial Statements 6.18 Losses 8.2 Material Contracts 4.18(a) Licensed Excluded Material Customers 4.21 Mitigation Agreement 6.6(c) MLS Business Recitals MLS Financial Statements 4.6(a) MSG Business Recitals MSG/MLS Arrangements 2.1(b)(i)(B) MSG/MLS Customer Deposits 2.1(b)(i)(L) Non-Compete Period 6.12(a) Objection Notice 2.4(c) OSH Laws 4.11(d) Owned Shared Spaces 4.14(d) PB Canada Preamble PB UK Preamble PBGS Preamble PBGS Common Stock Recitals PBI Preamble PBMS Preamble PBMS Common Stock Recitals PBMS/PBGS Business Recitals PCI-DSS 4.20(a) Permits 4.8(c) Potential Contributor 8.7 Preliminary June Financial Statements 4.6(d) Related Parties 10.11 Release 4.17(c)(iii) Restricted Territory 6.12(a) Securities Act 5.8 Seller Guarantees 6.15 Seller Indemnified Parties 8.3 Seller Plans 4.10(a) Sellers Preamble Shared MSA 6.4(d) Shared Spaces 4.14(d) Shares Recitals Straddle Period 6.10(f) Tax Cost/Benefit 8.4(c) Tax Losses 8.4(a) Tax Proceeding 8.4(d) Termination Date 9.1(c) Third Party Claim 8.5(a) Third Party IP 3.13(h4.14(c) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DTransferred Assets 2.1(b)(i) Outside Date 8.1(b)(iTransferred Contracts 2.1(b)(i)(A) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.29WARN Act 4.11(c)
Appears in 1 contract
Samples: Stock and Asset Purchase Agreement (Pitney Bowes Inc /De/)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities Accounting Principles 2.3 Balance Sheet 3.6(b)
(a3.7(b) Business Recitals 5.2(a)(i) Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 2.2(a) Closing Balance Sheet 2.7 Cash 2.4(a) Closing Date 2.6 COBRA 5.7(d2.2(a) Closing Indebtedness 2.4(a) Closing Net Working Capital 2.4(a) Closing Transaction Expenses 2.4(a) Code 1.1 Competing Business 5.3(a)(i3.11(b) Common Stock Recitals Company Recitals Company Group Employees 5.2(a)(ii) Company Registered Intellectual Property 3.15(a) Confidential Information 5.8(b5.3(a) Copyrights 1.1 Covered Rep Cap 7.5(a)(i) Covered Reps 7.2(a) Customer 5.3(a)(iii5.2(a)(iii) Debt Financing 5.21(aPayoff Letter 7.3(h) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Disclosure Schedules Article III Environmental Laws 3.17(d)(i3.17(e)(i) Equity Financing 5.21(aERISA 3.11(a)(i) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cEstimated Cash 2.3 Estimated Indebtedness 2.3 Estimated Net Working Capital 2.3 Estimated Transaction Expenses 2.3 Xxxxxx Preamble Final Closing Statement 2.4(a) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a3.7(a) Financing 5.21(aFiscal Year 2021 Bonuses 5.8(b) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aFundamental Representations 7.1(a)(i) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a2.4(c) Initial Allocation 2.1 Interim Financial Statements 3.5(a3.7(a) Intervening Event 5.17(j)(iiiIRS 3.11(b) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Key Employment Agreements Recitals Losses 7.2 Marks 1.1 Material Contracts 3.18(a) MEWA 3.11(c) Multiemployer Plan 3.11(c) Multiple Employer Plan 3.11(c) Net Adjustment Amount 2.4(f)(i) Notice Period 5.17(d)(i)(Dof Disagreement 2.4(b) Outside Date 8.1(b)(iOther Reps 7.2(b) Patents 1.1 Parent Recitals Parent Shares Recitals Payoff Indebtedness 2.2(b)(iii) PCI DSS 3.21(f) Permits 3.9(b) Permitted Encumbrances 3.13(a) Personal Information 3.26(a3.21(a) Post-Plan 3.11(a) Pledge Agreement 7.5(d) Preliminary Closing Claims 5.13(a) Pre-Balance Sheet 2.3 Preliminary Closing Contract Liabilities 2.4(f) Statement 2.3 Privacy Laws 3.26(a3.21(a) Proxy Statement 3.29Restrictive Covenant Agreements Recitals Rollover Shares Recitals Seller Preamble, Preamble, Preamble, Preamble Seller Contribution Recitals Seller Contribution Agreements Recitals Seller Releasee 5.6 Seller Releasor 5.6 Seller Representative Preamble Shares Recitals Tail Policy 2.2(c)(xvi) Tax Representations 7.1(a)(ii) Third Party Claim 7.4(a) Transaction Expenses Payoff Instructions 7.3(i) Trustee 3.2 WARN 3.12(j)
Appears in 1 contract
Samples: Stock Purchase Agreement (Compass Group Diversified Holdings LLC)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) Accounting Principles 1.1 Action 1.1 Affiliate 1.1 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Transaction 1.1 Ancillary Agreements 1.1 Antitrust Law 1.1 Applicable Date 3.6(dNet Product Working Capital Forecast Amount 1.1 Apportioned Taxes 6.4 Approved Budget 1.1 Asset Class 1.1 Assumed Liabilities 2.3(a) Assumed Liabilities 2.3 Plan 1.1 Auction 1.1 Avoidance Actions 1.1 Balance Sheet 3.6(b)
(a3.5(e) Bankruptcy Case 1.1 Bankruptcy Code 1.1 Bankruptcy Court Recitals Xxxx of Sale 2.9(b)(i) Books and Records 1.1 Breaches 3.15(c) Business 1.1, Recitals Business Day 1.1 Business Employee 1.1 Business Permits 2.1(a)(xiv) Buyer Preamble Buyer Employees 5.3(a)(iiMaterial Adverse Effect 1.1 Buyer Plans 5.4(j) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(iiTaxes 1.1 Cash Component 2.7(a) Claim Notice 7.4(a1.1 Closing 2.9(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 2.9(a) COBRA 5.7(d) 1.1 Code 1.1 Collateral 1.1 Commitment Letter 4.4 Commitment Parties 4.4 Commitment Party Related Person 9.13 Company Group 1.1 Company SEC Documents 3.5(a) Competing Business 5.3(a)(iBid 1.1 Competing Bid Obligations 5.8(f) Confidential Information 5.8(b) Contract 1.1 control 1.1 controlled by 1.1 Copyrights 1.1 Customer 5.3(a)(iiiCredit Bid Consideration 2.9(c)(i)(A) Debt Financing 5.21(aCure Claims 1.1 Current Representation 9.25(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DXxxxx Xxxx 9.25(a) DGCL 4.6 Direct Claim 7.4(cDesignated Buyer 2.11(a) Effect Designated Contract Make-Whole Amount 1.1 Designated Contracts 1.1 Designated Person 9.25(a) DIP Credit Agreement 1.1 DIP Loan Document 1.1 DIP Loan Parties 1.1 DIP Obligations 1.1 DIP Secured Parties 1.1 DIP Superpriority Claims 1.1 Disclosure Letter III Disputed Cure Claims 2.6(c) Employee Census 3.10(a) Employee Incentive Plan 5.4(g) Employee Plans 1.1 Encumbrance 1.1 Environmental Laws 3.17(d)(iClaim 1.1 Environmental Law 1.1 Environmental Permit 1.1 ERISA 1.1 ERISA Affiliate 1.1 Excess Cash Amount 1.1 Exchange Act 3.5(a) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cInsurance 2.1(a)(xv) Excluded Liabilities 2.4 Existing Stock 5.14(bExecutory Contract 2.6(a) Fairness Opinion 3.2(bExecutory Contract List 2.6(a) Expense Reimbursement Amount 8.3(a) FDA 1.1 Financial Statements 3.5(a) FFDCA 1.1 Final DIP Order 1.1 Final Order 1.1 Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Fraud 1.1 GAAP 1.1 GDPR 1.1 Goodwill 1.1 Governmental Authority 1.1 Designated Contract 1.1 Hazardous Substances 3.17(d)(ii) Materials 1.1 Health Care Permits 3.27(c) Laws 1.1 HIPAA 1.1 HSR Act 3.3(b1.1 IND 1.1 Indebtedness 1.1 Information Privacy and Security Laws 1.1 Infringe 1.1 Intellectual Property 1.1 Interests 1.1 Interim DIP Order 1.1 Inventory 1.1 IP Assignment Agreement 2.9(b)(ii) Indemnified IP License Agreement 2.9(b)(iii) IRS 1.1 Knowledge 1.1 Law 1.1 Lease 1.1 Leased Real Property 1.1 Liability 1.1 Lockbox Accounts 1.1 Material Adverse Effect 1.1 Material Contract 3.17(a) Material Contracts 3.17(a) Milestones 1.1 Morristown Facility 1.1 Morristown Lease 1.1 Nalpropion 1.1 Nalpropion Loan Documents 1.1 Nalpropion Loan Indebtedness 1.1 Nalpropion Shares 1.1 Nasdaq 3.5(b) NDAs 1.1 Net Product Working Capital 1.1 Order 1.1 Ordinary Course of Business 1.1 Organizational Documents 1.1 Outside Date 8.1(a)(iii)(C) Parties 1.1 Party 7.4(a1.1 Patents 1.1 Permits 3.7(b) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Permitted Encumbrance 1.1 Pernix Ireland DAC 1.1 Pernix Ireland DAC Cash 1.1 Pernix Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents Person 1.1 Personal Information 3.26(a) Data 1.1 Petition Date 1.1 Petitions Recitals Positive Product Working Capital 1.1 Positive Product Working Capital Credit Bid Consideration 1.1 Post-Closing Claims 5.13(aTax Period 6.4 Pre-Auction Designation Date 2.6(d) Pre-Closing Statement 2.8 Pre-Closing Tax Period 6.4 Prepetition DDTL Agreement 1.1 Prepetition DDTL Loan Documents 1.1 Prepetition DDTL Obligations 1.1 Product Approvals 1.1 Product Intellectual Property 1.1 Product Marketing Materials 1.1 Product Regulatory Materials 1.1 Product Working Capital Assets 1.1 Product Working Capital Liabilities 1.1 Products 1.1 Purchase Price 2.7(a) Purchase Price Allocation 2.10 Qualified Bidder 1.1 Qualified Leave Recipient 1.1 Real Property 1.1 Reference Statement 1.1 Regulatory Approvals 1.1 Release 1.1 Representatives 1.1 Sale Hearing 1.1 Sale Motion 5.8(a) Sale Order 1.1 Sale Procedures 1.1 Sale Procedures Order 1.1 SEC 3.5(a) Securities Act 3.5(a) Seller Preamble Seller Financial Statements 3.5(c) Seller Parent Preamble Seller Taxes 1.1 Seller Unaudited Financial Statements 3.5(c) Seller-Paid Buyer Taxes 2.7(a) Sellers Preamble Sellers Plans 5.4(j) Sensitive Data 1.1 Services Agreement 1.1 Shared GTN Contracts 1.1 Software 1.1 Specified Cure Claims 1.1 Specified DIP Credit Bid Consideration 1.1 Specified Interests 1.1 Specified Prepetition Credit Bid Consideration 1.1 Subsidiary 1.1 Successful Bidder 1.1 Tax Return 1.1 Taxes 1.1 Term Sheet 1.1 Termination Date 8.1(a) Trade Secrets 1.1 Trademarks 1.1 Transfer Taxes 6.1 Transferred Assets 2.1(a) Transferred Contracts 1.1 Transferred Employee 5.4(b) Transition Services Agreement 1.1 Treximet Assets 1.1 Treximet Bid 1.1 Treximet Business 1.1 Treximet Indenture 1.1 Treximet Intellectual Property 1.1 Treximet Letter of Credit 1.1 Treximet Products 1.1 Treximet Sale 1.1 Treximet Working Capital Liabilities 1.1 Treximet-Related Shared Contract Liabilities 2.4(f5.17(a) Privacy Laws 3.26(aunder common control with 1.1 Undisputed Cure Claims 2.6(a) Proxy Statement 3.29Unpaid Seller Taxes 2.7(a)
Appears in 1 contract
Samples: Asset Purchase Agreement (Pernix Therapeutics Holdings, Inc.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cDefinition Location Acquiror Preamble Acquiror Group 11.19(b) Acquiror Indemnified Party 9.2 Acquiror Permits 5.8(b) Acquiror Plan 6.12(a) Acquiror Prepared Tax Return 7.1 Acquiror SEC Documents 5.5(a) Acquisition Proposal 5.17(j)(i) 6.3 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EApplicable Accounting Principles 3.4 Associated Rights 11.19(b) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b4.6(b) Cancelled Shares 2.6(b) CERCLA 4.16(c)(ii) Certificate of Merger 3.1(b) Claim Notice 9.4(a) Closing 3.1(a) Closing Balance Sheet 3.5(a)(i) Closing Cash 3.5(a)(ii) Closing Date 3.1(a) Closing Indebtedness 3.5(a)(ii) Closing Net Working Capital 3.5(a)(ii) Closing Transaction Expenses 3.5(a)(ii) Communications 11.19(b) Company Preamble Company Annual Financial Statements 4.6(a) Company Employees 6.12(a) Definition Location Company Registered IP 4.14(e) Confidentiality Agreement 6.6 Debt Payoff Letter 8.3(g) DGCL Recitals Direct Claim 9.4(c) Disclosure Schedules Article IV Dissenting Shares 2.6(e)(i) Effective Time 3.1(b) Effectiveness Period 6.11(a) Environmental Laws 4.16(c)(i)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiEstimated Cash 3.4 Estimated Indebtedness 3.4(a)(ii) Buyer Estimated Net Working Capital 3.4(a)(ii) Estimated Transaction Expenses 8.4(c3.4(a)(ii) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Final Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements Statement 3.5(a) Financing 5.21(aFinal Pre-Closing Tax Return 7.1 Final Release Date 9.6(c) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aFirst Release Date 9.6(b) Group Health Plan 5.7(dGovernment Contract 4.17(a)(v) Hazardous Substances 3.17(d)(ii4.16(c)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bIndemnified Employees 6.13(a) Indemnified Party 7.4(a9.4(a) Indemnifying Party 7.4(a9.4(a) Independent Accounting Firm 2.8(a3.5(c) Initial Allocation 2.1 Information Statement 6.4(b) Interim Financial Statements 3.5(a4.6(a) Intervening Event 5.17(j)(iiiIRS 4.10(b) Intervening Event Change Letter of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hTransmittal 3.2(a)(i) Losses 7.2 Marks 1.1 9.2 Major Customer 4.21(a) Major Supplier 4.21(b) Majority Holders 3.6(c) Material Contracts 4.17(a) Merger Recitals MNPI 6.11(b) Multiemployer Plan 4.10(c) Multiple Employer Plan 4.10(c) Notice Period 5.17(d)(i)(Dof Disagreement 3.5(b) Outside Date 8.1(b)(iPC 11.19(a) Patents 1.1 PCI DSS 4.20(e) Permits 4.8(c) Personal Information 3.26(a4.20(a) Post-Closing Claims 5.13(aPlans 4.10(a) Pre-Closing Contract Liabilities 2.4(fPeriod 6.1 Definition Location Preliminary Closing Balance Sheet 3.4(a)(i) Preliminary Closing Statement 3.4(a) Privacy Laws 3.26(a4.20(a) Proxy Registration Statement 3.296.11(a) Release 4.16(c)(iii) Required Consents 6.7(b) Requisite Stockholder Approvals Recitals Stockholder Consent Recitals Stockholder Indemnified Party 9.3 Stockholder Representative 3.6(a) Sub Preamble Surviving Corporation 2.1 Tail Policy 6.13(a) Tax Proceeding 7.3 Third Party Claim 9.4(a) Transaction Expenses Payoff Instructions 8.3(h) Transfer Taxes 7.4
Appears in 1 contract
Samples: Merger Agreement (Veritone, Inc.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c401(k) Acquisition Proposal 5.17(j)(iTransfer Date 5.9(c) Affected Employees 5.9(c) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Audited Balance Sheet 3.6(b)
(a) Business Recitals Audited Financial Statements 3.6(a) Bonus Shares 5.8 Buyer Preamble Buyer Employees 5.3(a)(iiIndemnified Parties 7.2(a) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e5.9(a) CERCLA 3.17(d)(ii) Claim Notice 7.4(a1.1 Closing 2.2(a) Closing 2.6 Closing Balance Sheet 2.7 Adjustment Statement 2.3(a) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(i3.10(b) Common Stock Recitals Company Preamble Company Employees 5.9(a) Company Group Employees 5.2(a)(ii) Company Registered IP 3.14(e) Confidential Information 5.8(b5.6(a) Confidentiality Agreement 9.6 Copyrights 1.1 Customer 5.3(a)(iiiCore Representations 7.1(a) CTA Liability 6.7(b) D&O Indemnified Parties 5.10(a) Deductible 7.5(a) Deficiency 2.3(e) Disclosure Letter Article III Environmental Breach 7.4(b) Environmental Permits 3.16(b) ERISA 3.10(a)(i) Estimated Closing Debt Financing 5.21(a2.2(b) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DEstimated Closing Working Capital 2.2(b) DGCL 4.6 Direct Claim 7.4(cEstimated Section 338(h)(10) Effect 1.1 Environmental Laws 3.17(d)(iCost 2.2(b) Equity Financing 5.21(aEstimated Working Capital Deficiency 2.2(b) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cEstimated Working Capital Surplus 2.2(b) Excluded Liabilities 2.4 Existing Stock 5.14(bFractional Share Amount 2.2(d) Fairness Opinion 3.2(bGross-Up Payment 6.7(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a7.4(a)(i) Indemnifying Party 7.4(a7.4(a)(i) Independent Accounting Firm 2.8(a2.3(c) Initial Allocation 2.1 Interim Balance Sheet 3.6(b) Interim Financial Statements 3.5(a3.6(b) Intervening Event 5.17(j)(iiiIRS 3.10(b) Intervening Event Change of Recommendation 5.17(d)(iiLicenses 3.8(b) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Material Contracts 3.17(a) Multiemployer Plan 3.10(c) Multiple Employer Plan 3.10(c) New 401(k) Plans 5.9(c) Notice Period 5.17(d)(i)(Dof Disagreement 2.3(b) Outside Date 8.1(b)(i) Parent Preamble Parent SEC Documents 4.7 Patents 1.1 Personal Information 3.26(aPermitted Encumbrances 3.12(a) Plans 3.10(a)(iii) Post-Closing Claims 5.13(aTax Period 6.8(a) Pre-Closing Contract Liabilities 2.4(fTax Period 6.1(a)(ii) Privacy Laws 3.26(aRecords 5.1(a) Proxy Statement 3.29Representatives 2.3(b) Restricted Bonus Shares 5.8 Section 338 Allocation 6.2(c) Section 338(h)(10) Cost 6.7(a) Section 338(h)(10) Election 6.2(a)(i) Section 338(h)(10) Election Forms 6.2(a)(i) Securities Act 3.31 Seller Group 5.14 Seller Group Employees 5.2(b) Seller Indemnified Parties 7.3 Sellers Preamble Sellers’ Tax Contest Claim 6.8(a) Shares Recitals Straddle Period 6.5 Tax Contest Claims 6.8(a) TCC 401(k) Plan 5.9(c) Third Party Claim 7.4(a)(i) Transfer Tax 6.10 Trimco 3.30 Unrestricted Bonus Shares 5.8
Appears in 1 contract
Table of Definitions. The following words and terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c2006 Year-End Required Financial Information 6.13(b) Acquisition Proposal 5.17(j)(iAcquiror Preamble Acquiror Disclosure Schedules Article V Affected Employees 6.7(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b4.6(a) Bank Financing 5.6(a) Bank Syndication Period 6.12(b) Bond Financing 6.12(a) Bridge Financing 5.6(a) Certificate of Merger 2.2(b) Certificates 3.2(c) Closing 2.2(a) Closing Date 2.2(a) COD Amendment 3.1(g) Commitment Letter 5.6(a)(i) Company Preamble Company Health Care Licenses 4.8(b) Company Stockholder Approval 4.2(a) Confidentiality Agreement 6.8 Consideration Certificate 3.1(h) CP Satisfaction Date 6.12(a) Current Transaction Expense Tax Benefit Amount 6.17(a) D&O Indemnified Liabilities 6.11(a) D&O Indemnified Parties 6.11(a) Deductible Transaction Expenses 6.17(a) DGCL Recitals Disclosure Schedules Article IV Dissenting Shares 3.1(e) Effective Time 2.2(b) Employee Plans 4.10(a) ERISA 4.10(a) Financial Statements 4.6(a) Financing 5.6(a)(i) Financing Period 6.12(b) Former Properties 4.16(a) Future Stockholder Benefit 6.17(b) Future Transaction Expense Tax Benefit 6.17(b) Health Care Licenses 4.8(b) HIPAA 4.17(a)(vi) HSR Act 4.3(b) Interim Financial Statements 4.6(a) Knowledge of Acquiror 5.3(b) Lenders 5.6(a)(i) Letter of Transmittal 3.2(c) Majority Holders 3.3(b) March 2007 Required Financial Information 6.13(c) Marketing Period 6.12(b) Material Contracts 4.17(a) Merger Recitals MergerCo Preamble Order 4.8(b) Outside Funding Date 6.12(b) Paying Agent 3.2(a) Payment Fund 3.2(a) Pre-Funding Condition 6.12(b) Rabbi Trust 4.10(g) Required Financial Information 6.13(d) Securities Act 6.13(a) September 2006 Required Financial Information 4.10(g) SERP 6.17(a) Short 2007 Tax Year 5.6(d) Solvency 5.6(d)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiStockholder Benefit 3.3(a) Buyer Expenses 8.4(cSurviving Corporation 2.1 Termination Date 8.1(c) Buyer Welfare Plans 5.7(eTermination Fee 8.2 Total Merger Payment 3.1(h) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR USRPHC 4.15 WARN Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.294.11(c)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cDefinition Location 338 Election 5.10(a) Acquiror Preamble Acquiror Indemnified Parties 7.2 Acquisition Proposal 5.17(j)(iEngagement 8.19(a) Affected Employees 5.3(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EApplicable Accounting Principles 2.11(a) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b3.6(a) Basket Amount 7.5(a)(ii) Cancelled Shares 2.6(d) Cap 7.5(a)(i) Certificate of Merger 2.2(b) Closing 2.2(a) Closing Cash 2.11(b) Closing Date 2.2(a) Closing Indebtedness 2.11(b) Closing Net Working Capital 2.11(b) Closing Transaction Expenses 2.11(b) Company Preamble Company Patents 3.14(a) Company Registered Copyrights 3.14(a) Company Registered IP 3.14(a) Company Registered Marks 3.14(a) Company Stockholder Approval 3.2(a) Confidential Information 5.9(b) Confidentiality Agreement 5.4 Copyrights 1.1 Covenant Date 5.3(a) D&O Indemnified Liabilities 5.6(a) D&O Indemnified Parties 5.6(a) Data Breach 3.23 DGCL Recitals Direct Claim Notice 7.4(c) Disclosure Schedules Article III Dissenting Shares 2.7 Effective Time 2.2(b) Electing Employee 5.8(a) Election Period 5.8(a) Employee Plans 3.10(a) Environmental Laws 3.16(c)(i) Environmental Permits 3.16(c)(ii)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiEstimated Cash 2.11
(a) Buyer Estimated Indebtedness 2.11(a) Estimated Net Working Capital 2.11(a) Estimated Transaction Expenses 8.4(c2.11(a) Buyer Welfare Plans 5.7(eDefinition Location Final Closing Statement 2.11(b)
(a) CERCLA 3.17(d)(iiFundamental Representations 7.1(a) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bXxxxxx Xxxx 8.19(a) Indemnified Party 7.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a2.11(d) Initial Allocation 2.1 Interim Financial Statements 3.5(a3.6(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hLeases 3.13(b) Losses 7.2 Majority Holders 2.13(c) Marks 1.1 Material Contracts 3.17(a) Merger Recitals Merger Sub Preamble Net Adjustment Amount 2.11(g)(i) Notes 1.1 Notice Period 5.17(d)(i)(Dof Claim 7.4(a) Outside Date 8.1(b)(iNotice of Disagreement 2.11(c) Patents 1.1 Personal Payoff Letter 6.2(e) Permits 3.8(b) Potential Contributor 7.6 Preliminary Closing Statement 2.11(a) Protected Information 3.26(a3.23 RSUs 5.8(a) Post-Closing Claims 5.13(aSample Statement 2.11(a) Pre-Closing Contract Liabilities 2.4(fStockholder 2.9 Stockholder Indemnified Parties 7.3 Stockholder Representative 2.13(a) Privacy Laws 3.26(aSurviving Corporation 2.1 Termination Agreements 6.2(f) Proxy Statement 3.29Third Party Claim 7.4(a) Trade Secrets 1.1 Transfer Taxes 5.7 WARN Act 3.11(f)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(iDefinition Location Adjusted Variable Future Purchase Price 5.12(h) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EArbitrator 10.9(a) Alternative Financing 5.21(bBalance Sheets 3.8(b) Applicable Date 3.6(dBrand Transferee 5.12(b)(ii)b. Business 5.4(a)(i) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiBuyer’s Policy 7.2(e) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(iiCap Amounts 7.2(a) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 2.2(a) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(iCompany Preamble Company Group Employees 5.4(a)(ii) Confidential Information 5.8(bCompany IP 3.16(e) Company Registered IP 3.16(e) Confidentiality Agreement 5.7 Copyrights 1.1 Definition Location Country 5.12(b)(ii)b. Covered Parties 7.1 Customer 5.3(a)(iii5.4(a)(iii) Debt Financing 5.21(aDeductible 7.2(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Delivered Variable Purchase Price 5.12(f) Designated Lender 2.1(b) Dispute Notice 5.17(d)(i)(D7.4(b) DGCL 4.6 Direct Claim 7.4(cDisputed Matters 5.12(f) Effect 1.1 Disputing Parties 10.9(a) Disputing Party 10.9(a) EBITDA 5.12(c) Environmental Laws 3.17(d)(i3.18(e)(i) Environmental Permits 3.18(e)(ii) Equity Financing 5.21(aInterests Recitals Escrow 6.3(k) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cFinal Variable Purchase Price 5.12(f) Excluded Liabilities 2.4 Existing Stock 5.14(bFinal Variable Purchase Price Payment Date 5.12(f) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a3.8(a) Financing 5.21(aFixed Future Purchase Price 5.12(b)(i) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(aFunding Date 2.1(b) Group Health Plan 5.7(dFuture Closing Date 5.12(b) Future Dispute Notice 5.12(f) Future Purchase 5.12(b) Future Purchase Price 5.12(b) Hazardous Substances 3.17(d)(ii3.18(e)(iii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(aICC 10.9(a) Independent Accounting Firm 2.8(a5.12(f) Initial Allocation 2.1 Interim Financial Statements 3.5(aLoan Agreement 2.1(b) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hLoan Amount 2.1(b) Losses 7.2 7.1 Marks 1.1 1.1
(a) Minority Shareholders 3.7(a) Notice Period 5.17(d)(i)(D5.12(f) Outside Date 8.1(b)(iOffset Amount 7.2(f) Options 3.7(a) Other Shares Recitals Palladium Preamble Palladium Intellectual Property 5.13 Patents 1.1 Personal Information 3.26(aPermits 3.11(b) Post-Closing Permitted Encumbrances 3.14(a) Plans 3.13(a) Purchase Price 2.1(a) Definition Location Release 3.18(e)(iv) Released Claims 5.13(a5.6 Released Parties 5.6 Releasing Parties 5.6 Representatives 5.2 Restructure Subs 3.7(a) Pre-Closing Contract Liabilities 2.4(fRestructuring 3.7(a) Privacy Laws 3.26(aSecond Notice 5.12(h) Proxy Statement 3.29Seller Preamble Shares Recitals Third Party Transferee 5.13(c) Trade Secrets 1.1 Variable Future Purchase Price 5.12(b)(ii)
Appears in 1 contract
Samples: Share Purchase and Shareholders’ Rights Agreement (K Swiss Inc)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c401(k) Acquisition Proposal 5.17(j)(iPlan 7.3(j) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Accounting Principles 1.1 Balance Sheet 3.6(b3.7(b) Basket 8.5(b) Business 5.4(a)(i) Buyer Preamble Claim Notice 8.4(a) Closing 2.2(a) Closing Cash 2.4(a) Closing Date 2.2(a) Closing Deferred Revenue 2.4(a) Closing Indebtedness 2.4(a) Closing Net Working Capital 2.4(a) Closing Transaction Expenses 2.4(a) Code 3.11(b) Common Stock Recitals Company Recitals Company Group Employees 5.4(a)(ii) Company Registered Intellectual Property Rights 3.15(a) Company Source Code 3.15(s) Company Unregistered Intellectual Property Rights 3.15(c) Confidential Information 5.8(b) Confidentiality Agreement 5.8(a) Consultants 3.12(f) Consulting Agreements Recitals Contest 6.6(a) Contingent Issuance 5.15 Contribution Recitals Conversion Recitals Customer 5.4(a)(iii) Data Protection Laws 3.21(a) Debt Payoff Letter 7.3(h) Direct Claim 8.4(c) Disclosure Schedules Article III ERISA 3.11(a)(i) Estimated Cash 2.3 Estimated Deferred Revenue 2.3 Estimated Indebtedness 2.3 Estimated Net Working Capital 2.3 Estimated Transaction Expenses 2.3 Excess Amount 8.7(b) Exchange Act 4.7(a) Final Closing Statement 2.4(a) Financial Statements 3.7(a)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiFundamental Representations 8.1(a)(i) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bGeneral Cap 8.5(b) Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(a2.4(c) Initial Allocation 2.1 Interim Financial Statements 3.5(a3.7(a) Intervening Event 5.17(j)(iiiIRS 3.11(b) Intervening Event Change of Recommendation 5.17(d)(iiIssuance 2.7(b) Licensed Excluded IP 3.13(hIssuance Limit 2.7(a) Losses 7.2 Marks 1.1 8.2 Material Contracts 3.18(a) Membership Interests Recitals Net Adjustment Amount 2.4(f)(i) Notice Period 5.17(d)(i)(Dof Disagreement 2.4(b) Outside Date 8.1(b)(i9.1(d) Patents 1.1 Owner, Owners Preamble Parent Preamble Parent SEC Documents 4.7(a) Payoff Indebtedness 2.2(b)(iii) Permits 3.9(b) Permitted Encumbrances 3.13(a) Personal Information 3.26(a3.21(a) PostPhantom Plan 5.15 Phantom Plan Participants 5.15 Plans 3.11(a)(ii) Preliminary Closing Balance Sheet 2.3 Privileged Communications 10.19 PTO 3.15(a) Purchase Price Allocation 6.8 Restricted Period 5.4(a) Securities Act 4.6 Seller Preamble Seller Party, Seller Parties Preamble Set-Closing Claims 5.13(aoff Amount 8.9 Set-off Notice 8.9 Shares Recitals Spinoff Recitals Tax Consideration 6.8 Territory 5.4(a)(i) Pre-Closing Contract Liabilities 2.4(fThird Party Claim 8.4(a) Privacy Laws 3.26(aTransaction Expenses Payoff Instructions 7.3(i) Proxy Statement 3.29Valid Business Reason 5.12(c) Waiving Parties 10.19 WARN Act 3.12(l)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(iEngagement Section 11.19(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAllocation Section 7.2(a) Alternative Financing 5.21(bRecovery Section 9.7(a) Ancillary Business Employees Section 6.15(a) Applicable Date 3.6(dAccounting Principles Section 2.4(a) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(aDate Section 4.5 Basket Section 9.2(c) Books and Records Section 4.23 Business Recitals Employees Section 6.15(a) Buyer Preamble Buyer Employees 5.3(a)(iiIndemnified Parties Section 9.2(a) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(iiPlan Section 6.15(d) Claim Section 9.3 Claim Notice 7.4(aSection 9.3 Closing Section 2.3(a) Closing 2.6 Closing Balance Sheet 2.7 Cash Section 2.4(b) Closing Date 2.6 Section 2.3(a) Closing Indebtedness Section 2.4(b) Closing Net Working Capital Section 2.4(b) Closing Transaction Expenses Section 2.4(b) COBRA 5.7(dSection 4.9(g) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Company Recitals Confidentiality Agreement Section 6.7 Direct Claim 7.4(cSection 9.5 Disclosure Schedules Article III EESI Section 6.15(a) Effect 1.1 Employee Plan Section 4.9(a) Environmental Laws 3.17(d)(iSection 4.15(j)(i) Equity Financing 5.21(aEnvironmental Permits Section 4.15(j)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cERISA Section 4.9(a) Excluded Liabilities 2.4 Existing Stock 5.14(bERISA Affiliate Section 4.9(a) Fairness Opinion 3.2(bEstimated Cash Section 2.4(a) FDA 1.1 Estimated Indebtedness Section 2.4(a) Estimated Net Working Capital Section 2.4(a) Estimated Transaction Expenses Section 2.4(a) Final Closing Statement Section 2.4(b) Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(dSection 4.5 General Survival Date Section 9.1 Xxxxxx Xxxx Section 11.19(a) Hazardous Substances 3.17(d)(iiMaterials Section 4.15(j)(iii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act Section 3.3(b) Indemnified Party 7.4(a) Indemnifying Party 7.4(aParties Section 9.2(b) Independent Accounting Firm 2.8(aSection 2.4(d) Initial Allocation 2.1 Interim Financial Statements 3.5(aIRS Section 4.9(a) Intervening Event 5.17(j)(iiiJoint Instruction Section 2.2(a) Intervening Event Change Key Customers Section 4.18 Key Employee Offers Section 6.15(b) Key Employees Section 6.15 Material Contracts Section 4.16(a) Material Insurance Policies Section 4.11 Net Adjustment Amount Section 2.4(g)(i) Notice of Recommendation 5.17(d)(iiDisagreement Section 2.4(c) Licensed Excluded IP 3.13(hParent Guarantee Section 2.3(b)(vi) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DPermits Section 4.8(b) Outside Date 8.1(b)(iPipeline Sale Agreement Section 2.3(b)(vii) Patents 1.1 Personal Information 3.26(aPreliminary Closing Statement Section 2.4(a) Post-Closing Claims 5.13(aPurchased Interests Recitals Qualified Beneficiaries Section 6.15(e) Real Property Section 4.12(a) Release Section 4.15(j)(iv) Required Easements Section 4.12(c) Sample Statement Section 2.4(a) Securities Act Section 5.6 Seller Preamble Seller Indemnified Parties Section 9.2(b) Seller Management Co Section 6.15(a) Seller Taxes Section 9.2(a)(iii) SemGroup Section 4.12(g) Xxxxxxx Energy Section 3.5 Surviving Pre-Closing Contract Liabilities 2.4(fCovenants Section 9.1 Tax Representations Section 9.1 Termination Date Section 10.1(d) Privacy Laws 3.26(aThird-Person Claim Section 9.3 Transferred Employee Section 6.15(a) Proxy Statement 3.29Warranty Breach Section 9.2(a)(i)
Appears in 1 contract
Samples: Membership Interest Purchase Agreement (Blueknight Energy Partners, L.P.)
Table of Definitions. The following terms have the meanings set forth in the Sections sections referenced below: 510(k)s 3.27(c2011 Financial Statements 4.7(a) 2012 Financial Statements 4.7(a) 2013 Financial Statements 4.7(a) 2014 Financial Statements 4.7(a) 2015 Financial Statements 4.7(a) Access Letter 11.7 Acquisition Proposal 5.17(j)(iEngagement 11.17(a) Additional Deposit 2.1 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAncillary Document 10.1 Asset Level Claims 10.2(b) Alternative Financing 5.21(bAsset Level Deductible 10.2(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a4.7(a) Business Recitals Balance Sheet Date 4.7(a) Buyer Preamble Buyer Employees 5.3(a)(iiParties 11.1(b) Buyer Expenses 8.4(cCasualty 9.4(a) Buyer Welfare Plans 5.7(eCasualty Dispute Notice 9.4(b) CERCLA 3.17(d)(iiCasualty Election Date 9.4(d) Claim Notice 7.4(a10.3(b) Closing 2.6 Closing Balance Sheet 2.7 2.5(a) Closing Date 2.6 COBRA 5.7(d2.5(a) Code Commitment Objections 6.5(b) Common Shares Recitals Company Preamble Company Properties 4.8 Company Property 4.8 Condemnation Election Date 9.5(c) Damages 10.2(a) Deposit 2.1 Disclosed Survey Items 1.1 Competing Business 5.3(a)(iDisclosure Schedules Article III Entity Deductible 10.2(c) Confidential Information 5.8(bEntity Level Claims 10.2(c) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i4.16(c)(i) Equity Financing 5.21(aEnvironmental Permits 4.16(c)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Escrow Agent Preamble Escrow Service Charge 6.12 Estoppel Certificate 6.14 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(aDebt Extinguishment 2.2(b) Financing 5.21(a2.2(a) Financing Commitments 4.4 Finished Goods Inventory Xxxxx Xxxxx 11.17(a) Holdback 10.4(f) Holdback Claim Amount 2.8(a10.4(f) Group Health Plan 5.7(dHoldback Period 10.4(f) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bIndemnification Payment 10.4(c) Indemnified Party 7.4(a) 10.1 Indemnifying Party 7.4(a10.1 Initial Deposit 2.1 Integrated Plan 2.6 Monetary Seller Exception Cap 6.5(e) Independent Accounting Firm 2.8(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(aOutstanding Common Shares Recitals Permits 4.11(b) Post-Closing Covenants 10.1 Pre-Closing Claims 5.13(a10.2(a) Pre-Closing Contract Liabilities 2.4(fDeductible 10.2(c) Privacy Laws 3.26(aPreferred Shares 4.5(a) Proxy Statement 3.29prorations 2.5 Reconciliation Period 2.5 Refinancing 2.2(b) Report 6.5(a) Securities Act 5.5 Seller Preamble Seller Exceptions 6.5(e) Seller Parties 11.1(a) Seller Party Transaction Counsels 11.17(a) Share Acquisition 2.3 Share Redemption 2.4 Significant Casualty 9.4(a)(i) Significant Taking 9.5(a)(i) SNDA 6.16 Surviving Provisions 9.2(a) Taking 9.5(a) Tax Certiorari Proceeding 9.6(a) Tax Claims 10.2(c) Tax Deductible 10.2(c) Tax Matters 7.6 Third Party Claim 10.3(a) Title Company 6.5(a) Title Cure Period 6.5(d) Title Objections 6.5(c) Title Policy 6.5(a) Update Exception 6.5(c) Update Objection Deadline 6.5(c) Update Objections 6.5(c) Updated Rent Rolls 4.9(e) Valid Claim Notice 10.3(b) Violations 6.5(f)
Appears in 1 contract
Samples: Share Purchase Agreement (NorthStar Real Estate Income II, Inc.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(iAccounting Firm 5.8(e) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a3.5(a) Balance Sheet Date 3.5(a) Binder 5.15 Books and Records 2.1(i) Business Recitals Domain Names 3.13(a) Business Intellectual Property 2.1(d) Business Patents 3.13(a) Business Permits 2.1(h) Business Registered Copyrights 3.13(a) Business Registered IP 3.13(a) Business Registered Marks 3.13(a) Buyer Preamble Buyer Employees 5.3(a)(ii) Indemnified Parties 8.2 Buyer Expenses 8.4(cParent Recitals Buyer Savings Plan 5.6(d) Buyer Welfare Benefit Plans 5.7(e5.6(e)(i) CERCLA 3.17(d)(iiCap 8.5(a)(i) Claim Notice 7.4(aCBAs 3.16(a)(v) Classified Ventures Business 2.2(j) Closing 2.6 Date 2.7(a) Closing Balance Sheet 2.7 Net Working Capital 2.9(a) Closing Date 2.6 Statement 2.9(a) COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(iObligations 5.6(e)(ii) Confidential Information 5.8(b5.7(b) Confidentiality Agreement 5.7(a) Contracts 2.1(b) Copyrights 1.1 Customer 5.3(a)(iiiCurrent Assets 1.1 Current Liabilities 1.1 Deductible Amount 8.5(a)(ii) Debt Financing 5.21(aDisclosure Schedules Article III Domain Names 1.1 Employment Laws 3.10 (b) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Insurance Policy 5.15 Environmental Laws 3.17(d)(i3.15(c)(i) Equity Financing 5.21(aEnvironmental Permits 3.15(c)(ii) Equity Financing Commitment 4.4 ERM 5.18 ERM Phase I Investigation 5.18 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cEmployees 5.6(a) Excluded Liabilities 2.4 Existing Stock 5.14(bExcluded Real Property 2.2(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(aFundamental Representations 8.1 Guarantees 5.9 Hazardous Materials 3.15(c)(iii) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b) Hydraulic Lift Remedial Actions 5.18 Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(a2.9(c) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iiiInventory 2.1(g) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hLeased Real Property 2.1(c) Losses 7.2 8.2 Marks 1.1 Material Contracts 3.16(a) Minimum Loss Amount 8.5(a)(ii) Net Adjustment Amount 2.9(d)(i) Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(iof Disagreement 2.9(b) Patents 1.1 Personal Information 3.26(aPermits 3.7(b) Post-Closing Claims 5.13(a) Tax Period 6.1 Potential Contributor 8.6 Pre-Closing Contract Liabilities 2.4(fTax Period 6.1 Preliminary Closing Statement 2.8(a) Privacy Laws 3.26(aPreliminary Net Working Capital 2.8(a) Proxy Statement 3.29Price Allocation 2.10(a) Publications 2.1(l) Real Property 2.1(c) Receivables 2.1(e) Schedule Supplement 5.3 Seller Preamble Seller Indemnified Parties 8.3 Seller Savings Plan 5.6(d) Tangible Personal Property 2.1(f) Tax Representations 8.1 Termination Date 9.1(c) Third Party Claim 8.4(a) Title Policy 7.3(d) Transferred Assets 2.1 Transferred Employees 5.6(a) Wanderful Media Business 2.2(j) WARN Act 5.6(h)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Definition Location Acquisition Proposal 5.17(j)(i) 5.3 Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAssumed Restricted Common Stock 2.7(b) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b) Balance Sheet Date 3.6(b) Cancelled Shares 2.7(e) Certificate of Merger 2.2(b) Certificates 2.9(b) Claim Notice 8.1(c) Definition Location Closing 2.2(a) Closing Cash 2.13(a) Closing Date 2.2(a) Closing Indebtedness 2.13(a) Closing Net Working Capital 2.13(a) Closing Transaction Expenses 2.13(a) Company Preamble Company Registered IP 3.14(e) Company Stock Plans 2.7(b)(i) Company Tax Return 3.15(q) Confidentiality Agreement 5.8(a) Consideration Spreadsheet 2.11(a) Continuing Employees 5.12 Xxxxxx 10.20 Debt Payoff Letter 7.3(e) DGCL Recitals Direct Claim 8.4(c) Disclosure Schedules Article III Dissenting Shares 2.8 Effective Time 2.2(b) Effective Time Holder Indemnified Parties 8.3 Employee Offer Letters Recitals ERISA 3.10(a)(i) Escrow Cap 8.5(a)(i) Estimated Cash 2.12 Estimated Indebtedness 2.12 Estimated Net Working Capital 2.12 Estimated Transaction Expenses 2.12 Exchange Agent 2.9(a) Final Closing Statement 2.13(a)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(iiFundamental Representations 8.1(a)(i) Buyer Expenses 8.4(cHolder Representative 2.15(a) Buyer Welfare Plans 5.7(eHolder Representative Amount 2.15(b) CERCLA 3.17(d)(ii) Claim Notice 7.4(a) Closing 2.6 Closing Balance Sheet 2.7 Closing Date 2.6 COBRA 5.7(d) Code 1.1 Competing Business 5.3(a)(i) Confidential Information 5.8(b) Copyrights 1.1 Customer 5.3(a)(iii) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i) Equity Financing 5.21(a) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bHolder Representative Fund 2.15(b) Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(a2.13(c) Initial Allocation 2.1 Information Statement 5.4(a) Infringement Claim 5.5(b) Interim Financial Statements 3.5(a3.6(a) Intervening Event 5.17(j)(iiiIP Assignment 5.5(b) Intervening Event Change IRS 3.10(b) IT 5.2(b) Joinder Agreements Recitals Definition Location Key Employees Recitals Letter of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(hTransmittal 2.9(b) Losses 7.2 Marks 1.1 8.2 Majority Holders 2.15(c) Material Contracts 3.17(a) Merger Recitals Merger Sub Preamble Multiemployer Plan 3.10(c) Multiple Employer Plan 3.10(c) Net Adjustment Amount 2.13(f)(i) Non-Competition Agreements Recitals Notice Period 5.17(d)(i)(Dof Disagreement 2.13(b) Outside Offered Employees 5.12 Option Consideration 2.9(a) Option Grant Date 8.1(b)(i3.4(e) Patents 1.1 Parent Preamble Parent Indemnified Parties 8.2 Parent Plan 5.12 Parent Prepared Return 3.15(p) Permits 3.8(b)
(a) Personal Information 3.26(a3.20(a) Post-Closing Claims 5.13(aPlans 3.10(a)(iv) Pre-Closing Contract Liabilities 2.4(f) Tax Refund 6.6 Preliminary Closing Balance Sheet 2.12 Preliminary Closing Statement 2.12 Privacy Laws 3.26(a3.20(a) Proxy Statement 3.29Representative Losses 31 Requisite Effective Time Holders 5.4(b) Retained Privilege 10.20 Snapshot Time 5.15 Stockholder Consent Recitals Surviving Corporation 2.1(a) Tail Policy 5.14 Tax Claim 6.5 Termination Date 9.1(d) Transaction Expenses Payoff Instructions 7.3(f)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i5.3 Aggregate Option Consideration 2.9(a) Aggregate Share Consideration 2.7(a) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(E) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Accounting Principles 1.1 Balance Sheet 3.6(b)
(a) Business California Law Recitals Buyer Preamble Buyer Employees 5.3(a)(iiCancelled Shares 2.7(c) Buyer Expenses 8.4(cCertificate of Merger 2.2(b) Buyer Welfare Plans 5.7(eCertificates 2.10(b) CERCLA 3.17(d)(ii) Claim Notice 7.4(aCharter 1.1 Closing 2.2(a) Closing 2.6 Closing Balance Sheet 2.7 Cash 2.13(a) Closing Date 2.6 2.2(a) Closing Indebtedness 2.13(a) Closing Non-Cash Net Working Capital 2.13(a) Closing Transaction Expenses 2.13(a) COBRA 5.7(dCoverage 3.10(e) Code 1.1 Competing Business 5.3(a)(iCompany Preamble Company Holders Meeting 3.23 Company Indemnified Parties 5.14(a) Confidential Information 5.8(bCompany Indemnifying Parties 8.2 Confidentiality Agreement 5.10 Continuing Employees 5.9(c) Copyrights 1.1 Customer 5.3(a)(iiiConverted Restricted Share 2.9(d) Debt Financing 5.21(aPayoff Letter 7.3(e) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(DDelaware Law Recitals Disclosure Schedules Article III Dissenting Shares 2.8 Effective Time 2.2(b) DGCL 4.6 Direct Claim 7.4(cEmployee Plans 3.10(a) Effect 1.1 Environmental Laws 3.17(d)(i3.16(c) Equity Financing 5.21(aEnvironmental Permits 3.16(c) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cEPCRS 3.10(c) Excluded Liabilities 2.4 Existing Stock 5.14(bERISA 3.10(a) Fairness Opinion 3.2(bERISA Affiliates 3.10(a) FDA 1.1 Estimated Cash 2.12 Estimated Indebtedness 2.12 Estimated Non-Cash Net Working Capital 2.12 Estimated Transaction Expenses 2.12 Final Closing Statement 2.13(a) Financial Statements 3.5(a3.6(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(d) Fundamental Representations 8.1 Hazardous Substances 3.17(d)(ii3.16(c) Health Care Permits 3.27(cHolder Indemnified Parties 5.16(a) HIPAA 1.1 Holders Recitals HSR Act 3.3(b) Indemnified Party 7.4(a8.4(a) Indemnifying Party 7.4(a8.4(a) Independent Accounting Firm 2.8(a2.13(c) Initial Allocation 2.1 Information Statement 3.23 Infringe 3.14(f) Interim Financial Statements 3.5(a3.6(a) Intervening Event 5.17(j)(iiiInternational Employee Plan 3.10(a) Intervening Event Change of Recommendation 5.17(d)(iiInternational Employee Plan Beneficiary 3.10(a) Licensed Excluded IP 3.13(hInternational Pension Plan 3.10(l) International Transferred Assets Recitals International Transferred Shares Recitals IRS 3.10(a) Issuer Indemnified Parties 5.16(b) Losses 7.2 Marks 1.1 8.2 Majority Holders 2.15(a) Material Contracts 3.17(a) Merger Recitals Merger Sub Preamble Net Adjustment Amount 2.13(f) Notice Period 5.17(d)(i)(Dof Disagreement 2.13(b) Outside Date 8.1(b)(iOpen Source License 3.14(h) Patents 1.1 Option Consideration 2.9(a) Optionholder 2.9(a) Parent Preamble Parent Indemnified Party 8.5(b) Paying and Exchange Agent 2.10(a) Permits 3.8(b) Personal Information 3.26(a3.21(a) Post-Preferred Stockholder Written Consent Recitals Preferred Stockholders Recitals Preliminary Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Statement 2.12 Privacy Laws 3.26(a3.21(a) Proxy Representative Losses 2.15(c) Resale Registration Statement 3.295.15 Retirement Benefits 3.10(l) Sample Statement 1.1 SEC 4.5 SEC Filings 4.5 Securities Act 3.24(a) Securityholder Representative 2.15(a) Share Consideration 2.7(a) Shares 2.7 Stockholder Written Consent Recitals Stockholders Recitals Surviving Corporation 2.1 Tail Policy 5.14(b) Third Party Claim 8.4(a) Title IV Plan 3.10(d) Transaction Expenses Payoff Instructions 7.3(f) Transfer Taxes 6.1 Vested UK Options 2.9(g) WARN 3.11(d) Warrant Consideration 2.9(h) Written Consents Recitals
Appears in 1 contract
Samples: Merger Agreement (AOL Inc.)
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(cA&R Stockholder Agreement Recitals Acquiror Preamble Acquiror Indemnified Parties 5.2 Acquiror Preferred Stock 4.4(a) Acquisition Proposal 5.17(j)(iAcquiror SEC Documents 4.5(a) Acquiror Series B Preferred Stock Recitals Acquiror-Owned Shares 2.7(b) Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EApplicable Accounting Principles 2.13(a) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Business Recitals Buyer Preamble Buyer Employees 5.3(a)(ii) Buyer Expenses 8.4(c) Buyer Welfare Plans 5.7(eCancelled Shares 2.7(c) CERCLA 3.17(d)(ii3.16(f)(iii) Certificate of Designation Recitals Certificate of Merger 2.2(b) Claim Notice 7.4(a5.4(a) Closing 2.6 2.2(a) Closing Balance Sheet 2.7 2.13(a) Closing Date 2.6 COBRA 5.7(d2.2(a) Closing Indebtedness 2.13(a) Closing Net Working Capital 2.13(a) Code 1.1 Competing Business 5.3(a)(i3.10(b) Confidential Information 5.8(bCommon Merger Consideration 2.7(a)(iii) Copyrights 1.1 Customer 5.3(a)(iiiCompany Preamble Company Common Stock Recitals Company Optionholder 2.9 Company Registered IP 3.14(e) Debt Financing 5.21(a) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) Company Series A Preferred Stock Recitals Company Series B Preferred Stock Recitals Company Stockholder 2.7 DGCL 4.6 Recitals Direct Claim 7.4(c5.4(c) Effect 1.1 Disclosure Schedule Article III Dissenting Shares 2.8 Effective Time 2.2(b) Environmental Laws 3.17(d)(i3.16(f)(i) Equity Financing 5.21(aEnvironmental Permits 3.16(f)(ii) Equity Financing Commitment 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(cERISA 3.10(a)(i) Excluded Liabilities 2.4 Existing Stock 5.14(bFinal Closing Statement 2.13(a)
(a) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(dFundamental Representations 5.1(a)(i) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(b3.16(f)(iii) Indemnified Party 7.4(a5.4(a) Indemnifying Party 7.4(a5.4(a) Independent Accounting Firm 2.8(a2.13(c) Initial Allocation 2.1 Interim Financial Statements 3.5(a3.6(a) Intervening Event 5.17(j)(iiiIRS 3.10(b) Intervening Event Change Letter of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(D) Outside Date 8.1(b)(i) Patents 1.1 Personal Information 3.26(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.29Transmittal 2.10(a)
Appears in 1 contract
Table of Definitions. The following terms have the meanings set forth in the Sections referenced below: 510(k)s 3.27(c) Acquisition Proposal 5.17(j)(i) Acquired Companies Preamble Agreement Preamble Alternative Acquisition Agreement 5.17(a)(ii)(EAlternate Recovery 9.5(b) Alternative Financing 5.21(b) Applicable Date 3.6(d) Assumed Liabilities 2.3 Balance Sheet 3.6(b)
(a) Business Recitals ASM Common Share 1.1 ASM Parent Preamble ASM Warrant 1.1 Buyer 1 Preamble Buyer Employees 5.3(a)(ii2 Preamble Buyer Indemnified Parties 9.2 Buyer Parties Preamble Buyer Party Fundamental Representations 8.1(a) Buyer Expenses 8.4(cC Seller Preamble Cap 9.5(a)(i) Buyer Welfare Plans 5.7(e) CERCLA 3.17(d)(ii) Cash Certificate 2.3 Xxxxxxxxx Preamble Xxxxxxxxx Interests Recitals Claim Notice 7.4(aInformation 9.4(a) Closing 2.6 Closing Balance Sheet 2.7 2.2(a) Closing Date 2.6 COBRA 5.7(d2.2(a) Code 1.1 Competing Business 5.3(a)(iCLPS Preamble Coeur Mining Preamble Company Disclosure Schedules Article III Company Material Contracts 4.11(a) Confidential Information 5.8(bCompany/Seller Fundamental Representations 8.2(a) Copyrights 1.1 Customer 5.3(a)(iiiConfidentiality Agreement 6.6 Contingent Payment Amount 2.4 Contracts 4.11(a) Debt Financing 5.21(aDeductible Amount 9.5(a)(iii) Debt Financing Commitments 4.4 Debt Financing Source 4.4 Determination Notice 5.17(d)(i)(D) DGCL 4.6 Direct Claim 7.4(c) Effect 1.1 Environmental Laws 3.17(d)(i4.10(f)(i) Equity Financing 5.21(aEnvironmental Permits 4.10(f)(ii) Equity Financing Commitment FCPA 4.6(c) Fixed Capital Shares 4.4 Excluded Assets 2.2 Excluded Intellectual Property 2.2(c) Excluded Liabilities 2.4 Existing Stock 5.14(b) Fairness Opinion 3.2(b) FDA 1.1 Financial Statements 3.5(a) Financing 5.21(a) Financing Commitments 4.4 Finished Goods Inventory Amount 2.8(a) Group Health Plan 5.7(dGovernance Agreement 2.2(b)(xiv) Hazardous Substances 3.17(d)(ii) Health Care Permits 3.27(c) HIPAA 1.1 HSR Act 3.3(bMaterials 4.10(f)(iii) Indemnified Party 7.4(a9.4(a) Indemnifying Party 7.4(a) Independent Accounting Firm 2.8(a9.4(a) Initial Allocation 2.1 Interim Financial Statements 3.5(a) Intervening Event 5.17(j)(iii) Intervening Event Change of Recommendation 5.17(d)(ii) Licensed Excluded IP 3.13(h) Losses 7.2 Marks 1.1 Notice Period 5.17(d)(i)(DProduction Milestone 2.4 Issuance Cap 2.4 La Preciosa Preamble LP Sellers Preamble Minimum Loss Amount 9.5(a)(iii) Outside Date 8.1(b)(i10.1(c) Patents Permits 4.6(b) Potential Contributor 9.6 Preciosa Shares Recitals Purchase Price Allocation 7.5 Registration Rights Agreement 2.2(b)(xii) Release 4.10(f)(iv) Securities Act 5.10 Seller Indemnified Parties 9.3 Sellers Preamble Tax Authority 1.1 Personal Information 3.26(aTax Consideration 7.5 Third Party Claim 9.4(a) Post-Closing Claims 5.13(a) Pre-Closing Contract Liabilities 2.4(f) Privacy Laws 3.26(a) Proxy Statement 3.29Transfer Taxes 7.3 Variable Capital Shares 2.4
Appears in 1 contract
Samples: Share Purchase Agreement (Avino Silver & Gold Mines LTD)